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ABSTRACT 
 
 Myocardial ischemia-reperfusion injury occurs following the majority of cardiac 
events including myocardial stenosis and heart surgeries. As reactive oxygen species are one 
of the major contributors to ischemia-reperfusion injury, strategies to prevent their effects 
may be directed towards enhancing the antioxidant capacity of cells. Polyphenols, and in a 
more specific category, flavonoids are strong antioxidants, while possessing other biological 
activities such as anti-apoptotic, anti-inflammatory, and vasodilatory effects.  
I hypothesized that flavonoids are able to reduce ischemia-reperfusion-induced cell 
death through multiple mechanisms including reduction of oxidative stress and induction of 
cellular antioxidant enzymes. The hypothesis was tested in in vitro and in vivo phases. 
In the first phase of the studies, rat embryonic ventricular H9c2 cells were treated with 
various concentrations of polyphenols with or without ascorbate for 1-3 days before 
induction of ischemia and reperfusion. Ischemia was induced by exposure of the cells to a 
non-glucose containing solution bubbled with nitrogen, and reperfusion by returning the 
regular medium containing the corresponding polyphenols and/or ascorbate. Cell viability 
measurements using the MTT assay or counting acridine orange-stained cells showed that 
the best protection against cell death was given by catechin (44-58 %), epigallocatechin 
gallate (48%), proanthocyanidins (44%), and ascorbic acid (57-92%). A low concentration 
(10 µM) of catechin was more effective with a long-term (2 days) incubation time (64%), 
while a higher concentration (50 µM) could exert benefit even after 1 h pre-treatment (98%). 
Quercetin, resveratrol, cyanidin, and delphinidin displayed almost no protection.  
In the second part of the in vitro study, H9c2 cells were treated with 350 to 450 µM 
tert-butyl hydroperoxide for 24 h after pre-incubation with various concentrations of 
polyphenols with or without ascorbate for either short (1 h) or prolonged (3 days) periods. 
Unlike in the ischemia-reperfusion experiments, 3 days pre-treatment with polyphenols did 
not protect and often caused cytotoxicity. In short-term (1 h) pre-treatments, the best 
protection was obtained with 50 µM quercetin (95%), 50 µM epigallocatechin gallate 
(66%), and 100 µM catechin (28%). Pre-treatment with ascorbic acid (100 µM) with or 
without polyphenols did not improve cell survival except in one case where it enhanced 
cytoprotection by epigallocatechin gallate. 
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The second phase of the studies was performed with isolated rat hearts. Rats were fed 
diets containing broccoli sprouts (2%), saskatoon berries (5%), or green tea extract (0.25%) 
for 10 days before induction of global ischemia for 20 min and reperfusion for 2 h. Broccoli 
sprouts decreased cell death in ischemic-reperfused hearts as assessed by caspase-3 activity 
(86%) and DNA fragmentation (78 %), attenuated oxidative damage as detected by lower 
thiobarbituric acid reactive substances (TBARS) (116%) and preserved aconitase activity 
(82%). Green tea extract prevented apoptosis in hearts as detected by caspase-3 activity 
(85%), but did not inhibit DNA fragmentation. Berries showed lower TBARS (73%). None 
of the feedings significantly prevented necrosis as evaluated by the release of lactate 
dehydrogenase into the coronary effluents, improved coronary flow, or increased heart 
glutathione. 
Green tea extract was the only intervention capable of preserving the activity of 
glutamate cysteine ligase (78%) and quinone reductase (147%) in hearts. The sprouts group 
was the only group which induced these same enzymes in liver (40 and 44 %, respectively), 
as it was the only intervention which elevated total liver glutathione (12%). None of the 
interventions changed heme oxygenase-1 protein levels. Assessment of total polyphenol 
content revealed that broccoli sprouts had the lowest and green tea extract had the highest 
amount of polyphenols among the three plant materials, suggesting that the protection 
exhibited by broccoli sprouts was unlikely to be due to the polyphenols.  
In conclusion, flavonoids and flavonoid-rich foods can strengthen the cellular ability 
to fight against oxidative stress. A part of this effect could be due to their direct antioxidant 
activity, while in prolonged applications they may also activate cellular pathways to promote 
endogenous antioxidant defences of cells. Application of low doses of flavonoids and 
consumption of flavonoid-rich plants in long-term ensures their effectiveness while avoiding 
possible toxicity. However, plants such as broccoli sprouts may have other chemical 
ingredients bearing biological properties which may help cells to survive states of oxidative 
stress.  
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CHAPTER 1 
 
 INTRODUCTION 
 
 
1.1. Rationale 
 
According to the World Health Report of the World Health Organization (WHO) 
2003, cardiovascular diseases including coronary (ischemic) heart disease, stroke, and 
hypertension are the leading cause of death worldwide, making up to 29.2% of the total 
deaths in the world. Ischemic heart disease makes a contribution of 12.6%, still the highest 
culprit of death, among all cause mortalities. Heart disease was also the major cause of death 
in the U.S. in 2003 (U.S. National Vital Statistics Reports). In Canada, cardiovascular 
diseases including coronary heart disease, cerebrovascular disease, and raised blood pressure 
ranked first among the leading causes of death in 1997, making 36.8% of deaths in the 
country. However, heart diseases were the second major cause of death after cancer.  
Myocardial ischemia-reperfusion injury occurs following a number of medical 
situations including stenosis, angioplasty, and cardiac surgeries which in severe cases can 
result in serious heart morbidities. Heart failure is one of the aftermaths of ischemia-
reperfusion injury that in many cases a few years later terminates in death. Heart failure 
generally originates from death of myocardial cells due to pathological alterations resulting 
from ischemia and reperfusion. After death, leftovers of the dead cells are removed by 
phagocytes and neighbouring cells. Thereafter, as a part of the repairing process, 
myofibroblasts deposit collagen in the vacated area (Virag & Murry, 2003; Petrovic, 2004). 
Excessive synthesis of collagen can lead to thickening of the ventricular wall and ventricular 
remodeling (Heeneman et al., 2003). This reparative process, although advantageous in the 
short term as it prevents ventricular wall thinning and dilation, ultimately results in tissue 
stiffness, ventricular dysfunction and heart failure (Vinten-Johansen, 2007). In fact, the 
extent of ventricular remodeling reflects the size of infarction, which is one of the important 
determinants of the heart failure. Thus, limiting myocardial cell death is one of the strategies 
to attenuate post-ischemic injury and heart failure and to reduce the eventual mortality.  
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Ischemia preconditioning has been introduced as one the most powerful 
cardioprotective interventions against ischemia-reperfusion injury (Bolli, 2007). 
Preconditioning means enhancing the strength of the heart by a mild stress in order to better 
withstand a next-coming injurious insult. The mechanisms of preconditioning are not 
thoroughly understood, but it is postulated that alterations in gene expression and/or protein 
activity are involved. Preconditioning may be achieved by pharmacological and non-
pharmacological strategies. One of the pharmacological schemes for heart preconditioning is 
administration of flavonoids, a group of plant compounds whose cardioprotective properties 
have attracted attention. Numerous studies have succeeded to precondition the heart or 
cultured cardiomyocytes with various types of flavonoids (are reviewed below), and the 
outcomes have been promising. 
Flavonoids, which are a part of the more extended family of polyphenols, are well 
known for their antioxidant activities. They exert antioxidant effects by scavenging reactive 
oxygen species (ROS) (Jovanovic & Simic, 2000), chelating transition metals (Mandel et al., 
2006), and inhibiting enzymatic generation of ROS (Cos et al., 1998; Kim et al., 2004). 
Also, a part of the antioxidant activity of flavonoids is exerted through enhancement of 
phase 2 enzymes (Moon et al., 2006). Cardioprotective effects of flavonoids can also be 
attributed to their vasorelaxant (Zenebe et al., 2003), anti-inflammatory (Kim et al., 2004), 
and anti-platelet aggregation (Cos et al., 2004) characteristics.   
Our main goal was to evaluate the potential of flavonoids to precondition cardiac cells 
against ischemia-reperfusion injury. Explanations below will describe what our study is 
going to add to the literature. The study contained in vitro and in vivo/ex vivo experiments.  
 
1.1.1. In vitro studies  
 
Anti-apoptotic capacity of some flavonoids against a variety of insults especially 
oxidative stress has been indicated by many investigators (Watjen et al., 2005; Ruiz et al., 
2006; Mandel et al., 2005). However, the literature lacks information on whether some 
flavonoids are more protective than others. The availability of such knowledge to 
investigators helps to introduce more effective compounds for application in animal studies, 
although discovering the potential of a specific compound in inhibiting cell demise in vitro 
does not necessarily mean that it can show cardioprotection in animals and particularly 
humans. The initial intention was to do a comparison between anti-apoptotic effects of a 
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relatively extensive variety of flavonoids in ischemic-reperfused cardiomyocytes. However, 
later when the model of ischemia-reperfusion on the cardiomyocytes produced inconsistent 
results, the experiments were continued with hydroperoxides and the anti-apoptotic effect of 
the same flavonoids was tested in cardiomyocytes subjected to hydroperoxides.  
 
1.1.2. Ex vivo studies  
 
During the past 3 decades, enormous attempts have been made in experimental 
settings especially animal studies examining hundreds of pharmacological and non-
pharmacological interventions to prevent or at least attenuate myocardial ischemia-
reperfusion injury (Bolli et al., 2004). However, none of these interventions has been 
accepted as a standard treatment in clinical practice. One of the substantial reasons for this 
failure in translation of laboratory-effective interventions into standard medical procedures 
is the time of application. In clinical studies the interventions are mainly applied late in the 
ischemia or early in the reperfusion, whereas in experimental studies the interventions are 
administered prior to the ischemia. This disconnect between research and practical contexts 
arises from the unpredictable essence of some cases of myocardial ischemia-reperfusion 
injury. The unpredictable nature poses the necessity of interventions that can be 
recommended to high-risk but otherwise normal populations without exposing them 
unnecessarily to adverse consequences of the intervention.  
In investigating the cardioprotective potential of flavonoids, many studies have used 
flavonoids in the form of pure compounds administered via feeding, injection, or perfusing 
hearts with doses that generally cannot be achieved by a regular diet. Administration of high 
doses of flavonoids poses the possibility of toxicity. This raises the question of whether the 
cardioprotective effects of flavonoids can be exerted by low naturally available 
concentrations of flavonoids in foods. If flavonoid-rich foods can provide cardioprotection 
against ischemia-reperfusion injury, at least two benefits will be attained over their 
administration in pure form. On one hand, the likelihood of the flavonoid toxicity will 
decrease. Since the concentration of flavonoids in foods and their bioavailability at the 
absorption site is low, they are less likely to be deleterious if they are given in their naturally 
occurring context, whereas application of the high doses of pure compounds may put the 
body at the risk of toxicity. One the other hand, if flavonoid-rich foods are proved effective, 
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it is quite feasible to benefit from their cardioprotective effects in generally at risk 
populations such as elderly individuals or diabetics without requiring them to take possible 
medications.  
   
1.2. Hypothesis 
 
Flavonoids in vitro and in the diet are able to protect cardiac cells and reduce cell 
death caused by ischemia-reperfusion injury through multiple mechanisms including 
reduction of oxidative stress, improved cellular antioxidant capacity, induction of 
antioxidant enzymes, and enhancement of cellular ATP levels. 
 
1.3. Objectives 
 
Objective 1. To evaluate the ability of polyphenols to protect cultured cardiomyocytes 
from ischemia-reperfusion injury in vitro 
 
Specific objectives were: 
1.1. To establish the in vitro model of ischemia-reperfusion that could induce 
cell death in rat embryonic ventricular H9c2 cells  
1.2. To determine the extent to which various selected polyphenols can protect 
rat embryonic ventricular H9c2 cells and reduce cell death against simulated 
ischemia-reperfusion in vitro 
1.3. To examine whether ascorbate improves polyphenol protection of H9c2 
cells against in vitro ischemia-reperfusion injury 
 
Objective 2. To evaluate the ability of polyphenols and protect H9c2 cells against 
oxidative stress induced by hydroperoxides  
 
Specific objectives were: 
2.1. To assess the ability of various selected polyphenols to increase cell 
viability in H9c2 cells subjected to tert-butyl hydroperoxide 
2.2. To determine whether ascorbate can improve protection by polyphenols of 
H9c2 cells against tert-butyl hydroperoxide  
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Objective 3. To investigate whether feeding rats with flavonoid-rich foods protects 
their hearts against ischemia-reperfusion injury ex vivo  
 
Specific objectives were: 
3.1. To determine whether 10 days feeding with saskatoon berries, green tea 
extract, or broccoli sprouts decreases cardiac cell death induced by ischemia-
reperfusion in isolated rat hearts  
3.2. To examine whether the above-mentioned feeding strategies mitigate 
oxidative stress-induced biochemical alterations in hearts 
3.3. To determine whether the above mentioned feedings improve glutathione 
content in heart and liver tissues 
3.4. To evaluate whether the feedings enhance the protein expression and/or 
activity of phase 2 enzymes in heart and/or liver tissues 
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CHAPTER 2 
 
 LITERATURE REVIEW 
 
 
2.1. Introduction 
 
Ischemia, or inadequate blood flow, in heart occurs following vascular occlusion upon 
unwanted cardiac events such as heart attack or deliberate medical purposes such as 
angioplasty and coronary bypass surgery. During ischemia, cardiac cells, which are in 
constant need of oxygen and glucose, may seriously be injured and face death. Restoration 
of blood flow, so-called reperfusion, although the exclusive strategy to salvage the 
myocardial cells from ischemic death, can adversely impact their recovery. Accordingly, the 
resulting damage is called ischemia-reperfusion injury.  
Reperfusion after a period of ischemia may be more damaging than the same period of 
ischemia alone. For instance, in dogs 40 min coronary occlusion followed by 20 min 
reperfusion caused more damage than 60 min occlusion alone, evidenced by glycogen 
depletion, contraction bands, alteration in intracellular ionic concentrations, and cellular and 
mitochondrial swelling (Shen & Jennings, 1972). None of these changes was evident after 
60 min ischemia without reperfusion. Similarly, 60 min global heart ischemia in rabbits did 
not change the appearance of cells in the right ventricular wall, but 5 min reperfusion 
following the same course of ischemia was accompanied with cell swelling and 
manifestations of plasma membrane rupture (Walsh & Tormey, 1988).  
 
2.2. Myocardial cell death in ischemia-reperfusion injury 
 
The appearance of dead cells following ischemia-reperfusion in human hearts is well 
documented. Olivetti et al. (1996) studied cardiac tissues from ischemic patients who died 
within 10 days from the onset of myocardial infarction symptoms. Apoptosis was detected 
as early as 12 h after ischemia and apoptotic cells were still detectable 10 days afterwards. 
Quantitatively, 12% of cardiac cells in the adjacent region and 1% of cells in the area remote 
from the necrotic tissue were apoptotic. It is worth noting that the initial insult may not 
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necessarily cause an immediate cell death, but it could serve to trigger intracellular 
production of reactive oxygen species and cellular signaling leading to eventual cell death 
(Han et al., 2004).  
There is debate on which form of cell death, apoptosis or necrosis, predominates after 
episodes of ischemia-reperfusion. While some scientists have introduced necrosis as the 
major form of myocardial cell death (Zhao & Vinten-Johansen, 2002), there is evidence in 
favour of apoptosis as well (Kajstura et al., 1996). It has been suggested that apoptosis 
primarily occurs during reperfusion rather than ischemia (Zhao & Vinten-Johansen, 2002). 
Zhao and coworkers (2000) reported the existence of apoptotic cells after 1 h ischemia and 6 
h reperfusion, but not after 7 h ischemia alone. Similarly, Gottlieb et al. (1994) reported lack 
of apoptotic cells in rabbit myocardium after 4.5 h ischemia, while DNA nucleosomal 
fragmentations were evident after 30 min ischemia and 4 h reperfusion. However, some 
investigators (Kajstura et al., 1996) have provided evidence supporting the idea that 
apoptosis can occur during both ischemia and reperfusion. Other investigators document that 
both ischemia and reperfusion can cause apoptosis; however, reperfusion accelerates 
apoptosis in non-salvageable cells (Fliss and Gattinger, 1996; Veinot et al., 1997). 
According to Fliss and Gattinger (1996), reperfusion on one hand inhibits expansion of the 
apoptotic zone in ischemic myocardium, but at the same time it expedites the progress of 
apoptosis and therefore removes non-salvageable cells from the tissue. In agreement, Freude 
et al. (2000) while supporting for the absence of apoptotic cells in ischemic myocardium, 
provided evidence indicating that the apoptotic form of cell death is initiated during 
ischemia but reperfusion is needed probably to provide energy for completion of the 
process.  
 
2.2.1. Forms of cell death 
 
It is more than 150 years that cell death has been recognized as a normal event in 
living organisms. However, it was not until 1972 that the term “apoptosis” was designated to 
programmed or suicidal form of cell death by Kerr and colleagues (Kerr et al., 1972). 
Apoptosis is an energy-dependent process composed of a genetically controlled sequence of 
events. Apoptosis plays an important role in physiologically normal situations such as 
eliminating certain cells during development of embryos or cell turnover in adult tissues. 
Morphological characteristics of apoptosis include cell shrinkage, plasma membrane 
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budding, chromatin condensation which creates a horseshoe appearance for the nucleus, 
nuclear fragmentation, and cellular breakage into membrane-bound fragments, also known 
as apoptotic bodies (Fink & Cookson, 2005; Majno & Joris, 1995; Haunstetter & Izumo, 
1998). The apoptotic bodies can then be captured by neighbouring cells where their 
components are recycled. Splitting cells up into membrane-bound bodies prevents releasing 
cellular contents into the surrounding environment which could subsequently arouse 
inflammatory reactions. Biochemical features of apoptosis are activation of cysteine-
dependent aspartate-specific proteases (known as caspases), cleavage of DNA into 
fragments with lengths of multiples of 180- to 200- base pairs which appear on 
electrophoresis gels as ladder, appearance of phosphatidylserine on the outer side of the 
plasma membrane (Fink & Cookson, 2005; Majno & Joris, 1995; Haunstetter & Izumo, 
1998), and maintenance of ATP levels (Nicotera et al., 1998). The process of apoptosis 
requires ATP in several steps. Chromatin condensation and nuclear fragmentation are 
apoptotic steps requiring ATP (Bradbury et al., 2000). 
In contrast to apoptosis, necrosis, also called oncosis or accidental form of cell death, 
is manifested by increased membrane permeability, cellular and organelle swelling, and 
coagulation of cytoplasmic proteins (Majno & Joris, 1995). As a result of cell swelling, 
cellular contents and pro-inflammatory molecules are released, provoking inflammatory 
responses associated with migration and infiltration of macrophages into the necrotic region. 
However, similar to apoptosis, the cellular debris released from necrotic cells can be 
engulfed and reutilized by neighbouring cells (Fink & Cookson, 2005). DNA in necrosis is 
fragmented in random fashion, generating smears rather than ladders in electrophoresis gels 
(Fliss & Gattinger, 1996). In necrosis, disruption of mitochondrial membrane integrity 
makes mitochondria incapable of producing ATP which leads to rapid cellular ATP 
depletion (Yaglom et al., 2003; Halestrap et al., 2000). In fact, cellular ATP levels dictate 
whether cells die by apoptosis or necrosis (Nicotera et al., 1998). Since apoptotic cells have 
comparably higher contents of ATP and lower ADP to ATP ratio than necrotic cells, cellular 
ADP to ATP ratio has been suggested as an indicator for differential recognition of the mode 
of cell death between apoptosis and necrosis (Bradbury et al., 2000).  
Classical apoptosis and necrosis are two foremost forms of cell death. Other types of 
cell death have also been characterized, each possessing an exclusive pathway and 
displaying discrete morphological and biochemical manifestations (Fink & Cookson, 2005). 
Although the mechanisms of various forms differ, they may overlap under pathological 
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conditions. For instance, it has been shown that internucleosomal DNA fragmentation, 
which is one of the hallmarks of apoptosis, can also occur during early stages of necrosis, 
although by a mechanism distinct from that in apoptosis, with random DNA cleavage 
occurring later in the necrotic process (Dong et al., 1997).  
Furthermore, at a single time point in response to a particular noxious stimulus, 
several modes of cell death may coexist in a system and it is the culmination of the cross-
talk between these which eventually determines the primary form of death (Fink & 
Cookson, 2005). Inhibiting one pathway of cell death may not prevent cell death, but instead 
activate an alternative mode of death, switching the form of death from one to another 
(Lockshin & Zakeri, 2004). Factors such as type and intensity of the insult and growth or 
differentiation state as well as physiological conditions of cells are important in determining 
the predominant form of death (Fink & Cookson, 2005). For example, in response to an 
apoptotic stimulus cells may die from necrosis if their energy levels are rapidly depleted 
(Leist et al., 1997). Likewise, one particular stimulus which induces apoptosis at low 
concentrations may cause necrosis at higher concentrations (Kruman et al., 1997). It is 
likely, though, that during ischemia-reperfusion some cells are subjected to severe stress and 
undergo necrosis, whereas others which are located in the surrounding region proceed to 
apoptosis (Olivetti et al., 1996). Evidence shows that the magnitude of biochemical 
alterations is more substantial in necrosis than apoptosis (Kruman & Mattson, 1999).   
 
2.3. Culprits of myocardial ischemia-reperfusion injury 
 
Although the mechanisms responsible for heart ischemia-reperfusion injury have not 
yet been elucidated in detail, increasing evidence points at two major culprits of biochemical 
and pathophysiological changes during this clinical event: reactive oxygen species and 
calcium. These two factors are very likely to collaborate in causing the injury. However, 
what needs to be clarified is to what extent each contributes to the injury, and whether they 
occur simultaneously or if one occurs ahead and acts as a causative factor for the other.  
 
2.3.1. Reactive oxygen species  
 
Reactive oxygen species (ROS) such as superoxide anions, hydrogen peroxide, and 
hydroxyl radicals are molecules with unpaired electrons in their outer orbit. They are 
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generated through normal metabolic reactions and play a significant role in cellular 
signaling pathways (Thannickal & Fanburg, 2000). Through modulation of cellular redox 
state, these oxidant species are capable of inducing signaling pathways involved in gene 
expression, growth and differentiation, proliferation, adhesion, and apoptosis (Monteiro & 
Stern, 1996). The different roles of ROS in regulation of cell signaling are likely dependent 
on the cellular concentrations of ROS (Thannickal & Fanburg, 2000). For instance, low 
levels of oxidative stress in neonatal cardiac myocytes led to cell growth whereas high levels 
initiated apoptosis (Siwik et al., 1999).  
To affect signaling pathways, ROS likely oxidize sulfhydryl groups (-SH) on critical 
cysteine residues of cellular proteins, modifying the activity of an enzyme if the cysteine is 
positioned at the catalytic site of the enzyme or modifying the ability of a transcription 
factor to bind to DNA if the cysteine is within its DNA binding domain (Thannickal & 
Fanburg, 2000). ROS can also react with thiol groups of membrane receptor proteins and 
change the receptor binding properties and activity (van der Vliet & Bast, 1992) or interact 
with DNA, leading to alterations in DNA structure (Hwang & Bowen, 2007). Many of the 
ROS modifications of cellular proteins and DNA are initiated from interaction of ROS with 
unsaturated lipids in cellular membranes (Wilhelm, 1990). ROS have also potential to 
interact with and damage a range of mitochondrial lipids, proteins (Paradies et al., 2001), 
and DNA (Lee & Wei, 2005; Kang & Hamasaki, 2003).  
Superoxide (O2·−) is the prime source of other types of ROS (Lefer & Granger, 2000). 
It is unstable and after formation is readily converted to hydrogen peroxide (H2O2) either by 
the enzyme superoxide dismutase or by spontaneous dismutation (Thannickal & Fanburg, 
2000). Glutathione peroxidase, an enzyme located in cytosol and mitochondrial matrix 
(Green & O’Brien, 1970), and catalase are enzymes responsible for detoxification of H2O2. 
Unlike catalase (Ferrari et al., 1991), glutathione peroxidase exists in considerable 
concentrations in the heart (Lawrence & Burk, 1978) and detoxifies most of H2O2 in heart 
mitochondria (Antunes et al., 2002).  
Neither O2·− nor H2O2 have strong oxidative potential. However, H2O2 in the presence 
of reduced forms of transition metals such as iron can generate extremely reactive hydroxyl 
radicals (·OH) through the so-called Fenton reaction (Thannickal & Fanburg, 2000). In 
biological systems, however, transition metals are sequestered by proteins such as ferritin 
and therefore are prevented from freely catalyzing this process.  
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Some of the iron captured by iron-containing proteins can be released during cardiac 
ischemia-reperfusion (Berenshtein et al., 1997; Coudray et al., 1994; Lipscomb et al., 1998; 
Voogd et al., 1992). As a result of decompartmentalization of iron, production of ·OH 
increases in reperfused hearts and has been found associated with the occurrence of post-
ischemic ventricular fibrillation (Tosaki et al., 1993). In this regard, iron chelators such as 
desferoxamine have been found advantageous in attenuating ischemia-reperfusion injury of 
heart (Maxwell & Lip, 1997). The mechanism of iron mobilization during ischemia-
reperfusion is not yet clear. It has been found that reduced forms of flavins facilitate 
releasing iron from ferritin (Sirivech et al., 1974). Superoxide radicals may also contribute 
to this kind of release (Biemond et al., 1984). Acidosis caused by ischemia has also been 
proposed to stimulate iron dissociation from carrier proteins, while anoxia alone appeared 
insufficient to initiate iron release (Voogd et al., 1992). The last two possibilities are of 
importance in states of ischemia. It is worthwhile to note that although iron under conditions 
of oxidative stress such as ischemia-reperfusion is detrimental, at normal conditions it is 
harmless even though the cells are loaded with iron (van der Kraaij et al., 1988). 
 
2.3.1.1. Sources of reactive oxygen species upon myocardial ischemia-reperfusion 
 
During ischemia-reperfusion, production of ROS increases in the myocardium in 
amounts overwhelming the scavenging capacity of endogenous antioxidants (Dhalla et al., 
2000). Generation of ROS increases especially within the first minutes of reperfusion and 
can last for hours. Bolli et al. (1988) reported the maximum production of free radicals at 2 
min after reperfusion, being 90 times more than that during ischemia. The radicals then 
decreased after 20 min, but remained relatively elevated for a period of 2-3 h. Similarly, 
Duilio et al. (2001) found ROS elevation by 10 times between minutes 5 and 10 of 
reperfusion following 90 min coronary artery occlusion and a diminution of ROS thereafter, 
although ROS remained comparably high for at least 1 h. Some investigators have reported a 
small rise in ROS at the beginning of coronary artery occlusion as well (Zhu et al., 2007b). 
However, compared to coronary ligation models, hearts subjected to global ischemia 
seemingly generate more ROS during ischemia, probably because they establish more 
profound ischemia in the tissue (Zweier et al., 1987). In agreement with animal studies, lipid 
peroxides in coronary venous blood rose shortly after balloon inflation in 59% of patients 
undergoing angioplasty (Oldroyd et al., 1992).   
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An increasing body of evidence, mostly based on observed benefits of superoxide 
dismutase administration, points to O2·− as the primary culprit in ischemia-reperfusion injury 
(Marczin et al., 2003). There are many potential sources of O2·− including the mitochondrial 
electron transport system, plasma membrane and neutrophil NAD(P)H oxidase, xanthine 
oxidase (Sorescu & Griendling, 2002), arachidonic acid metabolism (Paravicini et al., 2004; 
Kamata & Hirata, 1999), cytochrome P-450, and nitric oxide synthases (Mansuy & Boucher, 
2002). Mitochondria are significantly important in the heart because the heart contains a 
high content of mitochondria (Benard et al., 2006). However, this does not necessarily mean 
that cardiac cells play the major role in the production of ROS over episodes of ischemia-
reperfusion, as non-myocardial cells, such as neutrophils and endothelial cells, are also of 
crucial importance in ischemia-reperfusion-stimulated ROS production (Figure 2.1) (Lefer 
& Granger, 2000). ROS generated in non-myocardial cells can diffuse to myocytes and 
leave detrimental effects on redox status and cellular homeostasis therein (Silverman & 
Stern, 1994).  
 
                            
 
Figure 2.1. Reactive oxygen species in myocardial ischemia-reperfusion injury. 
 
In ischemic-reperfused hearts, reactive oxygen species can be produced by various sources, 
particularly mitochondrial electron transport chain of cardiac cells, NADPH oxidase system of 
neutrophils, and xanthine oxidase enzyme of endothelial cells (adapted from Lefer & Granger, 
2000).  
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2.3.1.1.1. Mitochondrial respiratory chain 
 
The mitochondrial respiratory chain consumes nearly 90% of oxygen transported to 
the cell (Wakabayashi, 2002). Approximately 1-2% of this oxygen is converted to O2·− due 
to electron leakage from the mitochondrial electron transport chain (Kamata & Hirata, 1999) 
especially at the Qo site of complex III and the NADH dehydrogenase of complex I  
(Brookes et al., 2004) (Figure 2.2). Under normal situations, this O2·− causes no damage as it 
and the consequent H2O2 are quickly detoxified by mitochondrial superoxide dismutases and 
glutathione peroxidase, respectively (Szocs, 2004). Furthermore, cytochrome c located at the 
outer face of the mitochondrial inner membrane plays an important antioxidant role in the 
mitochondrial intermembrane space, seizing electrons from O2·− and transferring them to 
complex IV (Brookes et al., 2004). Accordingly, mitochondria not only efficiently scavenge 
ROS originating from intra-mitochondrial sites, but it also acts as a substantial sink for ROS 
from extra-mitochondrial sources (Zoccarato et al., 2004; Guidot et al., 1995). 
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Figure 2.2. Mitochondrial respiratory chain under normal conditions. 
 
Under physiological conditions only small amounts of electron leak from complexes I and III of 
the mitochondrial electron transport chain. I-V, respiratory complexes I-V; Q, coenzyme Q; 
Cytc, cytochrome c; e–, electron. 
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However, mitochondria play a considerable role in production of ROS during 
myocardial ischemia-reperfusion (Li & Jackson, 2002; Ambrosio et al., 1993). Complexes I 
and III have been recognized as sites of ROS production in ischemic-reperfused hearts 
(Becker et al., 1999; Szocs, 2004). During ischemia or hypoxia, due to insufficient amounts 
of oxygen, the activity of respiratory proteins including cytochrome c oxidase (complex IV) 
is inhibited and the electron transport chain becomes highly reduced, giving electrons 
opportunity to escape from their path through respiratory complexes and to reduce the 
remaining oxygen with subsequent formation of O2·− (Szocs, 2004; Maxwell & Lip, 1997) 
(Figure 2.3). In contrast to this notion, Hoffman et al. (2007) reported that in isolated 
mitochondria ROS generation declines during hypoxia, suggesting that extra-mitochondrial 
sources may be involved in augmenting ROS generation upon hypoxic circumstances.  
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Figure 2.3. Mitochondrial respiratory chain during ischemia. 
 
During ischemia, due to the lack of oxygen, the complex IV is inhibited, resulting in 
accumulation of electrons in the former complexes which results in increased superoxide 
production at complexes I and III. I-V, respiratory complexes I-V; Q, coenzyme Q; Cytc, 
cytochrome c; e–, electron. 
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The mitochondrial production of O2·− also increases during reperfusion when as a 
result of low tissue pH the release of oxygen from hemoglobin increases (Bohr effect), 
producing a transient hyperoxia which leads to overactivation of respiratory chain and 
augmentation of electron leakage (Wolbarsht & Fridovich, 1989) (Figure 2.4). Moreover, at 
the beginning of reperfusion, if due to ADP shortage complex V (i.e. ATP synthase) is 
inhibited, electrons can leak from the prior complexes of the respiratory chain, yielding 
formation of more O2·− (Ferrari et al., 1991). Furthermore, calcium accumulation which is 
one of the principal events during ischemia and particularly reperfusion hastens the 
enzymatic reactions of the Krebs cycle in mitochondria, producing more reducing 
equivalents for the mitochondrial electron transport chain and enhancing production of O2·−.  
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Figure 2.4. Mitochondrial respiratory chain during reperfusion. 
 
At early reperfusion, as a consequence of increased concentration of oxygen in the mitochondrial 
respiratory chain and elevation of calcium in mitochondria, respiration takes place faster, and as 
a result, generation of superoxide increases. However, if sufficient ADP is not available, 
phosphorylation reactions encounter depression. I-V, respiratory complexes I-V; Q, coenzyme 
Q; Cytc, cytochrome c; e–, electron. 
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Reperfusion and to a lesser extent ischemia intensify formation of lipid peroxides and 
conjugated dienes in heart mitochondrial membrane (Petrosillo et al., 2003). Phospholipids 
and proteins of the mitochondrial inner membrane are the primary targets of mitochodrially 
generated ROS. Cardiolipin is a phospholipid in the mitochondrial inner membrane that 
associates with cytochrome c and other proteins of the respiratory chain, and its appearance 
on the outer side of the mitochondrial inner membrane is one of the earliest indices of 
apoptosis (Garcia et al., 2002). The structure and content of cardiolipin is crucial for well 
being and activity of the respiratory proteins (Petrosillo et al., 2003). However, because of 
its high composition of unsaturated fatty acids, cardiolipin is highly susceptible to oxidation. 
ROS can change cardiolipin structure and negatively impact the activity of complexes III 
and IV. Similarly, ischemia-reperfusion has been shown to decrease cardiolipin content in 
mitochondria and to reduce activities of complexes I, III and IV that could be restored by 
exogenous administration of cardiolipin (Petrosillo et al., 2003; Paradies et al., 2004). As a 
result of cardiolipin depletion in mitochondrial inner membrane, cytochrome c, an important 
signaller of apoptosis, can be released from the inner membrane and promote signaling 
pathways leading to apoptosis (Iverson & Orrenius, 2004; Lesnefsky et al., 2004b). 
Decreased activity of respiratory complexes due to oxidative damage following ischemia-
reperfusion exacerbates electron leakage and generates more O2·−. These perturbations can 
be prevented through mitigation of electron leakage from mitochondrial electron transport 
chain (e.g. by blockage of complex I with rotenone or amobarbitol), further indicating the 
significant role of mitochondria in ROS production during ischemia-reperfusion injury 
(Lesnefsky et al., 2004a; Aldakkak et al., 2008, Chen et al., 2007).   
 
2.3.1.1.2. Xanthine oxidase  
 
It is decades since the enzyme xanthine oxidase has been proposed as the supreme 
source of ROS during myocardial ischemia-reperfusion (McCord et al., 1985; Hearse et al., 
1986). Recently, Duda et al. (2007) showed that allopurinol, a strong inhibitor of xanthine 
oxidase, almost totally blocked the generation of O2·− in post-ischemic guinea pig hearts. 
However, there is considerable skepticism about the role of xanthine oxidase in ischemia-
reperfusion injury of human heart. The ambiguity exist mostly around two issues: the nature 
of conversion from the dehydrogenase form of the enzyme to the oxidase form during 
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ischemia, and more importantly is the uncertainty about the expression of the enzyme in the 
human heart (Nishino, 1994).  
The enzyme is found primarily in its dehydrogenase form which normally consists 
about 90% of the total enzyme (Maxwell & Lip, 1997). This form oxidizes hypoxanthine 
with concomitant reduction of nicotinamide adenine dinucleotide (NAD):  
 
Hypoxanthine + 2H2O + 2NAD+ → Uric Acid + 2NADH + 2H+ 
 
A small portion of the enzyme in cells is present as the oxidase form which utilizes 
oxygen as electron acceptor with consequent generation of O2·−: 
 
Hypoxanthine + 2H2O + 2O2 → Uric Acid + 2O2·− + 2H+ 
 
Evidence shows that during ischemia some the dehydrogenase forms of the enzyme 
are converted to the oxidase form (Chambers et al., 1985). The conversion occurs via 
reversible oxidation of sulfhydryl groups or irreversible proteolytic digestion (Nishino et al., 
2005). It has been suggested that the protease responsible for the irreversible conversion is 
calcium-dependent, raising the possibility that calcium overload caused by ischemia-
reperfusion is involved in the conformational conversion of the enzyme (Maxwell & Lip, 
1997). Biochemical changes happening during ischemia also provide a suitable environment 
for O2·− production by xanthine oxidase. As a consequence of blood flow cessation which 
limits nutrient and energy delivery to the tissue, purine nucleotides are broken down to 
hypoxanthine and xanthine in order to supply energy during ischemic energy deprivation. 
However, hypoxanthine and xanthine are substrates of the xanthine oxidase, which can 
begin to work and produce O2·− when delivery of its other substrate, oxygen, is restored to 
the tissue.  
In heart, xanthine oxidase is mainly located in interstitial cells of the myocardium, 
coronary endothelial, and smooth muscle cells, but not in cardiac cells (Ashraf & Samra, 
1993). The activity of xanthine oxidase in mammals varies depending on the type of tissue 
and the species of animal. In humans, the enzyme activity in liver and intestine is high 
(Parks & Granger, 1986) and in heart is negligible (Parks & Granger, 1986; Eddy et al., 
1987). Nevertheless, some studies have reported protective effects of allopurinol in patients 
undergoing heart surgeries (e.g. Gimpel et al., 1995; Castelli et al., 1995). The reason for 
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this controversy may be other beneficial effects of allopurinol unrelated to its inhibition of 
xanthine oxidase activity. As an example, the effect of allopurinol in prevention of 
glutathione depletion and diminishing formation of lipid peroxides in rabbit ischemic-
reperfused hearts has been suggested to be due to direct antioxidant properties of allopurinol 
rather than to its xanthine oxidase suppressive activity (Godin & Garnett, 1989). Despite the 
mentioned reasons for exclusion of a remarkable role for xanthine oxidase in heart ischemia-
reperfusion injury in human, it is possible that the enzyme is responsible for at least some of 
the injury in human heart. Since human capillary endothelial cells contain xanthine oxidase 
in concentrations 1,000-10,000 times greater than other cells (Jarasch et al., 1986), it is 
plausible that xanthine oxidase located in the endothelium of coronary microvasculature is 
the origin of considerable O2·− in ischemic-reperfused myocardium. 
 
2.3.1.1.3. Neutrophils  
 
Cardiac ischemia-reperfusion injury triggers an acute inflammatory response in which 
neutrophils, via chemotactic attraction, infiltrate the myocardium and aggravate the damage 
in the already injured tissue (Frangogiannis et al., 2002). However, they are not exclusive 
triggers of apoptosis, as apoptosis has been observed in ischemic-reperfused myocardium 
even in neutropenic animals (Gottlieb et al., 1994). In their normal transit through the 
systemic circulation when neutrophils arrive to the reperfused tissue, they are exposed to 
chemotactic agents, mainly released from endothelial cells, and become activated (Korthuis 
& Gute, 1999) (Figure 2.5). Endothelial cells, in response to specific stimuli such as ROS 
(Ichikawa et al., 2004), release chemoattractants such as arachidonic acid metabolites 
including leukotriene B4 and thromboxane A2 (Welbourn et al., 1991), and adhesion 
molecules such as intercellular adhesion molecules (ICAM), vascular cell adhesion 
molecules (VCAM) and selectins, leading to neutrophil attraction, sequestration and 
adhesion to the microvasculature (Ichikawa et al., 2004; Seely et al., 2003). Accumulation 
and sequestration of neutrophils in the coronary microcirculation may lead to occlusion of 
the microvascular and thereby impair restoration of blood flow in the ischemic region, so-
called “no-reflow phenomenon” (Schmid-Schonbein & Engler, 1986).  
It is well-known that the interaction of neutrophils and endothelial cells results in 
endothelial cell dysfunction (Seal & Gewertz, 2005). Once activated, neutrophils release 
oxidants by means of their NADPH oxidase system located in their plasma membrane. 
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NADPH oxidase is a potential source of ROS during reperfusion; upon stimulation of the 
neutrophil, NADPH oxidase rapidly converts oxygen to O2·− (Kloner et al., 1989). Because 
of this powerful oxidase system, some researchers have proposed neutrophils as the major 
source of ROS in hearts reperfused after prolonged ischemia (Duilio et al., 2001). 
Furthermore, neutrophils have the enzyme myeloperoxidase, which converts H2O2 to the 
powerful oxidant hypochlorous acid. Additionally, after activation neutrophils become more 
adherent to the endothelium, releasing large quantities of proteases including elastase which 
degrade structural proteins such as elastin and cause endothelial permeability which 
facilitates neutrophil infiltration into the myocardium (Lefer & Lefer, 1996; Welbourn et al., 
1991). When the endothelium becomes permeable, intravascular fluid can seep into the 
interstitial space, leading to extravascular edema and aggravating the no-reflow phenomenon 
(Gute et al., 1998). It is worthwhile to note that many of the mechanisms implicated in 
endothelial dysfunction following ischemia take place due to clearance of nitric oxide as a 
result of the augmented O2·− concentration (Szocs, 2004). We will discuss this later. 
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Figure 2.5. Attraction and adhesion of neutrophils to the endothelium in an ischemic-
reperfused region. 
 
As a result of the elevation of reactive oxygen species, endothelial cells release chemoattractants 
and adhesion molecules which make the endothelium adhesive to neutrophils. Neutrophils upon 
adhesion release massive amounts of oxidants and proteases that worsen the oxidative condition 
and permeabilize the endothelium, leading to seepage of water and electrolytes into the 
interstitial space beneath and development of the no-reflow phenomenon. VCAM, vascular cell 
adhesion molecules; ICAM, intercellular adhesion molecules; TXA2 thromboxane A2; LTB4, 
leukotriene B4; HOCl, hypochlorous acid; •OH, hydroxyl radical.  
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Despite the potential of neutrophils in damaging post-ischemic myocardium, they may 
bring some benefits for the invaded tissue. For instance, by eliminating damaging agents and 
leftovers of dead cells they may attenuate intensification of inflammatory reactions (Suval et 
al., 1987). Furthermore, infiltrated monocytes and mast cells may contribute to healing of 
the injured tissue and scar formation by secreting cytokines and growth factors which are 
essential for proliferation of fibroblasts (Frangogiannis et al., 2002). 
 
2.3.1.1.4. Arachidonic acid metabolites 
 
Ischemia-reperfusion stimulates decomposition of plasma membrane phospholipids 
into their structural components such as arachidonic acid (Gross et al., 2005). The 
decomposition takes place mainly through activation of phospholipases, mostly 
phospholipase A2, by ROS (van der Vliet & Bast, 1992) and/or increased levels of calcium 
(Ivanics et al., 2001). Arachidonic acid can be oxidized through either cyclooxygenase and 
lipoxygenase pathways to the corresponding products (Gross et al., 2005) or in a non-
enzymatic fashion stimulated by ROS (Mobert & Becker, 1998).  
Although the activity of cyclooxygenase and lipoxygenase pathways is associated with 
production of ROS (Gunasekar et al., 1998), there is also evidence indicating 
cardioprotective effects of arachidonic acid metabolites. For instance, prostacyclins which 
are products of cyclooxygenase are important vasodilators and therefore can be beneficial in 
ischemia-reperfusion circumstances (Gross et al., 2005; Mobert & Becker, 1998).  
 
2.3.2. Calcium 
 
Calcium overload has been shown to be a critical event in ischemia-reperfusion injury, 
although the exact mechanisms of the overload are still to be elucidated. Reports on the 
exact time of the accumulation are also rather conflicting. In general, ischemia may cause 
some elevation in intracellular calcium, but reperfusion is what actually causes a sharp rise 
in the cytosolic calcium. 
Calcium overload has been suggested as a part of signaling pathways in both apoptosis 
and necrosis, although the degree of overload is likely higher in necrosis (Petrosillo et al., 
2004). Although calcium overload by its own is a pathological stimulus possessing the 
capacity to initiate cellular pathways towards cell death, in most cases the switch from a 
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normal physiological function to a lethal effect occurs in conjunction of calcium overload 
with some sorts of oxidative stress (Duchen, 2000). 
It is worthwhile to note that calcium in the cell behaves as a double edged sword; both 
calcium depletion and overload can lead to cell death. Depletion of mitochondrial calcium 
can lead to apoptosis due to a loss of mitochondrial membrane potential and cytochrome c 
release (Zhu et al., 2000). In contrast, high cytoplasmic levels of calcium can also cause 
increased mitochondrial calcium concentration and mitochondrial membrane depolarization, 
leading to either of the major forms of cell death, apoptosis or necrosis (Kruman & Mattson, 
1999). 
 
2.3.2.1. Mechanisms of calcium overload  
 
The intracellular concentrations of calcium (Ca2+) and sodium (Na+) increase and 
those of magnesium and potassium decrease during myocardial ischemia-reperfusion (Shen 
& Jennings, 1972). The elevation in intracellular Ca2+ appears to be preceded by an increase 
in intracellular Na+ and that in turn is preceded by augmentation in intracellular hydrogen 
(H+) (Ralenkotter et al., 1997). Indeed, decline of cytosolic pH during ischemia has been 
shown to be the primary cause of the Ca2+ overload. Nevertheless, because the activity of 
damaging proteases and phospholipases lessens at lower pH, the acidosis may also provide 
benefits for the ischemic tissue (Silverman & Stern, 1994).  
The mechanism of Ca2+ accumulation during ischemia-reperfusion as currently known 
is as follows: as cells face hypoxia/ischemia, they switch their means of ATP synthesis from 
aerobic (oxidative) to anaerobic (glycolysis) metabolism, leading ultimately to a drop in 
intracellular pH (acidosis) (Pierce & Czubryt, 1995; Akabas, 2004). Increased intracellular 
H+ activates cellular Na+/H+ exchangers to extrude H+ ions in exchange for Na+, correcting 
the acidic pH at the expense of Na+ accumulation. Voltage-gated Na+ channels may also be 
involved in Na+ accumulation during ischemia (Van Emous et al., 1997; Ji et al., 2004).  
To get rid of the extra Na+, the cell has a few ways available. Cellular pathways of Na+ 
efflux from the sarcolemmal membrane consist of Na+/K+ ATPase, Na+/Ca2+ exchanger, and 
Na+/K+/2Cl¯ cotransporter; of these the activity of the latter is likely preserved during 
ischemia (Anderson et al., 1996). In contrary, due to the shortage of ATP the activity of 
Na+/K+ ATPases is suppressed during ischemia and impairs Na+ exclusion from myocardial 
 23
cells (Cross et al., 1995). Furthermore, it has been shown that the increased concentration of 
inorganic phosphate (Pi) and acidic pH, both of which are characteristics of ischemia, also 
are important factors in the inactivation of Na+/K+ ATPase (Huang & Askari, 1984). 
Therefore, the only way that remains to expel Na+ from the ischemic cells is the Na+/Ca2+ 
exchanger, which brings Ca2+ ions in while sending Na+ out, leading ultimately to 
intracellular accumulation of Ca2+. 
The Na+/Ca2+ exchanger has a crucial role in causing Ca2+ overload during heart 
ischemia-reperfusion (Akabas, 2004). The exchanger is driven electrochemically, 
exchanging three Na+ ions per one Ca2+. In normal myocardial function, it works in the 
“forward mode”, transferring Na+ in and Ca2+ out of the cells. However, the mode of action 
could change to the “reverse mode” if the intracellular concentration of Na+ outweighs the 
extracellular one, a condition that happens in ischemia-reperfusion.   
Increased intracellular Ca2+ occurs when cells are unable to export excessive Ca2+ to 
the extracellular space. In human ventricle myocytes, the removal of Ca2+ from the 
cytoplasm is carried out mainly by the endoplasmic reticulum Ca2+ ATPase (70%), and 
partly through the sarcolemmal Na+/Ca2+ exchanger (28%) (Bers, 2002). The rest will be 
excluded through the sarcolemmal Ca2+ ATPase and mitochondrial Ca2+ uniporter. In 
ischemia, due to the lack of ATP, the activity of ATP-dependent pumps is impaired. At the 
same time, the Na+/Ca2+ exchanger is now operating in the reverse mode, carrying Ca2+ ions 
into the cytosol and taking Na+ out. This makes the situation more troublesome and 
confronts cells to Ca2+ overload.  
 
2.3.2.2. Mitochondria, sinks for cytosolic calcium  
 
In cells, mitochondria are able to function as Ca2+ sinks, mopping up large quantities 
of cytosolic Ca2+ without harming their own normal activities (Brini, 2003; Nicholls, 2005). 
They act as a unique buffer for cellular Ca2+, removing large amounts of Ca2+ from the 
cytosol when the intracellular concentration of Ca2+ is pathologically high, as in ischemia-
reperfusion, and releasing it back to the cytosol but at slower speeds, enabling cells to cope 
with high quantities of Ca2+. This is particularly important considering that intracellular 
concentrations of Ca2+ higher than normal may lead to hypercontraction of cardiac muscles. 
Under normal circumstances, however, the role of mitochondria in modification of cellular 
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Ca2+ is negligible as the endoplasmic reticulum has greater affinity and more rapid Ca2+ 
uptake than mitochondria (Langer, 1991; Richter & Kass, 1991).  
The mitochondrial matrix is enclosed by the outer and inner mitochondrial 
membranes; the latter possesses a low permeability to ions (Hajnoczky et al., 2003). Ca2+ 
gains access to the intermembrane space via voltage-dependent anion channels (VDAC) 
located on the mitochondrial outer membrane (Brookes et al., 2004). The passage of Ca2+ 
across the inner membrane mainly occurs through the mitochondrial Ca2+ uniporter and this 
pathway actually controls Ca2+ uptake by mitochondria. The affinity of the uniporter for 
Ca2+ is low, and very high concentrations of Ca2+ are required to activate it (Brini, 2003). 
Exposure of mitochondria to such high Ca2+ concentrations is achieved through cellular 
localization of mitochondria in regions of high cytosolic Ca2+ (Duchen, 2000). Indeed, Ca2+ 
is not evenly distributed throughout the cytosol (Brini, 2003); the concentration of Ca2+ is 
higher in areas close to openings of Ca2+ channels of the plasma membrane and those of the 
endoplasmic reticulum. 
 Ca2+ is transported across the mitochondrial inner membrane using the 
electrochemical gradient established by the mitochondrial membrane potential (∆ψm) with 
concomitant consumption and lowering ∆ψm (Brookes et al., 2004). Low concentrations of 
Ca2+ in the mitochondrial matrix also provide a negative gradient for Ca2+ and help Ca2+ to 
enter mitochondria (Duchen, 2000). The release of Ca2+ from mitochondria occurs mainly 
via mitochondrial Na+/Ca2+ exchangers, while the entering Na+ is exchanged with H+ by 
Na+/H+ exchangers, resulting in a further diminution of the membrane potential (Brookes et 
al., 2004). Thus, although neither Ca2+ influx nor Ca2+ efflux demands ATP, they both 
consume ∆ψm and therefore may promote depolarization of the mitochondrial membrane 
and collapse of ∆ψm, thereby affecting mitochondrial function and ATP production which is 
critical for hearts under ischemia-reperfusion states (Duchen, 2000). Some of the Ca2+ may 
also exit from mitochondria through the permeability transition pore (PTP), which is a 
megachannel extended at juxtapositional sites of the two mitochondrial membranes 
(Brookes et al., 2004). Under physiological conditions, the PTP may transiently open to 
release some Ca2+ collected in the matrix. However, long-lasting pore opening is generally 
associated with pathological states.  
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2.3.2.3. Mitochondrial consequences of calcium overload 
 
During ischemia, the mitochondrial uniporter probably loses its normal activity, as it 
relies on the mitochondrial membrane potential (Kapus et al., 1991) which also declines 
during ischemia (Di Lisa et al., 1995). Thus, Ca2+ uptake by mitochondria at the time of 
ischemia is largely carried out by the reverse mode of the sarcolemmal Na+/Ca2+ exchangers 
(Griffiths et al., 1998). However, both transporters regain their normal activities at 
reperfusion. 
In mitochondria, the primary role of Ca2+ is activation of oxidative phosphorylation 
and the major targets for Ca2+ are isocitrate dehydrogenase and α-ketoglutarate 
dehydrogenase of the Krebs cycle, pyruvate dehydrogenase, ATP synthase, and adenine 
nucleotide translocase (Brookes et al., 2004). In this way, Ca2+ enhances mitochondrial 
production of NADH and ATP. The overall impact of Ca2+ on mitochondria is acceleration 
of mitochondrial activities that is accompanied with further consumption of O2 and 
consequently production of more O2·−. However, the net influence of Ca2+ on generation of 
O2·− can not be ascertained as Ca2+ may in some ways decrease electron leakage from the 
electron transport chain. For instance, depletion of the transmembrane potential (∆ψm) 
following mitochondrial Ca2+ influx may decrease the electron leakage and O2·− production 
(Hajnoczky et al., 2003). Furthermore, uptake of Ca2+ in amounts higher than normal into 
mitochondria may depress respiration by inhibition of complex I activity (Hardy et al., 1991) 
and thereby may consequently mitigate generation of ROS.  
As a result of Ca2+ influx into mitochondria, mitochondrial membrane potential may 
transiently collapse, leading to inactivation of the ATPase complex and suppression of ATP 
production (De Gomez-Puyou et al., 1980). Moreover, high concentrations of Ca2+ can 
activate phospholipase A2 (Saris & Carafoli, 2005), leading to extensive conformational 
changes in proteins and phospholipids, particularly cardiolipin, within the mitochondrial 
membrane and thereby causing mitochondrial inner membrane permeability, PTP opening 
(Grijalba et al., 1999), and release of proteins residing in the mitochondrial intermembrane 
space including cytochrome c (Gogvadze et al., 2001). The opening of PTP by Ca2+ is 
considerably enhanced in the presence of ROS (Hajnoczky et al., 2003). However, if Ca2+ 
accumulation is mild, the PTP may later be resealed and mitochondria resume some of their 
metabolic activities to synthesize ATP required for the apoptotic death pathway, while at the 
same time the released cytochrome c continues its way towards activation of caspases and 
 26
initiation of the apoptotic cascade (Szalai et al., 1999). Nevertheless, even in the absence of 
apparent PTP opening mitochondrial Ca2+ accumulation alone can induce cytochrome c 
release (Gogvadze et al., 2001). The release of cytochrome c by Ca2+ could result from 
competition of Ca2+ with cytochrome c for binding to cardiolipin (Huang et al., 2006). In 
addition to initiation of the apoptosis cascade, the release of cytochrome c can result in 
inhibition of the oxidative system in the mitochondrial respiratory chain (Borutaite et al., 
1999) and consequently elevation of electron leakage from the electron transport chain on 
one hand and blockade of ATP synthesis on the other.  
 
2.3.2.4. Role of endoplasmic reticulum in calcium overload 
 
The endoplasmic reticulum is the major intracellular Ca2+ store and plays a significant 
role in establishment of normal Ca2+ homeostasis in cells (Richter & Kass, 1991). It takes up 
Ca2+ by Ca2+ ATPases and releases it by two channels: the inositol 1,4,5-triphosphate (IP3) 
channel and the ryanodine receptor channel; both of these channels can be activated upon 
elevation of intracellular concentration of Ca2+ (e.g. following ischemia), releasing vast 
amounts of Ca2+ into the cytosol (Boehning et al., 2003; Saris & Carafoli, 2005; White & 
McGeown, 2003). Also, inhibition of endoplasmic reticulum Ca2+ ATPase pumps, for 
instance as a result of ATP depletion during ischemia (Silverman & Stern, 1994), can 
deplete endoplasmic reticulum Ca2+ stores and cause a considerable rise in intracellular Ca2+ 
concentration (Bian et al., 1997). Moreover, a type of sarcolemmal Ca2+ entry channel 
(known as sarcolemmal membrane store-operated Ca2+ channels, among the best known of 
which are Ca2+ release-activated Ca2+ channels (CRAC)) is activated if Ca2+ stores in the 
endoplasmic reticulum are depleted (Hogan & Rao, 2007), further intensifying cellular Ca2+ 
overload. It is worth noting that complete depletion of endoplasmic reticulum Ca2+ stores 
can initiate apoptosis signaling independent of mitochondria via activation of Ca2+-sensitive 
proteases (Hajnoczky et al., 2003). 
The cross-talk between mitochondria and endoplasmic reticulum for maintaining 
cellular homeostasis and modification of pathological alterations is intriguing. The vicinity 
of endoplasmic reticulum and mitochondria allows this cross-talk for regulating Ca2+ 
signaling in the cell milieu (Brookes et al., 2004). For instance, as was mentioned earlier this 
proximity allows the uniporter in nearby mitochondria to sense high levels of Ca2+ and to 
become activated when the concentrations of Ca2+ in other parts of the cytosol are still not 
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high enough to achieve its activation (Duchen, 2000). Likewise, mitochondria keep the 
concentration of Ca2+ in areas adjacent to endoplasmic reticulum low even if the overall 
cytosolic level of Ca2+ is high, preventing stimulation of endoplasmic reticulum Ca2+ 
channels from releasing their Ca2+ stores into the cytosol. However, in pathological states 
mitochondria and eventually whole cells can be harmed from this vicinity as Ca2+ released 
from endoplasmic reticulum stores can lead to mitochondrial Ca2+ overload and swelling 
(Brookes et al., 2004).  
Cytochrome c also acts as a messenger in the cross-talk between mitochondria and 
endoplasmic reticulum. Cytochrome c released from mitochondria by any reason (such as 
mitochondrial Ca2+ overload) can bind to the IP3 receptor of the endoplasmic reticulum, 
prompting it to release Ca2+ (Boehning et al., 2004; Brookes et al., 2004). This creates a 
positive-feedback loop towards endoplasmic reticulum for emptying its Ca2+ stores on one 
side and to mitochondria for accumulating more Ca2+ and releasing more cytochrome c on 
the other.  
  
2.3.2.5. Intracellular consequences of calcium overload  
 
Elevation of intracellular Ca2+ could be detrimental for the cell in multiple ways 
(Silverman & Stern, 1994; Hajnoczky et al., 2003; Welbourn et al., 1991). It leads to 
hyperactivation of contractile proteins in heart muscle resulting in cardiac hypercontracture 
which is associated with increased consumption of ATP. A rise in intracellular Ca2+ also 
activates Ca2+-dependent enzymes, two major classes of which are proteases and 
phospholipases whose activity leads to destruction of cellular constituents. For instance, 
increased intracellular Ca2+ can result in activation of calpain proteases which digest 
cytoskeletal and plasma membrane proteins, features that are usually observed in the 
necrotic form of cell death (Fink & Cookson, 2005). Furthermore, the integrity of 
transmembrane proteins which serve to transport ions across cellular and subcellular 
membranes is dependent on their surrounding phospholipids, and therefore phospholipid 
degradation can lead to cellular ionic derangements. On the other hand, expelling excessive 
intracellular Ca2+ is achieved mainly through ATP-dependent Ca2+ pumps of the 
endoplasmic reticulum that exhaust the available cellular ATP and leave the cell in a more 
problematic situation (Suzoki et al., 1997). 
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2.3.3. Cross-talk between ROS and calcium  
 
ROS and Ca2+ do not work in completely distinct pathways. They concomitantly 
increase during ischemia-reperfusion and collaborate to cause the destructive biochemical 
consequences of the injury. Although they rise through seemingly separate mechanisms at 
the start, later each promotes pathological alterations in a way to intensify and aggravate the 
manifestations that the other one has on cellular and subcellular elements. Here are 
examples of possible interactions between ROS and Ca2+.  
Ca2+ overload can elevate formation of ROS. For instance, hypoxic-reoxygenated 
mitochondria produce more H2O2 when loaded with Ca2+ (Kowaltowski et al., 1995). Ca2+ 
can also activate Ca2+-dependent proteases involved in the conversion of xanthine 
dehydrogenase to xanthine oxidase (Maxwell & Lip, 1997). Nitric oxide synthase is another 
Ca2+-dependent enzyme which is activated upon Ca2+ overload and produces nitric oxide, a 
known inhibitor of respiratory chain complex IV, leading to enhanced electron leakage at 
complex III (Galkin et al., 2007). 
Likewise, ROS can amplify Ca2+ overload (Suzoki et al., 1997). It is reported that both 
endoplasmic reticulum and mitochondrial Ca2+ uptake can be inhibited by oxidants, although 
at high concentrations of Ca2+ the inhibitory effect of oxidants on mitochondria is rather 
negligible (Kaminishi & Kako, 1989). Inhibition of Ca2+ uptake by endoplasmic reticulum is 
important as it can trigger opening of Ca2+ release channels and depletion of endoplasmic 
reticulum Ca2+ stores (Bian et al., 1997). In addition, ROS may oxidize critical thiol groups 
of ryanodine receptors of the endoplasmic reticulum, stimulating the ryanodine channels to 
open and release Ca2+ (Brookes et al., 2004). IP3 channels also release Ca2+ when exposed to 
ROS (Suzoki et al., 1997).  
Like Ca2+, ROS can also facilitate PTP opening by modifying protein and lipid 
components of mitochondrial membranes (Hajnoczky et al., 2003). However, Ca2+ overload 
can enhance PTP opening by oxidants whereas oxidants alone are ineffective (Brookes & 
Darley-Usmar, 2004). 
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2.4. Signaling pathways in cell death  
 
2.4.1. Mitochondria: initiators or targets? 
 
Although mitochondria have long been known as significant contributors of signaling 
pathways leading to cell death, recent concepts have proposed them as targets rather than 
initiators of cell death (Chipuk et al., 2006; Bernardi et al., 2001). It has been suggested that 
in response to a death stimulus mitochondria experience two events (Lutter et al., 2001). In 
the first stage, the outer membrane is permeabilized and some proteins situated in the 
intermembrane space including cytochrome c are released to the cytosol. However, the 
integrity of the inner membrane is preserved and mitochondria relatively maintain their 
normal function at this stage. In the second phase, the mitochondrial inner membrane 
becomes permeable, permitting ions such as Ca2+ and water to seep into the matrix with 
consequent mitochondrial depolarization, swelling, and rupture. Since in apoptosis 
morphological features of swelling and rupture are not seen, the second stage is more likely 
to occur in necrosis rather than apoptosis. In the apoptotic form of death, however, the 
caspase activation probably takes place during the second part of the process while initially 
mitochondria are protected from caspase digestion and remain functional (Von Ahsen et al., 
2000). If mitochondria are able to retain their membrane potential after cytochrome c 
release, they can keep producing ATP to some extent before losing impermeability of the 
inner membrane.  
How are mitochondria able to produce ATP without cytochrome c? There are two 
possibilities. First, a residual amount of cytochrome c may still be in the mitochondria 
attached to the inner membrane and keep the mitochondria operational (Von Ahsen et al., 
2000). There is a report against this possibility showing that the release of cytochrome c 
from mitochondria in response to an apoptotic stimulus is rather rapid and coordinated, in an 
“all or nothing” fashion (Goldstein et al., 2000; Martinou et al., 2000). Another possibility is 
that small quantities of reduced cytochrome c on the cytoplasmic side of the outer 
membrane may act as electron carriers by entering the intermembrane space and transferring 
electrons from the cytosolic environment to the complex IV of the mitochondrial respiratory 
chain (La Piana et al., 1998). In fact, it has been shown that cytochrome c release does not 
hurt the integrity of the mitochondrial inner membrane, and mitochondria can sustain their 
activity before caspases are activated and degrade the mitochondria (Waterhouse et al., 
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2001). In this way, the mitochondria can respire and maintain their membrane potential 
which allows them to maintain at least some of their normal activities including production 
of ATP, and this may even allow cells to survive mild episodes of stress.  
Mitochondrial PTP opening has been suggested as the “point of no return” in 
mechanisms of cell death, and inhibition of PTP opening has been able to efficiently reduce 
cell death upon myocardial ischemia-reperfusion (Chipuk et al., 2006; Mattson & Kroemer, 
2003). As was mentioned earlier, PTP consists of pores at the specific areas of the inner and 
outer membranes. The key components of the PTP are VDAC in the mitochondrial outer 
membrane, adenine nucleotide translocase (ANT) in the inner membrane, and cyclophilin D 
within the mitochondrial matrix (Hajnoczky et al., 2003).  
The activity of the pore is regulated by a variety of stimuli. Ca2+, ROS, inorganic 
phosphate, depletion of adenine nucleotides, disulfides, and long-chain fatty acids are 
among promoters of the pore opening, whereas antioxidants, high-energy phosphates, 
reduced glutathione, and acidic pH act as inhibitors of the pore opening (Brookes et al., 
2004; Weiss et al., 2003). It is worth noting that not only oxidants promote PTP opening, but 
PTP also enhances ROS formation (Zorov et al., 2000; Saris & Carafoli, 2005). In fact, 
mitochondrial membranes act as partial barriers for respiration-produced ROS, confining 
ROS in mitochondria where they can be safely detoxified by mitochondrial antioxidant 
systems and preventing them from reaching the cytosol where they can initiate oxidative 
reactions. With PTP opening, this barrier no longer exists and mitochondrially generated 
ROS can easily access the cytoplasmic targets.   
 
2.4.2. Cytochrome c, pro-survival and pro-apoptotic 
 
Cytochrome c appears to have dual anti- and pro-apoptotic functions, as it participates 
in the production of ATP and inhibition of O2·− formation on one hand and in triggering 
apoptosis on the other. Cytochrome c can be released from cardiac mitochondria as early as 
30 min after global ischemia (Borutaite et al., 2003). Also, treatment of rat embryonic 
ventricular cells (H9c2) with H2O2 has been shown to induce release of cytochrome c as 
early as 30 min (Han et al., 2004). It has been suggested that cells in response to apoptotic 
stimuli release all of their cytochrome c within 5 min (Goldstein et al., 2000). However, 
cytochrome c in some cell types may not be released from all mitochondria; rather it is more 
likely that some, but not all, mitochondria release their cytochrome c in a rapid and 
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coordinated fashion, quantitatively high enough to activate the apoptotic cascade (Martinou 
et al., 2000). 
Cytochrome c is embedded into the outer face of the mitochondrial inner membrane 
mainly through binding to phospholipids, especially cardiolipin (Ott et al., 2002). Since the 
interaction of cytochrome c and cardiolipin occurs through both electrostatic and 
hydrophobic binding, cytochrome c may be dissociated from cardiolipin through either ionic 
alterations or oxidative modifications in the structure of cytochrome c and/or cardiolipin.  
Cytochrome c release may occur through Ca2+-dependent or Ca2+-independent 
mechanisms (Gogvadze et al., 2001). In the Ca2+-dependent mechanism, Ca2+ activates PTP 
opening leading to mitochondrial swelling and rupture followed by non-specific release of 
mitochondrial proteins including those in the matrix and intermembrane space to the cytosol. 
In the Ca2+-independent mode, pro-apoptotic proteins from the Bcl-2 family especially Bax 
are able to induce release of cytochrome c without causing PTP opening, likely through 
formation of specific pores in the outer membrane (Von Ahsen et al., 2000). Bax may also 
enhance Ca2+-dependent PTP-mediated release of cytochrome c.   
The release of cytochrome c may block electron transport in the mitochondrial 
respiratory chain and therefore augment electron leakage at complexes I and III while 
mitochondria due to loss of matrix antioxidant systems following PTP probably have limited 
ability to efficiently scavenge the generated ROS (Brookes et al., 2004). However, this 
inhibition of respiration after cytochrome c release may not occur in vivo as mitochondria 
normally have plenty (20 mM) of cytochrome c, and even after losing most of their 
cytochrome c there may be still a sufficient amount (as little as 1 µM) to maintain 
respiration.   
The presence of cytochrome c outside of mitochondria is likely necessary but probably 
not sufficient to activate apoptosis, as overexpression of Bcl-2 protein has prevented 
apoptosis even in the presence of intracellular cytochrome c (Gabriel et al., 2003; 
Zhivotovsky et al., 1998). Contrarily, cytochrome c in the cytosol may confer antioxidant 
activity through scavenging cytosolic O2·− (Brookes et al., 2004). 
 
2.4.3. Role of the Bcl-2 family in regulation of cell death 
 
Several proteins including those of the Bcl-2 family are believed to regulate opening 
of the PTP (Kutuk & Basage, 2006). Bcl-2 proteins are mainly expressed in the outer 
 32
mitochondrial membrane, the surface of the endoplasmic reticulum, and the nuclear 
membrane. They are categorised as anti-apoptotic proteins, such as Bcl-2, Bcl-xL, and Bcl-
w, and pro-apoptotic ones, including Bax, Bak, Bad, and Bid. It has been reported that 
myocardial cells when subjected to an episode of ischemia-reperfusion, as an effort for 
survival, increase expression of Bcl-2 protein by up to 19-fold without changes in Bax 
expression (Kajstura et al., 1996).  
Pro-apoptotic Bcl-2 family proteins have been shown to trigger release of cytochrome 
c and lead to apoptosis (Kutuk & Basage, 2006). Several mechanisms have been proposed 
for this release. For instance, pro-apoptotic Bcl-2 proteins, such as Bax and Bak, can act 
directly on the mitochondrial outer membrane, inducing its permeability with consequent 
release of cytochrome c to the cytosol (Green & Kroemer, 2004; Lutter et al., 2000; 
Armstrong, 2006; Hajnoczky et al., 2003). The interaction of Bax with the outer membrane 
may be independent of PTP opening and even happens earlier than PTP opening (Martinou 
et al., 2000; Green & Kroemer, 2004). The Bax-induced cytochrome c release in the absence 
of PTP may explain the mechanism by which cytochrome c is released from mitochondria 
without formation of a PTP and mitochondrial swelling. By this mechanism, cytochrome c is 
released in a more selective manner without changes in mitochondrial volume (Gogvadze et 
al., 2001).   
Anti-apoptotic members of the family demonstrate effects opposite to the pro-
apoptotic proteins. For instance, they protect mitochondrial outer membrane integrity and 
prevent release of cytochrome c (Hajnoczky et al., 2003; Armstrong, 2006; Lutter et al., 
2000). They also possess antioxidant properties and attenuate oxidative stress, which is one 
of the factors inducing PTP opening (Hockenbery et al., 1993).  
Moreover, pro- and anti-apoptotic members of the Bcl-2 family can regulate PTP 
opening by, respectively, increasing or decreasing sensitivity of the PTP to Ca2+ (Hajnoczky 
et al., 2003). They also affect Ca2+ release from endoplasmic reticulum, with anti-apoptotic 
members decreasing and pro-apoptotic molecules increasing Ca2+ release from endoplasmic 
reticulum (Green & Kroemer, 2004; Kruman & Mattson, 1999). In general, it is the balance 
between anti- and pro-apoptotic proteins of this family, such as the ratio of Bcl-2 to Bax, 
that determines the cell’s fate of death or survival upon exposure to a pathologic stimulus. 
The emerging evidence points to the existence of cross-signaling between ROS, Ca2+, 
and Bcl-2 proteins in regulating the mitochondrial and endoplasmic reticulum response to 
physiological and pathological circumstances. For instance, both ROS (Buccellato et al., 
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2004; von Harsdorf et al., 1999) and Ca2+ (Raynaud & Marcilhac, 2006; Mattson & 
Kroemer, 2003) can signal the activation of pro-apoptotic proteins of the Bcl-2 family. 
Likewise, both pro-apoptotic Bcl-2 family proteins and ROS increase Ca2+ release from 
endoplasmic reticulum (Hajnoczky et al., 2006). 
 
2.4.4. Downstream signaling of cytochrome c 
 
Following PTP opening, about 100 proteins are released along with cytochrome c 
from mitochondria, among which are apoptosis-inducing factor (AIF) and pro-caspase 9 
(Martinou et al., 2000; Lopez-Neblina et al., 2005; Ott et al., 2002; Nicotera et al., 1998; 
Garrido et al., 2006). In the cytosol, cytochrome c in the presence of deoxy-ATP binds and 
activates its adaptor protein, apoptotic protease activating factor (Apaf)-1, yielding 
formation of an apoptosome. The apoptosome then activates pro-caspase-9 and the resultant 
caspase-9 in turn activates pro-caspases -3, -6, and -7, which are effector caspases for the 
execution of apoptosis. Since the formation of the apoptosome requires ATP, in the absence 
of ATP the apoptosome will not develop and the cell may switch the form of death to 
necrosis.  
Caspases are generally divided into two groups: those which are related to apoptosis, 
i.e. caspase-2, -3, -6, -7, -8, -9, and -10, and those which are implicated in pyroptosis (a form 
of caspase-dependent cell death which is accompanied with activation of inflammatory 
cytokines), i.e. caspase-1, -4, -5, -11, -12, -13, and -14 (Fink & Cookson, 2005). Caspases in 
the first group can be divided into two subgroups: initiator caspases, i.e. caspase-2, -8, -9, 
and -10, and effector or executioner caspases, i.e. caspase-3, -6, and -7. The initiator 
caspases are firstly activated by upstream signals and then they pass the signal down by 
activating the effector caspases. However, the initiator caspases may also contribute to 
apoptosis in ways other than activation of effector caspases. For instance, caspase-9 is not 
only committed to activation of caspase-3, it also enlarges nuclear pores, allowing large 
molecules such as caspase-3 to enter the nucleus and find their targets (Faleiro & Lazebnik, 
2000).  
The effector caspases after activation can degrade a variety of proteins, from kinases 
to cytoskeletal proteins to transcriptional regulators, to develop biochemical and 
morphological characteristics of apoptosis (Fink & Cookson, 2005; Fan et al., 2005). Here 
are presented examples of their activity. Caspase-activated DNase (CAD) inhibitor (ICAD) 
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is one of the caspase targets which is typically bound to CAD and inhibits its activity (Fink 
& Cookson, 2005; Fan et al., 2005). Upon segregation from ICAD, CAD is activated and 
breaks DNA into certain-length fragments (Bradbury et al., 2000).  
Poly (ADP-ribose) polymerase (PARP) is another target of caspases. PARP is a 
nuclear enzyme which mediates the repair of single-strand DNA nicks by transferring the 
ADP-ribose group of NAD to a number of DNA repair enzymes, recruiting them to fix the 
damaged DNA (Tartier et al., 2003). However, if the DNA damage is extensive, large 
amounts of NAD will be consumed. To replace the consumed NAD, the cell utilizes ATP, 
leading to ATP depletion and necrosis (Fink & Cookson, 2005). Thus, in apoptosis, 
although the damage to DNA as a result of fragmentation is considerable, no repair is 
executed as caspases digest and inactivate PARP.   
Lamins and fodrin, which are important cell structural proteins, are other targets of 
caspases. Lamins are a family of proteins that make up the inner surface of the nucleus and 
are responsible for nuclear stability and chromatin structure (Ruchaud et al., 2002; Fink & 
Cookson, 2005; Fan et al., 2005). The cleavage of lamins by caspases causes chromatin 
condensation and margination, nuclear shrinkage, and DNA fragmentation. Fodrin is a 
major component of the membrane cytoskeleton. Breakdown of fodrin by caspases during 
apoptosis creates apoptotic bodies. 
The enzyme transglutaminase cross-links cytosolic proteins and creates a cross-linked 
protein scaffold which inhibits leakage of intracellular components into the extracellular 
space and thus prevents provocation of inflammatory responses (Fabbi et al., 1999). In 
viable cells, transglutaminase exists in an inactive form which can be activated during 
apoptosis via cleavage by caspase-3. Transglutaminase activity leads to formation of 
apoptotic bodies with intact membranes.  
Translocation of phosphatidylserine to the outer face of the cell membrane is another 
caspase-dependent hallmark of apoptosis (Botto, 2004; Wu et al., 2006). Phosphatidylserine 
is normally maintained on the cytoplasmic surface of the plasma membrane. During 
apoptosis, as a result of caspase activation, oxidative stress, and/or high intracellular Ca2+, 
the asymmetry of phospholipids in cell membrane is lost and phosphatidylserine moves to 
the outer leaflet of the membrane. Phosphatidylserine exposure enables phagocytes to 
recognize apoptotic cells and safely engulf them before they undergo secondary necrosis 
with subsequent activation of inflammatory responses.  
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It is worthwhile to note that there is another group of cysteine proteases called calpains 
which are Ca2+-dependent and are involved in both apoptosis and necrosis when cytosolic 
Ca2+ is elevated (Harwood et al., 2005; Fan et al., 2005; Moore et al., 2002). Calpains and 
caspases have common substrates. Although they can be activated by distinct stimuli and 
proceed through discrete pathways, they cross-talk in their signaling route towards cell 
death. 
 
2.5. Cardiac performance 
 
2.5.1. No reflow phenomenon  
 
Reperfusion does not always lead to complete restoration of blood flow; instead some 
areas in the vasculature of an ischemic tissue may remain occluded or receive impaired flow. 
This feature of reperfusion is called the “no reflow” phenomenon and is a consequence of 
microvasculature plugging with neutrophils and platelets concomitant with swelling and 
protrusions of endothelium (Reffelmann & Kloner, 2006). Myocardial cell swelling and 
interstitial edema probably also contribute to the obstruction. 
 
2.5.2. Ventricular dysfunction 
 
Re-establishment of blood flow to an ischemic heart may not entirely restore cardiac 
performance (Kloner & Jennings, 2001; Ferrari et al., 1999; Rinaldi & Hall, 2000). 
Furthermore, an ischemic heart may never recover its normal contractility and even 
terminate in heart failure. There are a variety of post-ischemic myocardial contractile 
disarrangements. For instance, after a short non-intense ischemia the majority of cells 
remain alive but the heart may not regain its normal contractility for a variable course of 
time lasting from hours to days. This transient reversible contractile depression is termed 
“stunning” and occurs despite restoration of the blood flow to the pre-ischemic level. On the 
other hand, a chronic mild ischemia can result in impaired blood flow concomitant with 
chronic depressed contractile function, called “hibernating”. However, as the damage is 
reversible, restoration of flow can lead to recovery of contractility. 
Cardiac arrhythmia is another type of perturbation after ischemia, and can be 
associated with manifestations of ventricular tachycardia and fibrillation (Maxwell & Lip, 
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1997). Reduction in systolic pressure and augmentation in diastolic tension are among the 
hemodynamic disturbances of reperfusion (Lefer & Granger, 2000). Since ROS and Ca2+ are 
blamed as principal factors causing ischemia-reperfusion damage, antioxidants and 
inhibitors of Ca2+ overload may be effective interventions for alleviating contractile 
disturbances after ischemia (Bolli, 1994 & 2003).  
 
2.5.3. Contribution of energy depletion to cardiac contractile dysfunction 
 
As heart contractility is highly dependent on cellular ATP resources, impairment of 
the mitochondrial oxidative phosphorylation system has a tremendous impact on the heart 
well being and function (Brookes et al., 2004). During ischemia, cells that are deprived of 
oxygen switch their metabolism from aerobic to anaerobic, and rely on the limited amount 
of ATP that is produced through glycolysis. This leads to decline of intracellular pH on one 
hand and rapid ATP depletion on the other. Depletion of cellular ATP is associated with 
ischemic contracture, also known as rigor contracture or rigor shortening (King & Opie, 
1998; Kingsley et al., 1991). The contracture is caused by the strong interaction between 
actin and myosin that in experimental conditions occurs at very low ATP concentrations. 
The development of rigor contracture is a key event happening during the progress of cell 
injury. It is worthwhile to note that excessive concentrations of Ca2+ at the beginning of 
reperfusion concomitant with restoration of ATP supply and normalization of intracellular 
pH may also trigger hypercontracture, although this time upon reperfusion (Piper et al., 
1998). 
 
2.6. Endothelial dysfunction 
 
As a result of ischemia-reperfusion, the cardiac circulatory system loses its normal 
function mainly due to endothelial dysfunction (Szocs, 2004). Endothelial function is 
dependent on the cellular level of nitric oxide (NO). The production of NO in endothelial 
cells drops as early as 2.5-5 min following the onset of reperfusion (Lefer & Lefer, 1996) 
and emerging evidence indicates that stimulation of endogenous NO production or 
administration of NO substrate improves resistance of hearts to ischemia-reperfusion injury, 
while inhibition of NO generation worsens post-ischemic complications (e.g. Liu et al., 
2007a; Pozo-Navas et al., 2006; Li et al., 2006b). NO has been recognized as the trigger as 
 37
well as a mediator of ischemia preconditioning (Dawn & Bolli, 2002; Szigeti et al., 2004; Li 
et al., 2004). 
NO has vasodilatory, anti-inflammatory, and anti-platelet activities (Laursen et al., 
2006; Reichenbach et al., 2005). It is unstable, possessing a half-life as short as 1 s (Miller, 
2001; Szocs, 2004). The NO half-life in biological environments closely depends on the 
concentration of O2·−. Antioxidants, such as superoxide dismutase, glutathione, and vitamins 
E and C, have been shown to elevate NO bioavailability.  
Several mechanisms have been proposed for NO protection of myocardium from 
ischemia-reperfusion injury. For instance, NO prevents neutrophil adhesion to the 
endothelium via reducing expression of endothelial adhesive molecules such as ICAM-1 and 
P-selectin, therefore inhibiting neutrophil and platelet aggregation and activation and 
suppressing subsequent inflammation (Pagliaro et al., 2003; Laude et al., 2002). 
In contrary, injurious effects of NO have also been reported. These effects are the 
outcome of the reactivity of NO with other reactive molecules. NO is typically a low activity 
ROS that can react with other free radicals such as superoxide and lipid peroxyl radicals. 
The products, such as peroxynitrite, react with amino acid residues on proteins, leading for 
instance to modification of cysteine residues (S-nitrosylation) in proteins and thereby 
altering the conformation and activity of cellular enzymes such as those involved in the 
mitochondrial respiratory chain (Clementi et al., 1998). Most of detrimental effects of NO 
are attributed to peroxynitrite (Pacher et al., 2007; Ferdinandy & Schulz, 2003).  
Peroxynitrite (ONOO−), a product of reaction of NO with O2·−, can decompose to 
strong oxidizing agents such as nitrogen dioxide and hydroxyl radical that can nitrate and 
hydroxylate cellular biomolecules including lipids, proteins, and sugars (O’Donnell et al., 
1999). Although hydroxyl radicals have been designated as the most toxic species of ROS, 
ONOO− may be even more destructive as it is comparably more stable and therefore can 
diffuse farther into cellular compartments and even pass the cell membrane and hit 
extracellular targets (Beckman et al., 1994). 
Marked increases in production of O2·− during ischemia-reperfusion provide a suitable 
context for formation of ONOO−. Growing evidence indicates that levels of NO, O2·−, and 
ONOO− greatly increase at reperfusion, and that application of NOS inhibitors or superoxide 
dismutase has beneficial impacts on contractile performance of hearts after ischemia (Pacher 
et al., 2007). Mitochondria, being the primary cellular producers of O2·−, have been 
suggested as a great source of ONOO¯ generation (Packer et al., 1996). The produced 
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ONOO− can damage mitochondrial proteins, lipids, and DNA. As a target, ONOO− can 
inactivate manganese superoxide dismutase (MnSOD), one of the two chief mitochondrial 
O2·− quenchers (Macmillan-Crow & Cruthirds, 2001). Indeed, ONOO− appears to be the 
only oxidant capable of inactivating MnSOD through nitration of critical tyrosine residues. 
It is noteworthy that in the presence of physiological concentrations of ascorbate, 
mitochondria detoxify peroxynitrite via its decomposition to yield NO (Barone et al., 2003). 
NO is produced by nitric oxide synthases (NOS). Three isoforms of NOS have been 
identified: endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS). 
Activation of nNOS and eNOS has been found necessary and advantageous for normal 
function of endothelium, while induction of iNOS results in generation of large amounts of 
NO which may have deleterious effects (Razavi et al., 2005). All three NOS isoforms are 
expressed in cardiac myocytes (Raij, 2006). In biphasic fashion, myocardium uses eNOS 
and iNOS for rapid and prolonged production of NO, respectively. During reperfusion, 
production of moderate amounts of NO (probably by eNOS) inhibits neutrophil infiltration 
and results in myocardial protection (Vinten-Johansen et al., 1999). However, depending on 
the amount of oxidative stress (Berges et al., 2003) high levels of NO produced by iNOS 
may deliver protective (Wakeno-Takahashi, 2005; Das & Sarkar, 2007) or harmful effects 
(Li et al., 2005; Egi et al., 2004). 
Depending on pathological circumstances and concentration of NO, NO may display 
anti- or pro- apoptotic properties (Razavi et al., 2005). Anti-apoptotic effects of NO are 
mainly mediated by low amounts of NO following stimulation of eNOS. The eNOS has 
shown the potential to block apoptosis in myocardial infarction and heart failure. The anti-
apoptotic effect of NO is performed through S-nitrosylation of proteins that are implicated in 
apoptosis signaling, such as caspases, activator protein-1, and transglutaminase. Some of the 
protective effects of NO against apoptosis may also be exerted through induction of 
protective proteins such as heme oxygenase-1, heat shock proteins, and metallothionein. The 
pro-apoptotic effects of NO are mostly due to high concentrations of NO produced by iNOS, 
resulting in the generation of ONOO−. However, ONOO− alone may not be sufficient to 
develop PTP opening and apoptosis, as it particularly promotes PTP in Ca2+-loaded 
mitochondria, pointing to a synergism between Ca2+ and ONOO− and exemplifying the 
extent of complications in ischemia-reperfusion injury (Brookes & Darley-Usmar, 2004). 
Moreover, high levels of NO may switch the form of cell death from apoptosis to necrosis 
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by inhibiting mitochondrial respiration and decreasing ATP synthesis in spite of deferring 
cytochrome c release and inactivating the effector caspases (Leist et al., 1999).  
 
2.7. Ischemia preconditioning 
 
Ischemia preconditioning is one of the most potent anti-ischemic interventions known 
to date. It consists of increasing resistance of an organ, tissue, or a number of cells by means 
of utilizing a non-harmful stimulus prior to the exposure to a noxious insult such as ischemia 
(Bolli, 2007; Das & Maulik, 2006). Preconditioning may be exerted by a wide variety of 
stress stimuli; one of the most investigated is achieved by brief (3-5 minutes) transient 
cycles of ischemia and reperfusion. Although the mechanisms of preconditioning are not 
entirely elucidated, it is likely that in response to mild primary instigations specific proteins 
in cells are activated and particular genes are expressed, leading ultimately to reinforcement 
of the tissue for better withstanding subsequent stresses. In other words, upon 
preconditioning the heart senses the stress and changes its phenotype in a way to be more 
defensive and better protected.   
Preconditioning consists of two phases: an early phase (classical preconditioning), 
which appears within minutes and wanes within 2-4 hours, and a late phase, which occurs 
12-24 hours later and persists for 3-4 days (Bolli, 2007; Eisen et al., 2004; Qiu et al., 1997) 
(Figure 2.6). The mechanisms of cardioprotection by the two phases are probably different; 
while post-translational alterations such as changes in the activity of existing proteins are 
suggested to develop the early phase, induction and expression of relevant genes and 
synthesis of proteins is probably the basis of the late phase. The cardioprotective strength of 
the two phases is also different. The early phase is highly powerful but short-lasting, 
whereas the late phase is less effective but lasts longer. Therefore, the early phase alleviates 
the severity of damage (infarct size) in the acute phase and reduces mortality, while the 
delayed type protects mainly against the chronic aspects of injury such as contractile 
dysfunction (e.g. myocardial stunning) although it is also effective in reducing infarct size.    
Still much needs to be known about preconditioning and its underlying mechanisms. 
The early preconditioning relies on recruitment of G-protein-coupled receptors to activate a 
number of signaling pathways including various protein kinases and eNOS (Murphy, 2004; 
Post & Heusch, 2002; Otani, 2004) (Figure 2.6). These signaling pathways cardioprotect 
through effects on mitochondria, the best known effect being activation of mitochondrial 
 40
KATP channels. Mitochondrial KATP channels, which activate an inward current of potassium 
across the mitochondrial inner membrane, reduce the membrane potential and therefore 
attenuate mitochondrial Ca2+ uptake. Mitochondrial KATP channels may also increase Ca2+ 
release in mitochondria. Additionally, the opening of mitochondrial KATP channels results in 
a mild increase in mitochondrial volume (swelling) that causes a trend towards closing the 
voltage-dependent anion channels (VDAC). Closing such channels is beneficial as it 
prevents transmission of glycolytically-generated ATP from cytosol to the mitochondria, 
where it can be consumed by F1F0-ATPase activity favoured during ischemia as a result of 
decreased membrane potential.  
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Figure 2.6. Major differences in the characteristics and proposed mechanisms of ischemia 
preconditioning.  
 
ROS, reactive oxygen species; GPCR, G protein-coupled receptor; PI3K, phosphatidylinositol-
3-kinase; PKC, protein kinase C; TyrK, tyrosine kinase; MAPK, mitogen-activated protein 
kinases; eNOS, endothelial nitric oxide synthase; Mito, mitochondria, VDAC, voltage-
dependent anion channels; NO, nitric oxide; NF-κB, nuclear factor-κB; iNOS, inducible nitric 
oxide synthase; COX-2, cyclooxygenase-2; SODs; superoxide dismutases; HO-1, heme 
oxygenase-1; PGI2, prostacyclin; PGE2, prostaglandin E2. 
 
 41
The signaling pathways evoked by early preconditioning also trigger transduction 
pathways for development of late preconditioning. Transduction pathways that are activated 
during the process of late preconditioning lead to activation of transcription factors 
(especially nuclear factor-κB) and subsequently induction of corresponding genes and 
protein synthesis (Bolli, 2007; Post & Heusch, 2002; Otani, 2004). Proteins such as iNOS, 
cyclooxygenase-2, heme oxygenase-1, and superoxide dismutases have been recognized as 
mediators of late preconditioning. iNOS and cyclooxygenase-2 probably work through 
improvement of vascular flow, and superoxide dismutases and heme oxygenase-1 act mainly 
via suppression of ROS. Elevation of activity and/or expression of endogenous antioxidants 
have been shown following ischemia preconditioning (Dhalla et al., 2000). However, the 
absence of augmented levels of antioxidants and antioxidant enzymes has also been reported 
in preconditioned myocardium by a number of investigators (Tang et al., 1997), although the 
induction of ischemia preconditioning was not verified in their study. 
Late preconditioning or so-called “second window of protection” is more beneficial 
than the early phase as it produces prolonged protection. The late preconditioning can be 
developed by various stimuli, dividable into two groups: non-pharmacological, such as 
ischemia and exercise, and pharmacological, such as adenosine agonists and NO donors 
(Eisen et al., 2004). ROS can also act as triggers of the late preconditioning. Administration 
of a complex of ROS scavengers has been shown to block activation of this type of 
preconditioning (Sun et al., 1996). Nevertheless, ROS are advantageous as effectors of the 
late preconditioning as long as their cellular levels do not exceed the antioxidant capacity of 
the cell; otherwise they will be more destructive than helpful.   
Preconditioning of the myocardium has been revealed to decrease myocardial energy 
demand, resulting in a reduced rate of ATP consumption and thereby a diminished rate of 
anaerobic glycolysis and lactate production, which in turn prevents acidosis (Eisen et al., 
2004) and accumulation of Na+ and Ca2+, resulting ultimately in diminution of overall 
injury.  
Recently, a protection by similar repetitive brief cycles of ischemia and reperfusion 
applied at the beginning of reperfusion, called post-conditioning, has been discovered 
(Vinten-Johansen, 2007; Rodríguez-Sinovas et al., 2007). Post-conditioning is in fact a form 
of gradual reperfusion which has long been known to be effective to prevent reperfusion 
injury. The mechanism of protection by post-conditioning is unclear, but it seems that 
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deceleration of neutralizing pH and gradual reintroduction of oxygen which allow cells to 
prevail over ionic and oxidative disturbances at early reperfusion are implicated.  
 
2.8. Cellular antioxidant network  
 
2.8.1. Non-enzymatic antioxidants 
 
Human studies have shown depletion of non-enzymatic antioxidants such as 
glutathione, ascorbic acid, and vitamin E following myocardial ischemia-reperfusion 
(Marczin et al., 2003). Hydrophilic antioxidants, such as ascorbate and glutathione, that 
work in the cytosol and extracellular fluids seem to respond to oxidative stress earlier than 
lipophilic antioxidants such as ubiquinol and vitamin E that act in membranes (Haramaki et 
al., 1998). This suggests that antioxidants in cells are engaged in a network, having a 
systematic relationship with one another and being utilized in a certain order. In such a 
network, aqueous phase antioxidants, e.g. ascorbate and glutathione, work at the front line of 
defence against oxidative stress, protecting aqueous cell biomolecules such as proteins and 
DNA from oxidation, and also helping to regenerate lipid phase antioxidants from their 
oxidized forms. In this system, ascorbic acid serves to regenerate vitamin E from vitamin E 
radicals (Nagaoka et al., 2007), and is in turn regenerated by glutathione (May et al. 1996). 
Therefore, lipid phase antioxidants are likely preserved in cells as long as hydrophilic 
antioxidants have not been consumed.  
Many authors have pointed to the existence of the antioxidant network in the cellular 
entity (Marczin et al., 2003; Blomhoff, 2005). This antioxidant network concept 
authenticates the preference of combined treatments of antioxidants over their separate 
application upon conditions of severe oxidative stress such as ischemia-reperfusion.  
 
2.8.1.1. Glutathione  
 
Glutathione (GSH) or γ-glutamyl-cysteinyl-glycine is the prominent intracellular non-
protein sulfhydryl compound that is found in cells in millimolar (0.5-10) concentrations 
(Lash, 2006; Chakravarthi et al., 2006; Wu et al., 2004; Dickinson & Forman, 2002). GSH is 
mainly synthesized in the liver, although it can be made in any cell type. Since cytoplasm is 
the major site of GSH synthesis, most of cellular GSH (85-90%) is found in the cytosol, 
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with the rest being located mainly in mitochondria, nuclear matrix, and peroxisomes. The 
activity of GSH relies on the thiol residue of the cysteinyl group that allows glutathione to 
act as both a reductant and a nucleophilic compound.  
By working as a reductant, GSH can react in a direct non-enzymatic mode with 
carbon-centred radicals, donating an electron from its cysteine residue and being itself 
oxidized to glutathione disulfide (GSSG) (Lash, 2006). Moreover, GSH keeps sulfhydryl 
residues of cellular proteins in their reduced form. This protection of sulfhydryl groups by 
GSH could happen through reducing highly reactive peroxides catalyzed by glutathione 
peroxidase or through entering in thiol-disulfide exchange reactions catalyzed by thiol 
transferases. As a nucleophile, GSH is conjugated to electrophilic groups of xenobiotic and 
cytotoxic compounds by means of the catalytic effect of glutathione S-transferases, making 
hydrophilic glutathionyl conjugates from toxic substances that can then easily be excreted. 
Thus, the major role of GSH is to maintain intracellular redox homeostasis and to defend 
cells not only against ROS but also against other toxic insults.  
The conversion of intracellular GSSG to GSH is performed by glutathione reductase, a 
flavoprotein that converts one molecule of GSSG to two molecules of GSH using NADPH 
as electron donor (Noctor et al., 2002). Thus, the amount of GSH + 2GSSG defines total 
cellular glutathione, almost 15% of which is attached to proteins (Wu et al., 2004). The ratio 
of GSH to GSSG reflects cellular redox state and antioxidant potential of cells and is 
generally more than 10 under normal circumstances. Apart from conversion to GSH, an 
alternative route for intracellular GSSG is exclusion from cells, a mechanism that prevents 
suppression of the cellular GSH to GSSG ratio.  
The extent of myocardial damage and the speed of mechanical recovery after 
ischemia-reperfusion are strongly dependent on glutathione levels in the heart tissue (Singh 
et al., 1989). Accordingly, DNA fragmentation that occurs during the process of cell death 
has been found associated with oxidative stress-induced glutathione depletion (Higuchi, 
2004). Administration of glutathione has mitigated post-ischemic injury in rat hearts where 
ascorbic acid was ineffective, although the best protection was observed in co-treatment 
with glutathione and ascorbate, implying the existence of a synergism between the two 
hydrophilic antioxidants (Gao et al., 2002). 
Ischemia-reperfusion has been demonstrated to result in a decrease in glutathione and 
an increase in malondialdehyde in hearts of animals (Ozer et al., 2005; Lapenna et al., 1996; 
Roth et al., 1997) and heart (De Vecchi et al., 1998) and blood samples (Akila et al., 2007) 
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of humans. Lowered concentrations of the reduced form of glutathione are likely to be 
concurrent with elevated levels of its oxidized form (Ji et al., 1993; Arduini et al., 1988). 
Alteration in glutathione status of the myocardium is supposedly worsened by intensification 
of oxidative stress during ischemia-reperfusion (Haramaki et al., 1998). Reperfusion has 
been shown to cause a sustained liberation of the reduced and especially oxidized forms of 
glutathione from the heart concomitant with suppressed cardiac function, both correlating 
with the duration of ischemia (Ferrari et al., 1990).  
Glutathione is one of the few agents which detoxify peroxynitrite without forming 
other toxic compounds (Ronson et al., 1999). Hearts treated with glutathione had a reduced 
formation of peroxynitrite in the first minutes of reperfusion and better mechanical function 
after ischemia and upon exposure to peroxynitrite (Cheung et al., 2000). The reaction of 
glutathione with peroxynitrite results in formation of thiol-containing compounds such as 
nitrosothiols that can subsequently convert to nitric oxide (Ronson et al., 1999). 
Furthermore, biological properties of nitric oxide and nitrosothiols are similar. For instance, 
similar to nitric oxide, nitrosothiols have vasodilatory and anti-neutrophil activities (Rassaf 
et al., 2002; Ronson et al., 1999).  
 
2.8.1.2. Ascorbic acid 
 
Plasma levels of ascorbate decrease upon ischemia-reperfusion in human hearts and 
may remain low for up to 2 weeks (Ballmer et al., 1994). Similarly, tissue concentrations of 
ascorbate diminish in ischemic-reperfused hearts depending on the length of reperfusion and 
severity of oxidative stress (Haramaki et al., 1998). The reduction in cardiac tissue ascorbate 
is associated with release of ascorbyl radicals in coronary flow (Pietri et al., 1990). 
Nevertheless, oral supplementation with vitamin C may or may not lead to alleviation of the 
injury. For instance, whereas in a study high dosage of ascorbic acid exhibited a remarkable 
protection on myocardium of patients undergoing bypass operation (Dingchao et al., 1994), 
in another study application of high-dose ascorbic acid, although it increased total 
antioxidant capacity and preserved antioxidant enzyme activities in plasma of patients 
undergoing heart valvular surgery, it did not prevent metabolic alterations such as increased 
generation of lactate during ischemia (Marczin et al., 2003). Similarly, some animal studies 
have also found no cardioprotection from ascorbate against ischemia-reperfusion injury 
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(Rump et al., 1998). The difference in experimental conditions such as dosage and time of 
ascorbate administration may be the cause of the discrepancies. 
The effectiveness of ascorbate administration in attenuation of myocardial 
microvascular damage after ischemia has been found greater than that of Trolox, although 
the best protection was seen in application of the combined treatment (Molyneux et al., 
2002). Ascorbate also has a sparing effect on glutathione (Meister, 1994). 
 
2.8.1.3. Vitamin E 
 
Similar to other antioxidants, myocardial tissue vitamin E level depletes during 
ischemia-reperfusion events (Barsacchi et al., 1992; Coghlan et al., 1993; Westhuyzen et al., 
1997). Likewise, a drop in blood levels of α-tocopherol and β-carotene after myocardial 
infarction in humans has also been observed in some (Muzakova et al., 2001) but not all 
studies (Ballmer et al., 1994; Tangney et al., 1998). Similar to ascorbic acid, vitamin E 
supplementation may or may not deliver beneficial effects. The disagreements may be a 
result of difference in severity of oxidative stress, the status of other antioxidants, and the 
time course of vitamin E supplementation. For instance, vitamin E may be more helpful in 
severe cases of myocardial infarction (Dhalla et al., 2000). Further, studies show that the 
increase of vitamin E concentration in myocardial tissue after oral administration may 
require days to weeks (Mickle et al., 1991). However, even if an appropriate amount of 
vitamin E is loaded in the tissue and prevents vitamin E depletion during cardiac operation, 
expected biochemical and clinical benefits may not be achieved (Westhuyzen et al., 1997). 
 
2.8.2. Enzymatic antioxidants  
 
ROS are formed during normal cellular metabolism and under pathophysiological 
circumstances. To quell deleterious effects of ROS, cells have developed an organized 
system of antioxidant enzymes. They engage, for instance, superoxide dismutase to detoxify 
O2·− with subsequent production of H2O2, which is in turn converted to water by glutathione 
peroxidase or catalase with simultaneous oxidation of glutathione (Dhalla et al., 2000; 
Dickinson & Forman, 2002). The oxidized glutathione can then be reduced back to the 
glutathione by glutathione reductase. Glutathione S-transferase is another enzyme which 
conjugates electrophiles and lipid peroxides with glutathione, facilitating their excretion 
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from the body. Therefore, similar to non-enzymatic antioxidants, the enzymatic antioxidants 
participate coordinately in reactions against oxidative stress. As depicted in the Figure 2.7, 
the coordinated action of various cellular antioxidants ensures efficient detoxification of 
ROS and electrophilic compounds.  
Although the available literature mostly indicates depletion of non-enzymatic 
antioxidants during ischemia-reperfusion, reports on activity of enzymatic antioxidants are 
contradictory as all cases of increase, decrease, or no alteration in their activities have been 
reported (Marczin et al., 2003; Arduini et al., 1988). For instance, some studies have shown 
no effect of ischemia-reperfusion on activities of catalase, glutathione peroxidase, and 
superoxide dismutase (Kihlstrom et al., 1989; Coudray et al., 1995), or on glutathione 
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Figure 2.7. Coordinated action of some of cellular antioxidants.  
 
GSH, glutathione; GSSG, glutathione disulfide; GPx, glutathione peroxidase; GR, glutathione 
reductase; GST, glutathione S-transferase; SOD, superoxide dismutase; AscH2, ascorbic acid; 
Vit E, vitamin E; Vit E•, vitamin E radical (adapted from Juurlink, 2001). 
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peroxidase and glutathione reductase (Curello et al., 1985). In contrast, some investigators 
have reported reduced activities of glutathione peroxidase, glutathione reductase, and 
catalase (Ji et al., 1993), reduced activities of glutathione peroxidase and catalase and 
increased activity of glutathione S-transferase (Porreca et al., 1994), or decreased activity of 
glutamate cysteine ligase and unmodified activity of glutathione reductase (Lapenna et al., 
1996). Similar discrepancies have been observed in human studies. For instance, cyanotic 
patients undergoing open heart surgery showed elevated activities of glutathione peroxidase, 
catalase, and superoxide dismutase after reperfusion (Kim et al., 1994), whereas patients 
undergoing cardiopulmonary bypass had lower catalase, higher glutathione reductase, and 
unchanged glutathione peroxidase activities after the surgery relative to the pre-operation 
values (Inal et al., 1999).  
Also, in some reports antioxidant enzyme activities have changed during ischemia but 
returned to the pre-ischemic levels upon reperfusion. For instance, in a study by Prasad et al. 
(1992) activities of superoxide dismutase and catalase decreased during ischemia and 
returned to control levels during reperfusion. A similar pattern was observed after increased 
activity of glutathione reductase during ischemia (Arduini et al., 1988). Moreover, the 
response of enzyme activities to stimuli may differ depending on the isoform of the enzyme 
and its cellular location. For example, the mitochondrial form of superoxide dismutase 
decreased after both ischemia and reperfusion, whereas the cytoplasmic type remained 
unchanged (Arduini et al., 1988). Likewise, although the activities of both cytoplasmic and 
mitochondrial glutathione peroxidase increased upon ischemia, only the mitochondrial form 
showed further elevation during reperfusion.   
The activity of catalase in the myocardium is known to be scant (Dhalla et al., 2000). 
Nonetheless, catalase might have a significant role in protecting hearts during ischemia-
reperfusion where the concentration of ROS in myocardium increases remarkably. However, 
results of administration of catalase as well as that of superoxide dismutase are inconclusive. 
For example, although both superoxide dismutase and catalase reduced production of 
hydroxyl radicals in ischemic-reperfused hearts, they conferred no improvement in cardiac 
contractile function (Tosaki et al., 1993). Combined treatment with superoxide dismutase 
and catalase, however, was effective in improving post-ischemic myocardial function 
(Kazimoglu et al., 2004; Tosaki et al., 1993; Galang et al., 2000; Lefer & Granger, 2000). 
Nevertheless, there are also studies that have not found improvement of contractile function 
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and limitation of infarct area upon co-administration of superoxide dismutase and catalase 
(Przyklenk & Kloner, 1989). 
 
2.8.2.1. Phase 2 enzymes 
 
Xenobiotics and antioxidants in cells provoke coordinated induction of a particular 
class of genes which enhance cellular defence against oxidative stress (Jaiswal, 2004; Chen 
& Kunsch, 2004; Lee & Johnson, 2004). These genes encode for a number of phase 2 
detoxification enzymes including NAD(P)H:quinone oxidoreductase (NQO)1, NQO2, 
glutathione S-transferase, γ-glutamate cysteine ligase (GCL), heme oxygenase (HO)-1, UDP 
glucuronyl transferase, ferritin, and metallothionein-1. Promoters of these genes contain a 
common cis-element, termed antioxidant response element (ARE), which is involved in the 
transcriptional activation of the genes primarily governed by nuclear factor-E2-related 
factor-2 (Nrf2). Over exposure to oxidative stress the expression of genes possessing ARE is 
coordinately regulated by Nrf2. Thus, Nrf2-deficient mice are very sensitive to electrophilic 
and chemical damages. Nrf2 is normally sequestered in the cytosol by Keap1 (Kelch-like 
ECH-associated protein 1) (Jaiswal, 2004). The mechanism of Nrf2 activation is not yet 
clear. Phosphorylation of Nrf2 and modification of redox-sensitive cysteine residues in 
Keap1 are among the possible ways to dissociate Nrf2 from Keap1.  
A number of antioxidant enzymes such as superoxide dismutase and catalase are not 
currently known as phase 2 enzymes; however, they may be induced by Nrf2. Zhu et al. 
(2005) showed that incubation of cardiac fibroblasts by dithiole-3-thione led to induction of 
Cu/Zn-superoxide dismutase, catalase, glutathione, glutathione reductase, glutathione 
peroxidase, glutathione S-transferase, and NAD(P)H:quinone oxidoreductase; the expression 
of all except glutathione peroxidase was abolished in Nrf2-/- cells. Similarly, Chen and 
Kunsch (2004) have listed a number of detoxification and antioxidant genes that their 
coordinated expression is regulated through an Nrf2/ARE mechanism; among these genes 
are glutathione-dependent genes, such as glutathione peroxidase, glutathione reductase, 
peroxiredoxin, as well as two well known phase 2 enzymes glutathione S-transferase and 
glutamate cysteine ligase. It is noteworthy that phase 2 enzymes may be induced by 
transcription factors other than Nrf2. For instance, HO-1 may be induced by Nrf2 as well as 
activator protein-1 (AP-1) and NF-κB (Hill-Kapturczak et al., 2001). Similarly, AP-1, NF-
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κB, Nrf1, and Nrf2 mediate induction of glutamate cysteine ligase (Soltaninassab et al., 
2000; Kwong et al., 1999). 
 
2.8.2.1.1. NAD(P)H:quinone oxidoreductase 
 
NAD(P)H:quinone oxidoreductase (NQO1) , also referred to as DT-diaphorase, is a 
flavoprotein that, using either NADH or NADPH as electron donor, catalyzes the two 
electron reduction of electrophilic compounds quinones and quinonoids to hydroquinones 
without formation of semiquinones (Ames et al., 2002; Chen et al., 2000b; Ross, 2004; Chen 
& Kunsch, 2004). The hydroquinones then can be conjugated and excreted. The two 
electron reduction is a unique feature of NQO1 as other quinone reductases such as 
cytochrome P450 reductase catalyze one electron reduction to generate semiquinone radicals 
which can stimulate oxidative reactions. Interestingly, NQO1 has long been recognized as a 
chemoprotective agent and its induction is used as a means for identification of potential 
anti-carcinogens (Dinkova-Kostova & Talalay, 2000).  
NQO1 is mainly committed to maintain two critical lipid soluble antioxidants, 
coenzyme Q and vitamin E quinone, in their reduced forms, i.e. ubiquinol and vitamin E 
hydroquinone, thereby protecting cellular membranes from oxidative damage (Genova et al., 
2003; Dinkova-Kostova & Talalay, 2000). NQO1 has also been recognized as an O2·− 
scavenger, although weaker than superoxide dismutase (Zhu et al., 2007a). However, the 
high levels of NQO1 in cells especially after exposure to oxidants make it a significant O2·− 
scavenger. NQO1 may also stabilize p53, which is a transcription factor with tumor 
suppressor activity (Ross, 2004). The p53 protein has a major role in cessation of cell cycle 
and initiation of apoptosis, although a role for which in upregulation of glutathione 
peroxidase has also been reported (Tan et al., 1999). NQO1 and p53 share in numerous 
stimulants, and NQO1 has been shown to stabilize p53 and therefore promote apoptosis 
(Ross, 2004). Stabilization of p53 by NQO1 is likely one of the mechanisms of the anti-
tumor and anti-carcinogenic properties of NQO1.  
NQO1 has been found in high amounts in rat aortic smooth muscle cells, rat 
embryonic cardiac H9c2 cells, and human aortic smooth muscle and endothelial cells (Zhu 
et al., 2007a). In spite of the high levels of the enzyme in rat and mouse liver, human liver 
did not show appreciable amounts (Ross, 2004). In human tissues, NQO1 is primarily 
located in epithelial and endothelial cells. High levels of NQO1 in these tissues may provide 
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a mechanism by which NQO1 protects against harmful agents that are directed to the body 
from gut, airways, or vascular system. Nevertheless, upon over-exposure of cells to 
oxidative stress, considerable amounts of NQO1 can be expressed in other tissues.  
 
2.8.2.1.2. Heme oxygenase-1  
 
Heme oxygenases are rate-limiting enzymes that catalyze degradation of heme into 
biliverdin, carbon monoxide, and ferrous iron (Perrella & Yet, 2003; Chen & Kunsch, 2004; 
Katori et al., 2002). Three isoforms of heme oxygenase have been identified: HO-1, -2, and -
3. HO-1 is a phase 2 protein and can be induced by a number of stimulators including heme, 
cytokines, nitric oxide donors, and ROS, as well as conditions of oxidative stress such as 
organ transplantation, atherosclerosis, and ischemia-reperfusion. Heme is a strong pro-
oxidant and its degradation limits generation of ROS. High levels of heme can be released 
upon ischemia-reperfusion from damaged tissues and from injured red blood cells (Kumar & 
Bandyopadhyay, 2005; Katori et al., 2002; Tsuchihashi et al., 2004). The source of free 
heme in tissues is mainly heme-containing proteins such as myoglobin, catalase, superoxide 
dismutase, glutathione peroxidase, cytochromes, soluble guanylate cyclase, and nitric oxide 
synthases (Zhuang et al., 2003). 
The first two mentioned products of heme breakdown by heme oxygenases, biliverdin 
and carbon monoxide, provide benefits for the cell. Biliverdin, which itself is an antioxidant, 
is rapidly reduced to bilirubin, a powerful peroxyl radical scavenger and one of the most 
important antioxidants in serum and tissues (Chen & Kunsch, 2004; Katori et al., 2002). 
Carbon monoxide is a vasodilatory, anti-inflammatory, and anti-apoptotic agent. The ferrous 
iron resultant from the activity of heme oxygenases could act as a co-factor for oxidative 
reactions. However, it is quickly picked up by endoplasmic reticulum and then exported 
from cells where it is captured by iron-binding proteins, such as ferritin, and quelled. 
Increased intracellular iron levels have been shown to up-regulate apoferritin protein 
synthesis. Indeed, the apoferritin up-regulation may be a part of the antioxidative response 
attributed to HO-1. Moreover, HO-1 up-regulates an ATP-dependent iron pump, which 
resides along with HO-1 in the microsomal membrane of the endoplasmic reticulum and 
mediates the transport of non-protein-bound iron from the cytoplasm into the microsomal 
vesicles, where it can be released to the vascular system by means of exocytosis.  
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Localization studies have revealed that the induction of HO-1 occurs in cardiac cells 
including those located around blood vessels (Sharma et al., 1999). The presence of HO-1 in 
pre-vascular areas suggests that carbon monoxide generated by HO-1 may play a role in 
regulating vascular tone. A considerable amount of HO-1 may also be expressed in 
monocytes/macrophages and myofibroblasts (Hangaishi et al., 2000).  
HO-1 is believed to play a role in ischemia preconditioning of heart (Jancso et al., 
2007; Sharma et al., 1999). Overexpressing HO-1 in myocardial cells has improved the 
outcome of ischemia-reperfusion resulting in better contractile recovery and improved 
hemodynamic parameters, smaller infarct area, less apoptosis and ventricular remodelling, 
reduced myocardial fibrosis and scarring, and suppressed inflammation (Perrella & Yet, 
2003; Liu et al., 2006; Tang et al., 2005; Vulapalli et al., 2002; Yet et al., 2001; Hangaishi et 
al., 2000). Human HO-1 gene transfer to rats 8 weeks prior to coronary ligation reduced 
oxidative damage and infarct size, myocardial fibrosis and left ventricular remodeling, 
suggesting the method of HO-1 gene transfer as a potential treatment for patients at high risk 
of heart attack (Melo et al., 2002; Liu et al., 2006). HO-1 may also protect cardiac cells from 
oxidative injury caused by pressure stress (Perrella & Yet, 2003).  
It has been shown that HO-1 remains unaffected in hearts during ischemia but is 
induced during reperfusion primarily by ROS, as ROS scavengers could inhibit its induction 
(Maulik et al., 1996). Hangaishi et al. (2000) detected an increase of HO-1 expression 24 h 
after the establishment of reperfusion, with a further elevation at 48 h, and a reduction 
thereafter. Furthermore, HO-1 expression increased, sometimes by 4 times, in non-
fibrillating ischemic-reperfused hearts, but remained unchanged in fibrillating hearts, 
indicating a protecting effect of HO-1 against ischemia-induced ventricular fibrillation 
(Pataki et al., 2001; Bak et al., 2003).  
 
2.8.2.1.3. γ-glutamylcysteine synthetase  
 
The enzyme γ-glutamylcysteine synthetase, better known as glutamate cysteine ligase 
(GCL), catalyzes the rate-limiting step in GSH synthesis (Wu et al., 2004; Wild & Mulcahy, 
2000; Dickinson & Forman, 2002). GSH is synthesized in two sequential ATP-dependent 
steps. In the first step, which is catalyzed by GCL, glutamate and cysteine are ligated 
through a peptidic bond between the γ-carboxyl group of the glutamate and the amino group 
of the cysteine. This γ-linkage protects GSH from degradation by intracellular proteases. 
 52
The only enzyme capable of breaking this γ-linkage is γ-glutamyl transpeptidase present at 
the outer surface of the plasma membrane and committed to transfer the glutamyl moiety of 
all forms of glutathione to other amino acids, thereby facilitating glutathione degradation. 
The second stage of GSH synthesis is catalyzed by glutathione synthetase which binds 
glycine to γ-glutamylcysteine and forms GSH.  
The synthesis of GSH is primarily controlled by GCL (Wu et al., 2004; Wild & 
Mulcahy, 2000; Dickinson & Forman, 2002; Chen & Kunsch, 2004). Many factors such as 
oxidative and nitrosative stress, inflammatory cytokines, cancer and cancer therapy, and 
protein deficiency affect GCL expression or activity. For instance, oxidative stress has been 
identified as one of the stimulators of GCL activity. GSH itself exerts a negative feedback 
effect on GCL activity and GSH synthesis. The availability of cysteine has a positive impact 
on the synthesis. Glutamate, however, in high concentrations in plasma, as in some 
neurological diseases, may counteract GSH synthesis via competition with cysteine for 
entering cells (Wu et al., 2004). However, high intracellular glutamate concentrations, which 
occur rarely, enhance GSH synthesis.  
GCL consists of two subunits, a heavy subunit with catalytic activity and a light 
subunit with regulatory activity (Soltaninassab et al., 2000; Wild & Mulcahy, 2000). The 
catalytic subunit is responsible for the enzymatic activity. It contains binding sites for the 
substrates, i.e. glutamate and cysteine, and is the site of feedback-inhibition by GSH. The 
regulatory subunit regulates the propensity of the catalytic subunit to bind substrates or to be 
inhibited by GSH. Interaction of the regulatory subunit with the catalytic subunit decreases 
the Km for glutamate and increases the Ki for GSH inhibition. The numerous factors that can 
affect the activity of GCL exert their effect through activation or inhibition of either or both 
subunits. A mechanism by which the activation is achieved is through formation of disulfide 
bonds. It has been revealed that both catalytic and regulatory subunits of human GCL 
possess cysteine residues. Formation of at least 2 disulfide bonds in the catalytic subunit, 
one of them with the regulatory subunit, is necessary for the enzyme activity. 
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2.9. Flavonoids 
 
Flavonoids are a subgroup of the more extended family of polyphenols. Polyphenols 
constitute a widespread group of plant compounds implicated in plants’ wellbeing, growth 
and reproduction, pigmentation, and protection against micro-organisms and enemies 
(Bravo, 1998). They are widely distributed in plants from the root and stem to leaves, 
flowers, and fruits. Their quantities in fruit and vegetables are influenced by numerous 
factors including light, environmental conditions, plant species, degree of ripeness, 
germination, processing, and storage. As an example, cherry tomatoes possess six times 
more quercetin per gram fresh weight than normal size varieties of tomatoes, probably 
because polyphenols are generally synthesized and stored in the skin, and therefore smaller 
varieties have a higher skin to volume ratio (Crozier et al., 1997). Total dietary intake of 
polyphenols is firmly dependent on the food culture and the individual food preferences, but 
has been estimated to be about 1 g/day (Scalbert & Williamson, 2000) and that of flavonoids 
between 2 and 70 mg/day (Hertog et al., 1995). Moreover, it has been reported that 10% of 
the population and 30-70% of patients with specific diseases consume herbal medicines, 
which naturally contain considerable amounts of polyphenols (Galati & O’Brien, 2004). 
There are more than 8000 polyphenolic compounds identified, each with a structure 
containing at least one phenol which is a hexagon ring (benzene) with a hydroxyl group 
(Svobodova et al., 2003). Based on their chemical structure, polyphenols can be divided into 
at least 10 different classes, one of the major groups of which is flavonoids (Bravo, 1998; 
Tapiero et al., 2002).  
 
2.9.1. Classification 
 
Flavonoids were discovered in the 1930’s when a factor extracted from lemon juice 
could attenuate vessel permeability and bleeding in scorbutic guinea pigs where vitamin C 
was not effective, leading to their nomination as vitamin P although this terminology was 
later dismissed (Dragsted, 2003). More than 5000 flavonoids have been identified (Ross & 
Kasum, 2002). The basic structure of flavonoids consists of two benzene rings (A and B) 
with a pyran ring (C) in the middle (Figure 2.8-A). Flavonoids are divided into several 
subclasses including flavonols, flavanols (including proanthocyanidins), flavanones, 
flavones, isoflavones, and anthocyanins (Tapiero et al., 2002; Bravo, 1998). 
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 Figure 2.8.  A. Basic structure of and numbering system of flavonoids. B. Epicatechin 
 
 
Flavonols are represented by quercetin, kampferol, and myricetin (Tapiero et al., 2002; 
Hertog et al., 1997b). They are wide-spread in fruit and vegetables, and may contribute 
largely to our daily flavonoid consumption. Quercetin, one of the most studied flavonoids, is 
ingested especially through consumption of tea, onions, red wine, and apples. 
Flavanols include catechins, which are largely found in green tea (Figure 2.8-B). 
Black tea has far less catechin than green tea due to oxidation of catechins during 
fermentation. Other major sources of flavanols are chocolate, apples, pears, grapes, and red 
wine (Gu et al., 2006). Proanthocyanidins or condensed tannins (Figure 2.9-A) are high-
molecular weight oligomers and polymers of catechins, and are the most ubiquitous 
polyphenols in nature after lignans (Gu et al., 2004). The major sources of 
proanthocyanidins in the diet are chocolate, grapes, and apples.  
Isoflavones, such as genistein and daidzein, are phytoestrogens and may be beneficial 
in prevention of breast and prostate cancer, menopausal symptoms, cognitive disabilities, 
osteoporosis, and heart diseases (Cooke, 2006). Soy bean is a rich source of isoflavones.  
Anthocyanins (Figure 2.9-B), such as cyanidin, malvidine, and delphinidin, provide 
red and purple pigments for fruits. They are abundant in red and black cherries, berries, 
grapes, and legumes. Consumption of 200 g of black grapes and berries can afford about 1 
to 1.5 g anthocyanins (Manach et al., 2005).  
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    Figure 2.9. A. Proanthocyanidins. B. Anthocyanins.  
 
 
2.9.2. Bioavailability and metabolism 
 
In nature, flavonoids are generally present as glycosides, conjugated to sugars, 
although their aglycone forms may also exist (Ross & Kasum, 2002). The aglycones have 
stronger antioxidant activity than glycoside forms. The weakening of the antioxidant activity 
of flavonoids after glycosylation may be due to removing hydroxyl groups by conjugated 
glycosides, and thereby inhibiting them from scavenging ROS or chelating transition metals. 
Furthermore, as glycosylation enlarges the molecule, the passage through membranes may 
decrease upon glycosylation, leading ultimately to less antioxidant activity. Nonetheless, 
glycosylation enhances water solubility of the compound and subsequently improves its 
absorption from the gastrointestinal tract.  
Flavonoid glycosides can be hydrolysed from sugar moieties by hydrolases at the 
intestinal brush border or by colonic micro-organisms (Tapiero et al., 2002; Depeint et al., 
2002; Kroon et al., 2004). They may also be transported via a sodium-dependent glucose 
transporter into enterocytes where the sugar moieties are removed by β-glucosidases. After 
release from sugars, the flavonoid aglycones undergo conjugation reactions involving 
glucuronidation and sulfation with or without methylation. The conjugations occur in 
enterocytes and liver, in the latter as a part of detoxification processes. Conjugation 
facilitates their excretion and thereby shortens their plasma half-life. Almost all flavonoids 
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in plasma and urine are as conjugated forms. Thus, cells in the body are usually exposed to 
flavonoid metabolites and conjugates rather than aglycones.  
The conjugates are physically and chemically different from aglycones, and thereby 
their biologic properties are also different (Kroon et al., 2004; Manach et al., 1998). For 
instance, as the conjugation blocks electron movement over the rings, the conjugated 
molecules display less potential for redox and therefore antioxidant activity, although this 
greatly depends on the position of the conjugation. One apparent example of the reduced 
antioxidant activity resulting from post-absorption structural modification of flavonoids is 
O-methylation of catechol group in the B ring which remarkably lowers the reactivity 
potential of the molecule for reaction with ROS (Pollard et al., 2006). Conjugation is, in 
fact, one of the defensive mechanisms of the body against flavonoids as pro-oxidants. As 
flavonoids possess antioxidant activity, they might also accompany oxidative consequences. 
By conjugation, the body reduces their antioxidant and potential pro-oxidant effects (Cano et 
al., 2002). 
Flavonoids differ in the magnitude and velocity of absorption and the rate of 
elimination and plasma half-life (Manach et al., 2005). The information available on 
bioavailability and plasma kinetics of flavonoids is greatly variable. Overall, they have low 
intestinal bioavailability and rapid urinary and biliary excretion, and therefore with a regular 
diet their plasma concentration rarely exceeds 1 µM (Scalbert & Williamson, 2000). Manach 
et al. (2005) according to the data provided by 97 bioavailability studies in humans 
suggested that the best rate of absorption among flavonoids is seen in gallic acid and 
isoflavones, followed by catechins, flavanones, and quercetin glycosides. Gallic acid 
although has a good absorption, its conjugation with catechins decreases the bioavailability 
of catechins. 
Proanthocyanidins and anthocyanins have shown very low bioavailability (Manach et 
al., 2005). For instance, the absorption rate of anthocyanins from concentrated black current 
juice has been found less than 1% (Matsumoto et al., 2001). However, anthocyanin 
availability may have been underestimated because of technical complications in measuring 
anthocyanin metabolites (Manach et al., 2005). In contrast to other flavonoids that are 
separated from their glycosides during the absorption process, anthocyanins appear in 
plasma in unmodified glycosylated forms, although some glucuronide- and sulphate-
conjugated forms in plasma have also been detected (Manach et al., 2005; Kroon et al., 
2004, Dell’Agli et al., 2004). Polymerization markedly impairs the absorption of 
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proanthocyanidins (Manach et al., 2005; Spencer, 2003). Nevertheless, they may be cleaved 
to smaller units (i.e. monomers, dimers, etc) by gastric juice or by intestinal microflora, get 
absorbed, and yield some of the benefits that are currently attributed to proanthocyanidins. 
Urinary excretion of proanthocyanidin dimers has been reported in rats (Baba et al., 2002).  
Quercetin metabolites are excreted very slowly, having a half-life of 11-28 h in plasma 
(Manach et al., 2005) probably due to tight binding to serum albumin (Dufour & Dangles, 
2005). This may explain accumulation of quercetin in plasma during long-term 
supplementation (Manach et al., 2005). In this way, considerable concentrations of quercetin 
can be achieved through maintaining a regular diet with moderate amounts of quercetin. 
Contrarily, anthocyanins and catechins are excreted as rapidly as they are absorbed. For 
instance, anthocyanins reach the highest levels in plasma within 1-4 h and the maximum 
level in urine on average 2.5 h after ingestion. Although catechins have shown short plasma 
half-life and rapid elimination, they may still be capable of accumulating in plasma over a 
period of consumption (van hef Hof et al., 1999), although they are still cleared as quickly as 
one day after stopping their consumption (Henning et al., 2006).  
In vitro, the biological effects of flavonoids are achieved by concentrations (in the 
micromolar range) higher than those accessible in plasma in vivo (mostly in the nonomolar 
range) (Manach et al., 2005). However, flavonoid conjugates may bind to some cell 
receptors or cellular components, resulting in their accumulation after prolonged ingestion 
(Depeint et al., 2002). Moreover, as flavonoids are hydrophobic, they tend to partition into 
membranes, are accumulated and protected from rapid excretion (Brookes et al., 2002). 
 
2.9.3. Beneficial effects of flavonoids on the cardiovascular system 
  
2.9.3.1. Antioxidant capabilities  
 
Generally speaking, flavonoids are strong antioxidants, and because of their 
antioxidant activity as well as their abundance in fruit and vegetables they may partly 
contribute to the currently known health benefits of plant foods. Studies have shown 
antioxidant effects of flavonoids in a wide range of oxidative systems. Their antioxidant 
activity appears to involve several mechanisms, one of which is electron/hydrogen donation 
facilitated by electron delocalization over the aromatic rings (Duthie & Crozier, 2000). The 
reaction rate constant for some flavonoids may even be more than that of vitamin E due to 
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the existence of multiple hydroxyl groups in the molecule and also because of the particular 
aromatic structure which supports extended delocalization of unpaired electrons. Figure 2.10 
depicts a number of possible mechanisms by which flavonoids are postulated to protect heart 
against ischemia-reperfusion injury. We will talk about these effects effects in the next few 
sections.  
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Figure 2.10. Biological properties of flavonoids that may help against myocardial ischemia-
reperfusion injury. 
 
Flavonoids may exert cardioprotective effects through various mechanisms including antioxidant 
activities, which inhibit inflammatory responses, and increase vasorelaxation capacities. For 
more information please refer to the Sections 2.9.3.1 to 2.9.3.3.     shows inhibition of enzyme 
activity or scavenging effect. XO, xanthine oxidase; LOX, lipoxygenase; COX, cyclooxygenase; 
PLA2, phospholipase A2; Nf-κB, nuclear factor-kappa B; AP-1, activator protein-1; O2·−, 
superoxide radical; H2O2, hydrogen peroxide; •OH, hydroxyl radical; ONOO¯, peroxynitrite; 
LO•, alkoxyl radical; LOO•, peroxyl radical; Tyr•, tyrosyl radical; eNOS, endothelial nitric oxide 
synthase; iNOS, inducible nitric oxide synthase; NO, nitric oxide; cGMP, cyclic guanosine 
monophosphate.  
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2.9.3.1.1. Superoxide radicals 
 
Numerous studies have pointed to the ability of flavonoids, especially 
epigallocatechins, to scavenge superoxide radical (O2·−) (i.e. Jovanovic & Simic, 2000; Cos 
et al., 1998; Chun et al., 2003; Maffei Facino et al., 1996). However, higher than in vivo 
attainable concentrations might be needed to enable flavonoids to play a considerable role in 
scavenging O2·−, and it is more likely that other endogenous antioxidants provide a greater 
contribution in quenching intracellular O2·− (Huisman et al., 2004).  
Flavonoids counteract O2·− by two modes of action: direct scavenging activity and 
inhibition of xanthine oxidase. Nonetheless, a specific molecular structure is seemingly 
required for manifestation of these and other activities. This implies that not all flavonoids 
possess antioxidant activity and that those which possess antioxidant activity do not 
necessarily follow the same mechanisms for exhibiting the antioxidant effect. By this way, it 
is very likely that a specific flavonoid inhibits xanthine oxidase activity but is incapable of 
scavenging O2·−. More strikingly, it is possible that a particular structure exerts xanthine 
oxidase inhibition but at the same time stimulates O2·− production (Cos et al., 1998). 
 
2.9.3.1.2. Peroxynitrite  
 
A number of flavonoids including epicatechin, quercetin, myricetin, and 
proanthocyanidin oligomers have been shown to prevent peroxynitrite-induced oxidation 
and more effectively nitration reactions (Sadeghipour et al., 2005; Wippel et al., 2004; 
Arteel et al., 2000; Terao et al., 2001). In general, peroxynitrite (ONOO¯) has an unstable 
nature and can be protonated to peroxynitrous acid, which is quickly cleaved to toxic 
reactive chemicals, such as nitrogen dioxide and hydroxyl radical, which can nitrate and 
oxidize a variety of cellular molecules including proteins and DNA. Alternatively and 
predominantly, ONOO¯ can react with carbon dioxide, yielding ultimately nitrogen dioxide 
and carbonate radicals that both have very high rate constants for reaction with biomolecules 
and can initiate many oxidation and nitration reactions (McCarty, 2007; Pacher et al., 2007). 
A nitration target for ONOO¯ is tetrahydrobiopterin, one of the NOS cofactors, resulting in 
impaired NOS activity and endothelium dysfunction. ONOO¯-induced inhibition of 
prostacyclin synthetase also produces endothelial dysfunction. Accordingly, scavenging 
ONOO¯ by flavonoids is particularly useful for maintaining endothelial function. 
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The mechanism of flavonoid protection against ONOO¯ is not yet fully understood. 
Some of the protective effects of flavonoids against ONOO¯ may result from their action on 
O2·−, one of the precursors of ONOO¯ formation. As it was mentioned, flavonoids can 
inhibit O2·− by either scavenging O2·− or inhibiting xanthine oxidase activity. Moreover, 
flavonoids may, through suppression of inflammatory reactions, inhibit activation of 
neutrophils, which upon activation generate considerable amounts of O2·− and nitric oxide 
(Paulino et al., 2006). Catechol-containing flavonoids, such as epicatechin and quercetin, 
can inhibit ONOO¯-induced oxidation reactions, being themselves transformed into quinone 
and o-quinone, which can then be conjugated to glutathione, yielding glutathionyl adducts, 
and excreted (Pollard et al., 2006). On the other hand, reaction of ONOO¯ with methylated 
and conjugated flavonoids results in formation of mono- and di-nitrated and nitrosated 
products (nitration products). The mechanism of flavonoid inhibition of nitration products is 
a matter of debate; whereas some have suggested a direct effect for flavonoids through 
competition with tyrosine to be nitrated by ONOO¯ (Pannala et al., 1997; Kerry & Rice-
Evans, 1999), others pose the possibility of flavonoid interaction with ONOO¯ reaction 
intermediates such as tyrosyl radicals (Klotz & Sies, 2003). Yokozawa et al. (2003) reported 
that oral administration of epicatechin gallate to rats for 3 weeks decreased plasma 
concentration of nitrotyrosine which had been elevated as a result of lipopolysaccharide 
administration plus renal ischemia-reperfusion. Little is known about the biological effects 
of nitration products of flavonoids although some have pointed to their mutagenic as well as 
chemotherapic properties (Pollard et al., 2006). 
 Flavonoids may be able to scavenge ONOO¯ at concentrations that are achievable in 
vivo (McCarty, 2007). Cyanidin-3-O-glucoside at concentrations as low as 8.5 nM has been 
shown capable of ameliorating ONOO¯ damaging effects on endothelium, such as DNA 
damage and defective relaxation (Serraino et al., 2003).  
 
2.9.3.1.3. Peroxyl radicals and lipid peroxidation 
 
Flavonoids can inhibit lipid peroxidation through either electron donation and 
blocking lipid oxidation chain reactions (Ozgova et al., 2003) or inhibiting lipoxygenases, 
which catalyze enzymatic lipid peroxidation in cellular membranes (Cos et al., 2004). 
Flavonoids are known as scavengers of peroxyl radicals (Nakao et al., 1998; Sato et al., 
1999) and have shown ability to protect low density lipoprotein (LDL) and plasma lipids 
 61
from oxidation (Day et al., 1997; Boadi et al., 2005), in some reports being even more 
powerful than trolox (Plumb et al., 1998). Six weeks consumption of flavonoids led to 
attenuation of atherosclerotic lesions in apolipoprotein E deficient mice, lowered ex vivo 
LDL uptake by macrophages, and reduced ex vivo LDL susceptibility to oxidation despite 
unmodified levels of plasma cholesterol (Hayek et al., 1997). Similarly, flavonoids from 
pomegranate juice counteracted development of atherosclerotic lesions in atherosclerotic 
mice and inhibited macrophage-induced oxidation of LDL (Aviram et al., 2002).  
However, the feasibility of consuming effective dietary doses of flavonoids must also 
be taken into consideration as the concentrations that are usually used in in vitro or animal 
studies are quite high and achieving the same doses by dietary intake is hard or impossible. 
For instance, green tea polyphenols have been able to reduce blood cholesterol levels in 
hypercholesterolemic and blood pressure in hypertensive animals, but at doses achievable by 
20 cups of green tea per day for humans (Hara, 1992). Similarly, Lotito & Frei (2004) 
reported that despite the fact that apple extract prolonged the half-life of plasma antioxidants 
(urate and α-tocopherol but not ascorbic acid) and delayed lipid peroxidation in vitro, 
consumption of apples (5 in one dose) by humans did not produce the same benefits. Also, 
one-time ingestion of proanthocyanidin-rich chocolate by individuals, although it increased 
the concentration of epicatechin in plasma, did not cause a significant change in plasma 
antioxidant capacity or plasma lipid peroxidation indices (Wang et al., 2000). Likewise, 
controlled clinical trials have failed to demonstrate benefits of drinking 5-6 cups of tea per 
day for 1-4 weeks on cholesterol levels and blood pressure (Bingham et al., 1997; Hodgson 
et al., 1999), although more prolonged intakes of tea as a dietary habit may deliver some 
benefits (Stensvold et al., 1992).   
 
2.9.3.1.4. Hydroxyl radicals and hydrogen peroxide 
 
Studies have also indicated the inhibitory effect of flavonoids such as myricetin, 
quercetin, morin, and proanthocyanidins on hydroxyl (·OH) radicals (Chen et al., 2002; Zou 
et al., 2002; Jung et al., 2003; Maffei Facino et al., 1996; Sato et al., 1999). In vivo, a part of 
the inhibitory effect of flavonoids on ·OH is probably exerted through blocking generation 
of ·OH in the Fenton reaction by means of scavenging O2·− and H2O2 and/or chelating 
transition metals. A protective effect of flavonoids against hydrogen peroxide-induced 
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cytotoxicity has also been reported (Melidou et al., 2005; Dajas et al., 2003; Estany et al., 
2007). 
 
2.9.3.1.5. Metal chelation  
 
One of the mechanisms by which flavonoids confer their antioxidant effect is chelation 
of metal ions, such as iron and copper (Mandel et al., 2006; Gabrielska & Oszmianski, 2005; 
Morel et al., 1993; Maffei Facino et al., 1996). This property of flavonoids is in agreement 
with the well-known phenomenon of binding metals by flavonoids and polyphenols in the 
gut which negatively affects the bioavailability of these metals and may lead to mineral 
deficiencies (Bravo, 1998). Transition metal ions are critical co-factors of the Fenton 
reaction, which generates ·OH from H2O2, and therefore their chelation by flavonoids makes 
them unavailable for this kind of reaction. Melidou et al. (2005) found that flavonoid 
protection of cells against H2O2-induced DNA damage was in good correlation with the iron 
binding capacity of flavonoids rather than the electron donating potential. Interestingly, it 
has been suggested that specific flavonoids upon binding metals may behave as a superoxide 
dismutase, scavenging O2·−, more potent than the parent flavonoids while devoid of catalytic 
activity for conversion of H2O2 to ·OH (Kostyuk et al., 2007; Malesev & Kuntic, 2007). 
Flavonoids can bind metals in metal:flavonoid ratios of 1:1, 1:2, 2:2, and 2:3 (Fernandez et 
al., 2002).  
 
2.9.3.1.6. Interaction of flavonoids with other cellular antioxidants 
 
It was pointed out in the previous sections that lipophilic antioxidants are likely to be 
the last antioxidants that are depleted upon exposure to oxidative stress, and that other 
cellular antioxidants such as ascorbic acid and glutathione are at the front line of defence 
against oxidants. It has been suggested that flavonoids can act as intermediate antioxidants, 
protecting lipophilic antioxidants and being protected by hydrophilic antioxidants (Lotito & 
Fraga, 2000 & 1999). For instance, catechins did not prevent ascorbic acid oxidation in 
human plasma treated with a peroxyl radical generator, but they reduced oxidation of α-
tocopherol and β-carotene, and lessened the rate of lipid peroxidation. Catechin oxidation 
did not occur unless the existing ascorbic acid was totally oxidized. In the presence of metal 
ions, however, flavonoids can prevent oxidation of ascorbic acid through a chelating 
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mechanism (Clemetson & Andersen, 1966), although this may not be physiologically 
relevant but may be of benefit in pathological circumstances.  
Despite compelling evidence indicating the occurrence of ascorbic acid depletion prior 
to flavonoid oxidation under situations of oxidative stress, in non-pathological conditions 
flavonoids can elevate concentrations of ascorbic acid as is shown by proanthocyanidins 
which increased plasma levels of ascorbic acid and reduced those of vitamin E (Maffei 
Facino et al., 1999). The decrease of the vitamin E plasma level in this case may be an 
outcome of an inhibitory effect of ascorbic acid on the release of vitamin E from the liver.  
 
2.9.3.1.7. Flavonoid induction of phase 2 enzymes 
 
A large number of studies have focused on the effect of flavonoids, mostly 
stimulatory, on phase 2 enzymes. Because detoxifying xenobiotics and carcinogens is the 
major commitment of phase 2 enzymes, induction of phase 2 enzymes by flavonoids has 
been posed as one of the mechanisms of the chemopreventive effects of flavonoid 
application (reviewed in Moon et al., 2006). Flavonoid induction of phase 2 enzymes is 
flavonoid-, enzyme-, and cell/organ type-specific. This means that inducing a particular 
phase 2 enzyme by a certain flavonoid in a specific organ does not mean that the enzyme 
could be induced by other flavonoids in the same organ, or by the same flavonoid in other 
organs, or that the same flavonoid could induce other phase 2 enzymes in the same cell and 
organ type. Interestingly, an inhibitory effect of quercetin on glutathione S-transferase P1-1 
has also been indicated, probably as a result of inhibitory effect of quercetin oxidation 
products with critical cysteine residues of the enzyme (van Zanden et al., 2003).  
 
2.9.3.1.7.1. NAD(P)H:quinone oxidoreductase 
 
Increased activity and expression of NAD(P)H:quinone oxidoreductase (quinone 
reductase) has been seen with application of a number of flavonoids in a variety of cells. For 
instance, one month administration of green tea in drinking water (0.2%, w/v) increased 
quinone reductase activity in small bowel, liver, and lungs of SKH-1 hairless mice (Khan et 
al., 1992). Similarly, buccal pouch and liver quinone reductase activities were increased 
over 14 weeks administration of 0.05% green and black tea polyphenols in the diet (Chandra 
Mohan et al., 2005). Epigallocatechin gallate and epicatechin gallate have shown a powerful 
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induction of antioxidant response element (ARE)-mediated gene expression in human 
cervical carcinoma HeLa cells (Chen et al., 2000a). The induction of the ARE appeared to 
be structurally related to the gallate group at position 3. Similarly, dietary administration of 
ellagic acid to rats caused a 9-fold increase in hepatic and 2-fold increase in pulmonary 
quinone reductase activity, and an 8-fold increase in hepatic quinone reductase mRNA level 
(Barch & Rundhaugen, 1994). Chlorogenic acid also increased enzyme activities of 
glutathione S-transferase and quinone reductase in the JB6 mouse epidermal cell line (Feng 
et al., 2005). In contrast, two weeks gavage administration of a number of flavonoids 
including quercetin (100 mg/kg) to rats did not considerably affect the activity of quinone 
reductase in heart, liver, and colon, except for tangeretin and chrysin which caused a 2-fold 
increase in heart and colon, respectively (Breinholt et al., 1999). 
Induction of phase 2 enzymes by flavonoids has not always yielded desirable 
outcomes. For instance, treatment of a rat hepatocyte cell line with anthocyanins especially 
cyanidin, delphinidin, malvidin, and kuromanin elevated activities of quinone reductase and 
a number of glutathione-related enzymes, but it was not remarkably associated with 
prevention of H2O2-induced cell death (Shih et al., 2007). Also, incubation with higher 
concentrations of anthocyanins decreased activities of phase 2 enzymes concomitantly with 
activation of death signals (Srivastava et al., 2007).  
 
2.9.3.1.7.2. Glutamate cysteine ligase 
 
Little data are available regarding flavonoid impact on glutamate cysteine ligase 
(GCL). Myhrstad et al. (2002) reported induction of the catalytic subunit of GCL by onion 
extracts, quercetin, kampferol, or apigenin, but not myricetin although it has a very similar 
structure to quercetin, in COS-1 cells (monkey kidney cell line). Also, feeding mice with 
berries for 3-4 weeks elevated induction of GCL in skeletal muscle and brain but decreased 
it in liver, although these alterations were only seen in half of the mice (called responders) 
and GCL in the other half was not changed by berries (Carlsen et al., 2003). However, in 
spite of the induction of GCL in some organs by berries, the concentration of glutathione 
only increased in gastrocnemius muscle (Moskaug et al., 2005). The reason that merely half 
of the animals exhibited induction of GCL in response to berries could be the variability of 
intestinal absorption and the effect that gut micro-organisms can exert on physical and 
biological characteristics of flavonoids.  
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2.9.3.1.7.3. Heme oxygenase-1 
 
Similar to GCL, none of the studies available in the literature has examined the 
promotive effect of flavonoids on heme oxygenase (HO)-1 in heart cells. Here are reports on 
other cell types. Szabo et al. (2004) treated rats orally with flavonoids from sour cherry seed 
for 2 weeks, and then subjected their retina to ischemia-reperfusion. HO-1 expression and 
activity was reduced as a result of ischemia-reperfusion, and 10-30 mg/kg of flavonoid-rich 
extract of sour cherry could prevent these reductions. In cell culture studies, flavonoids 
(fisetin, myricetin, quercetin, eriodictyol, toxifolin, epicatechin, and epigallocatechin 
gallate) induced expression of both Nrf2 and HO-1 in human retinal pigment epithelial cells 
(Hanneken et al., 2006). Also, incubation of bovine aortic endothelial cells with chalcone 
induced expression of HO-1 and increased nuclear accumulation of Nrf2 (Liu et al., 2007b). 
Similarly, quercetin induced expression of HO-1 in BV-2 microglia cells (Chen et al., 2005). 
Hydroxychalcone also showed an ability to induce expression of HO-1 in RAW 264.7 
macrophages (Abuarqoub et al., 2006).  
 
2.9.3.2. Vasorelaxation  
 
Besides antioxidant effects, flavonoids possess other properties that help in alleviation 
of ischemia-reperfusion injury, for instance, through better re-establishment of blood flow in 
post-ischemic hearts. The vasorelaxation effect has mostly been investigated for the family 
of polyphenols rather than the flavonoid subclass. A variety of polyphenols have shown a 
capacity to induce relaxation in blood vessels. Their mechanisms of action are varied and 
may be exerted in endothelium-dependent or -independent fashions. It has been shown that 
some polyphenols, such as quercetin and resveratrol, could induce vasorelaxation by both 
mechanisms (Chen & Pace-Asciak, 1996), although in the absence of endothelium much 
higher concentrations of polyphenols are required (Andriambeloson et al., 1997).  
The endothelium-dependent relaxation is mediated by NO. NO, which is produced in the 
endothelium, is delivered to smooth muscle cells where it manifests its biological function 
(Martin et al., 2002). An up-regulatory effect of polyphenols on NO levels has been 
indicated through activation of eNOS or by removing O2·−, thereby inhibiting consumption 
of NO in the reaction to form ONOO¯ (Huk et al., 1998; Benito et al., 2002; Pechanova et 
al., 2004). As eNOS is a calcium-dependent enzyme, elevation of intracellular Ca2+ has been 
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suggested as the mechanism of the endothelium-dependent NO-mediated vasorelaxation by 
polyphenols (Stoclet et al., 1999; Zenebe et al., 2003; Martin et al., 2002; Andriambeloson et al., 
1999). The Ca2+ rise, which was mediated by increased production of O2·− by polyphenols and 
inhibited by application of superoxide dismutase plus catalase (Duarte et al., 2004), was due to 
stimulating Ca2+ entry from extracellular milieu and Ca2+ release from intracellular stores 
(Martin et al., 2002).  
Polyphenol-stimulated NO production activates guanylate cyclase which synthesizes 
cyclic GMP (cGMP) (Dell’Agli et al., 2004; Fitzpatrick et al., 1993). cGMP, which is an 
important mediator of vasodilation, acts by activating protein kinases which phosphorylate 
and activate a number of target proteins including those involved in ion channels. Activating 
these channels leads to Ca2+ removal from the cytosol to either endoplasmic reticulum or the 
extracellular environment (Nauli et al., 2001). The resulting low intracellular Ca2+ mitigates 
cellular contractility and produces relaxation. In contrast to the aforementioned mechanism 
for polyphenol-induced vasorelaxation, inhibition of NO-cGMP-mediated vasorelaxation 
has also been observed by some flavonoids (Huang et al., 2004). 
The mechanism of endothelium-independent relaxation by polyphenols is as yet 
uncertain. However, it is likely that signaling pathways downstream from cGMP are 
activated in smooth muscle cells independently of NO. Among downstream mechanisms are 
regulating activity of protein kinases and phosphodiesterases (a family of enzymes 
responsible for the breakdown of the vasorelaxants cyclic AMP (cAMP) and cGMP), 
inhibition of the Ca2+ influx from extracellular and intracellular resources, and activation of 
voltage-dependent potassium channels (Chan et al., 2000; Ajay et al., 2003; Novakovic et 
al., 2006). The blockade of extracellular Ca2+ influx and Ca2+ release from endoplasmic 
reticulum may be one of the possible mechanisms of flavonoid protection in states of 
ischemia-reperfusion.  
Other mechanisms of flavonoid relaxation of blood vessels are stimulating production 
of prostacylin PGI2 (Aldini et al., 2003), increased activity, but not expression, of eNOS 
(Benito et al., 2002), inhibiting expression of iNOS but increasing expression and/or activity 
of eNOS (Hung et al., 2004; Olszanecki et al., 2002), augmenting NO half-life by 
scavenging O2·− (Huk et al., 1998), inhibition of the renin-angiotensin system (Cos et al., 
2004), and scavenging peroxynitrite and therefore preserving tetrahydrobiopterin, the 
confactor of NOS (McCarty, 2007).  
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Studies in both humans and animals have shown that supplementing the diet with 
flavonoids can result in vasodilation. However, it is not yet clear whether this can be 
achieved through a high-flavonoid diet as concentrations that have caused relaxation are 
much higher than plasma levels of flavonoids attainable by diet (McCarty, 2007).  
 
2.9.3.3. Anti-inflammatory and anti-aggregatory effects 
 
Similar to other properties of flavonoids, anti-inflammatory effects of flavonoids 
depend on the type of flavonoid and are extremely different from one flavonoid to another 
(Kim et al., 2004). Flavonoids have shown the capacity to suppress the enzymes involved in 
eicosanoid pathways, such as phospholipase A2, cyclooxygenases, and lipoxygenases, 
thereby inhibiting production of inflammatory mediators. Further, flavonoids may inhibit 
production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, 
interleukin (IL)-1β, IL-6, and interferon-γ, and chemotactic agents. Flavonoids may also 
have an inhibitory effect on expression of adhesion molecules such as ICAM-1, VCAM-1, 
and E-selectin (Kris-Etherton et al., 2004; Gonzalez-Gallego et al., 2007). Many of these 
effects are exerted through blocking activities of enzymes implicated in signaling pathways 
especially protein kinase C and mitogen-activated protein kinase (MAPK), with downstream 
inhibition of transcription factors NF-κB and AP-1 (Manthey, 2000; Gonzalez-Gallego et 
al., 2007), although stimulation of NF-κB-induced gene expression by some flavonoids has 
also been reported (Cos et al., 2004). Flavonoid inhibition of protein kinase C has been 
suggested to occur through competitive binding of flavonoids with ATP at the active site of 
the enzymes (Manthey, 2000). Elevation of cAMP secondary to inhibition of 
phosphodiesterases has also been suggested as the mechanism of the anti-inflammatory effects 
of flavonoids (Manthey, 2000). Inhibition of phosphodiesterases probably occurs due to 
structural similarity of the purine ring of cAMP and benzopyran structure of flavonoids (Ferrell 
et al., 1979).  
Schramm et al. (2001) reported that one-time consumption of high-proanthocyanidin 
chocolate decreased the plasma leukotriene to prostacyclin ratio concomitantly with an 
increase in plasma epicatechin. The leukotriene to prostacyclin ratio was also decreased in 
human aortic endothelial cells after incubation with proanthocyanidins. The reduction of 
leukotrienes likely results from inhibition of lipoxygenases (Selmi et al., 2006; Sies et al., 
2005). Lipoxygenases possess an active ferric form of iron which is required for their 
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catalytic activity (Schewe et al., 2001). The activity of the lipoxygenases is abolished if the 
ferric iron is reduced to the ferrous form. ROS can activate the enzyme, while flavonoids 
have been suggested to inactivate it through either scavenging ROS or reducing the active 
ferric form of the enzyme. 
Administration of flavonoids can mitigate vascular permeability via reduction of the 
number of leukocytes adherent to the endothelium (Bouskela & Donyo, 1997). 
Epigallocatechin gallate at physiologic concentrations reduced neutrophil migration into 
cultured human endothelial cells (Riemersma et al., 2001). Similarly, proanthocyanidins 
decreased expression of VCAM-1, but not ICAM-1, and mitigated leukocyte-endothelial 
cell interaction (Sen & Bagchi, 2001). Similar results have been observed in human studies. 
Taking 100 mg/day proanthocyanidins for one month decreased plasma concentrations of 
ICAM-1, VCAM-1, and E-selectin in systemic sclerosis patients (Kalfin et al., 2002). 
Moreover, cocoa flavanols inhibited IL-2 expression in stimulated leukocytes (Selmi et al., 
2006). However, the response of inflammatory substances to flavonoids may be diverse, as 
for example small molecule proanthocyanidins (dimers, trimers) suppressed, while 
comparably larger molecules of proanthocyanidins stimulated, expression of IL-1β. 
Contrary to this, small molecular weight proanthocyanidins were incapable of exhibiting 
endothelium-dependent relaxation in rabbit aortic rings, whereas large polymers 
demonstrated this kind of vasodilation.  
Flavonoids have also been shown to inhibit platelet activation and aggregation (Cos et 
al., 2004; Manthey, 2000). As an example, intake of proanthocyanidin- and epicatechin-rich 
cocoa decreased markers of platelet activation and function, leading to inhibition of platelet 
aggregation and prolongation of blood coagulation time (Rein et al., 2000). The anti-platelet 
effect of flavonoids may be due to increased production of prostacyclin which via synthesis 
of cAMP reduces platelet aggregation (Kris-Etherton & Keen, 2002). Flavonoids may also 
decrease platelet activation through inhibition of phosphodiesterases responsible for 
degradation of cAMP (Manthey, 2000). Furthermore, given that NO has a protective role in 
maintaining a non-adhesive endothelium (Bertuglia & Giusti, 2003), and considering that 
flavonoids are stimulators of NO generation, they may inhibit adhesion of leukocytes and 
platelets to the endothelium through up-regulation of NO. Moreover, as inflammatory 
responses are greatly induced by oxidative stress, flavonoid inhibition of inflammation may 
be at least partly due to attenuation of oxidative stress.  
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2.9.4. Epidemiological studies  
 
Epidemiological studies on the association of flavonoid consumption and the risk of 
cardiovascular disease are subject to controversies. Although in most cases an elevated risk 
of cardiovascular diseases has been associated with low intakes of flavonoids, there are also 
some reports rejecting this hypothesis or even documenting the opposite to it. Here are 
examples of the inconsistencies. 
A 5- and 10-year follow-up study of men aged 65-84 years in Zutphen Netherlands 
between 1985 and 1995 revealed that flavonoid intake, mainly from black tea, onions, and 
apples, was inversely linked with mortality from coronary heart disease and less strongly 
with incidence of myocardial infarction and all-cause mortality (Hertog et al., 1993 and 
1997a). The results also showed a dose-response negative correlation between flavonol 
intake and the risk of death from cardiovascular diseases and a first heart attack. Similarly, a 
25-year follow-up of 16 cohorts from the Seven Countries Study demonstrated that the 
average consumption of flavonoids was inversely associated with death caused by heart 
disease (Hertog et al., 1995). More interestingly, the analysis of data revealed that flavonoid 
intake alone explained nearly 25%, and flavonoid intake along with the incidence of 
smoking explained 90% of the differences in the rates of coronary heart disease among the 
16 cohorts. Also, moderate tea consumption has been found associated with lower 
prevalence of ventricular arrhythmias in patients with acute myocardial infarction (Mukamal 
et al., 2006). There are further studies documenting an inverse relationship between the 
amount of daily flavonoid intake and the incidence and mortality from coronary heart 
disease (Mojzisova & Kuchta, 2001). 
However, there are also epidemiological studies that contest the benefits of flavonoids 
in human populations. For instance, a 14-year follow-up study on 1900 Welsh men aged 45-
59 years revealed no association between flavonol consumption (mainly received from black 
tea) and the incidence of ischemic heart disease. Contrariwise, flavonol intake had a mild 
positive correlation with mortality from infarction and cancer and a strong relation with total 
cause mortality (Hertog et al., 1997b). The authors assumed that milk that is a customarily 
added to tea in the United Kingdom may have limited flavonoid absorption. Nevertheless, 
addition of milk to black tea (15 ml milk to 135 ml tea) has not been shown to change 
bioavailability of tea flavonols (Hollman et al., 2001). Consistent with Hertog and 
colleagues (1997b), a 5-year study on 34,789 male professionals aged 40-75 years showed 
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no association between flavonoid intake and incidence of nonfatal myocardial infarction, but 
raised the possibility that flavonoids reduce risk of mortality in people with a medical 
history of coronary heart disease (Rimm et al., 1996). 
 
2.9.5. Flavonoid cytotoxicity 
 
While describing beneficial features of flavonoids, their possible damaging effects 
should not be ignored. In fact, any kind of antioxidant could potentially act as pro-oxidant, if 
after delivering its antioxidant effect its oxidized form is not scavenged properly. The pro-
oxidant effect of flavonoids become especially manifest in the presence of transition metals 
(Galati & O’Brien, 2004). Generally speaking, flavonoids upon exposure to various forms of 
electrophiles and ROS donate one or more electrons with concomitant oxidation to phenoxyl 
radicals, semiquinones, and quinones. These oxidized forms of flavonoids must be 
scavenged by ascorbate in order to be converted back to their original forms (Jovanovic & 
Simic, 2000) or conjugated to glutathione and excreted (Galati et al., 2001); otherwise they 
will initiate oxidative reactions (Galati & O’Brien, 2004).  
In the presence of transition metal ions, the redox reactions including those of 
flavonoids are accelerated, generating greater amounts of radicals and reactive species. For 
instance, in the presence of flavonoids, the generation of hydroxyl radicals by metal-
catalyzed Fenton reactions increases (El Hajji et al., 2006). It has been found that addition of 
copper ions accelerates auto-oxidation of quercetin, producing large amounts of H2O2, while 
addition of iron attenuates quercetin auto-oxidation as iron-quercetin complexes seem to be 
relatively more stable.  
Surprisingly, cytotoxic effects of flavonoids may not originate from stimulating 
formation of reactive oxygen species as some studies failed to prevent cytotoxic and DNA-
damaging effect of flavonoids by antioxidants (Sasaki et al., 2007; Watjen et al., 2005). For 
instance, Sasaki et al. (2007) reported that quercetin at moderate concentrations (33 µM) 
induced death in PC12 neuronal cell line, and that N-acetylcysteine and glutathione could 
not inhibit its toxicity, although N-acetylcysteine and glutathione prevented H2O2-induced 
cell death. Interestingly, quercetin did not protect cells against H2O2 cytotoxicity but rather 
exacerbated it.  
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Other possible explanations for flavonoid cytotoxicity may be perturbation in cellular 
normal metabolism including inhibition of enzymes such as protein kinase C and DNA 
topoisomerases that leads to cell demise (Middleton et al., 2000).   
Some authors have suggested that cytoprotective concentrations of flavonoids are 
generally lower than their cytotoxic concentrations, for some flavonoids such as quercetin as 
much as 5-10 times (Watjen et al., 2005). However, depending on the circumstances of 
oxidative stress, the opposite may occur. For instance, Yamanaka et al. (1997) found that 1.5 
µM of catechins inhibited LDL oxidation when added in the initiation phase of LDL 
oxidation, but hastened it if added later in the propagation phase, when higher 
concentrations of catechins were effective in lowering oxidation.  
The cytotoxic potential of flavonoids is complicated and it is hard to predict whether a 
particular flavonoid under specific circumstances exhibits anti- or pro-oxidant effect. Even 
under similar conditions and with similar concentrations, some flavonoids may exhibit 
antioxidant behaviour while others act as pro-oxidant (Choi et al., 2003). Some flavonoids 
have exhibited antioxidant activity against peroxynitrite-induced DNA strand cleavage, but 
they mostly also were capable of causing DNA strand breaks when applied in combination 
with NO (Ohshima et al., 1998). Environmental conditions are also intervening. For 
example, slightly alkaline pH, such as that in the intestine, has been shown to enhance auto-
oxidation of flavonoids (Duarte Silva et al., 2000).  
 
2.9.6. Flavonoid protection of heart against ischemia-reperfusion injury 
 
Because the number of studies examining the effect of flavonoids on myocardial 
ischemia-reperfusion injury is large, here are presented only those which are relevant to our 
study. 
 
2.9.6.1. Catechins 
 
Catechins and the most abundant source of catechins, i.e. teas, have attracted much 
attention in the field of ischemia-reperfusion. Townsend et al. (2004) found that oral 
administration of 0.1% green tea extract in drinking water for 7 days or perfusing isolated 
hearts with epigallocatechin gallate for 30 min before global ischemia (35 min) and 
reperfusion (2 h) reduced myocardial apoptosis and infarct size. Green tea extract and 
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epigallocatechin gallate also improved hemodynamic markers including left ventricular 
systolic and diastolic pressure and reduced expression of Fas, active caspase-3, and 
phosphorylated p38 proteins. Potenza et al. (2007) fed SHR hypertensive rats for 3 weeks 
with food supplemented with 200 mg/kg/day epigallocatechin gallate, and then exposed the 
isolated hearts to 30 min ischemia and 2 h reperfusion. Hearts from treated animals had 
better coronary flow, limited infarct size, and improved post-ischemic ventricular recovery 
determined by higher left ventricular developed pressure and lower left ventricular end 
diastolic pressure. At least a part of the beneficial effects of epigallocatechin gallate has 
been postulated to be NO-dependent (Potenza et al. 2007; Hotta et al., 2006).  
Similarly, Modun et al. (2003) treated rats orally with 250 mg/kg/day catechin for 10 
days before isolation of hearts and induction of ischemia (30 min) and reperfusion (30 min). 
Catechin decreased the incidence and duration of ventricular fibrillation, improved left 
ventricular developed pressure while reducing left ventricular diastolic pressure, ameliorated 
cardiac performance, and lowered tissue lipid peroxides and lactate dehydrogenase released 
into the effluents. Catechins have also shown to protect the heart against chronic ischemic 
injury. Suzuki et al. (2007) administered 20 mg/kg/day tea catechins to rats orally during 28-
day chronic ischemia, and found improved cardiac function and blood pressure, and 
decreased infarct size and thickening of the left ventricular inner wall in the tea-fed group. 
Catechins also reduced the number of infiltrating neutrophils into the myocardium, lowered 
expression of adhesion molecules and chemoattractants, and inhibited activation of NF-κB 
and AP-1 as well as matrix metalloproteinase.  
Perfusing isolated hearts with catechins has also shown benefits. Hirai et al. (2007) 
perfused hearts with epigallocatechin gallate and gallocatechin gallate for 4 min before 
ischemia (40 min) and throughout reperfusion (40 min). Catechin-treated hearts had lower 
abnormalities of blood pressure, preserved ATP levels, and less cytosolic Ca2+ 
concentrations. Catechins also prevented activation of caspase-3 in a different preparation of 
ischemic-reperfused hearts and inhibited Ca2+ uptake by isolated mitochondria incubated in 
a high Ca2+ medium. Addition of catechin to perfusate also inhibited elevation of low 
molecular weight iron and preserved ascorbic acid in hearts subjected to 10 min global 
ischemia and 5 min reperfusion (van Jaarsveld et al., 1996). Intravenous application of 
catechins has also been advantageous. Aneja et al. (2004) reported that intravenous 
administration of epigallocatechin gallate at the end of coronary artery occlusion (30 min) 
and during reperfusion (2 h) resulted in milder histological damage and necrosis, lower 
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plasma concentrations of creatine phosphokinase and interleukin-6, less incidence of 
neutrophil infiltration, and reduced activation of NF-κB and AP-1 in rats.  
 
2.9.6.2. Proanthocyanidins  
 
Proanthocyanidins whose basic structure is similar to catechins have also shown 
benefits. Pataki et al. (2002) administered 50 and 100 mg/kg/day oligomeric 
proanthocyanidins from red grape seeds for 3 weeks to rats, and then subjected the hearts to 
30 min global ischemia and 2 h reperfusion. Hearts in the treated groups had a dose-
dependent lower incidence of ventricular tachycardia and fibrillation, greater left ventricular 
developed pressure, and better recovery of coronary and aortic flow, but no improvement in 
the heart rate. Proanthocyanidin-treated animals also had lower hydroxyl radicals released to 
the heart effluents. The number of apoptotic cells was fewer, the infarct area was smaller, 
and the amount of malondialdehyde released into the effluents at the beginning of 
reperfusion was lower in proanthocyanidin group (Sato et al., 1999 & 2001). Similarly, 
supplementation of the diet with 1% oligomeric proanthocyanidins for 3 weeks reduced the 
duration of ventricular fibrillation and lowered lactate dehydrogenase release into coronary 
effluents of hearts exposed to 20 min global ischemia and 30 min reperfusion (Al Makdessi 
et al., 2006). 
Adding proanthocyanidins to the perfusate has also shown promising results. In a 
model of low-flow (1 ml/min) ischemia (40 min), perfusing hearts with oligomeric 
proanthocyanidins improved cardiac contractile function, decreased arrhythmias, and 
attenuated coronary perfusion perturbations (Berti et al., 2003). The beneficial effect of 
proanthocyanidins on coronary vasculature may be a result of stimulating synthesis of 
prostaglandinF1α and nitric oxide (Berti et al., 2003; Maffei Facino et al., 1996). 
In an attempt to determine which part of polyphenols in red wine contributes to the 
well-known benefits of red wine, Fantinelli et al. (2005) segregated red wine polyphenols 
into four phenolic fractions consisting of polymeric proanthocyanidins, anthocyanins, 
flavonols and flavanols, and resveratrol, and added the fractions as well as the original red 
wine into the perfusate for 10 min before ischemia (20 min) and the first 10 min of 
reperfusion (30 min). Only proanthocyanidins exhibited the same protective properties as 
red wine, evidenced by restoration of left ventricular developed pressure, prevention of left 
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ventricular end diastolic pressure rise, low rate of lactate dehydrogenase release in the 
effluent, and diminished amount of lipid peroxidation.  
 
2.9.6.3. Anthocyanins  
 
Anthocyanins from black soybean seed coat orally administered in doses of 25, 50, 
and 100 mg/kg to rats 24 h before coronary artery occlusion for 30 min and reperfusion for 
24 h reduced infarct size (Kim et al., 2006). Also, reperfusing hearts for 30 min with 
cyanidin-3-glucopyranoside added to the perfusate following 30 min ischemia reduced 
production of malondialdehyde and preserved energy content (mainly ATP and NAD) in the 
myocardium (Amorini et al., 2003). Heart cells also showed a good uptake and 
accumulation of cyanidin. Furthermore, in a human study three months consumption of 
pomegranate juice showed improvement in myocardial perfusion and reduction in the risk of 
ischemia, as assessed by treadmill exercise or pharmacologic stress test (Sumner et al., 
2005).  
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CHAPTER 3 
 
PROTECTION BY FLAVONOIDS AGAINST DEATH OF RAT 
EMBRYONIC VENTRICULAR (H9c2) CELLS INDUCED BY 
SIMULATED ISCHEMIA-REPERFUSION  
 
 
 
3.1.   Introduction 
 
Ischemia or insufficient blood supply to the myocardium initiates a number of 
metabolic and ionic perturbations that can cause cell death and tissue necrosis. Reperfusion 
or restoration of blood circulation to the ischemic myocardium, although a necessary 
strategy to salvage myocardial cells from ischemic insult, paradoxically exacerbates the 
trauma that has already been caused by ischemia.  
The pathological changes in heart tissue following ischemia and reperfusion mostly 
originate from deprivation of cells from oxygen. Insufficient oxygen results in cessation or 
deceleration of mitochondrial functions in particular oxidative phosphorylation that 
subsequently augments the electron leakage from the respiratory chain and increases 
generation of superoxide radicals (Powers et al., 2007). On the other hand, the impairment 
of oxidative phosphorylation is associated with suppression of the citric acid cycle and 
diminishing oxidation of fatty acids which are the major source of energy for heart cells 
(Solaini & Harris, 2005). Under such conditions, cardiac cells which are in constant demand 
for energy are compelled to activate anaerobic metabolism provided from the available 
glycogen stores. However, during ischemia cells have no or limited access to the blood 
stream, making it difficult to expel the extra lactate. This results in acidification of the 
intracellular milieu and consequently emergence of ionic disturbances such as elevation of 
sodium and calcium in the cytosol.  
Severe disturbances in cellular homeostasis that occur during ischemia and reperfusion 
can terminate cell viability. Although recent notions have implicated myocardial cell 
renewal as a part of normal cardiac homeostasis (Nadal-Ginard et al., 2003) that can be of 
clinical importance after myocardial infarction (Beltrami et al., 2001), cardiac tissue likely 
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has limited ability to replace the dead cells and therefore prevention of cell death during 
ischemia-reperfusion bears therapeutic implications. Polyphenols and especially flavonoids 
are well acknowledged for their antioxidant and protective effect in circumstances of 
oxidative stress. They have also been recognized as potent anti-apoptotic agents. The aim of 
this study was to compare the effect of a selected group of polyphenols, mainly flavonoids, 
on cell death caused by a model of ischemia-reperfusion in cell culture using rat embryonic 
ventricular cells. While a few individual polyphenols have been examined for their ability to 
protect in models of heart ischemia-reperfusion in culture (Chang et al., 2007; Townsend et 
al., 2004), there has been no comparison of a range of different polyphenols to determine 
which compound/s is/are the most protective. 
 
3.2. Materials and Methods    
 
3.2.1. Cell culture  
 
Rat embryonic ventricular myocardial cells, H9c2 (American Tissue Culture 
Collection, Manassas, VA), were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) containing 1.5 g/l NaHCO3 and 1.0 g/l glucose, supplemented with 10% fetal 
bovine serum (FBS), 100 U/ml penicillin, and 100 U/ml streptomycin. Tissue culture flasks 
were kept at 37ºC in a humidified atmosphere of 5% CO2. The medium was changed every 
2-3 days and the cells were subcultured regularly. For experiments, cells were cultured on 
24- or 96-well plates, kept in DMEM with 10% FBS until confluency and were switched to 
the DMEM with 2% FBS.  
 
3.2.2. Treatment with polyphenols 
 
 Confluent cells were treated with various concentrations of polyphenols for various 
time courses prior to ischemia-reperfusion. Polyphenols were prepared in dimethyl sulfoxide 
(DMSO). Because DMSO is toxic to the cells, polyphenols were added to the medium in 
concentrated solutions to keep DMSO concentration equal to or less than 0.05% v/v. 
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3.2.3. Model of ischemia-reperfusion 
 
 Unless otherwise indicated, ischemia was induced by replacing the medium with 
ischemia-mimetic solution (described below) and reperfusion was established by re-
introducing DMEM with 2% FBS to the cells. To remove polyphenols, cells including 
controls were washed twice with phosphate-buffered saline (PBS) (140 mM NaCl, 2.7 mM 
KCl, 8.1 mM Na2HPO4, and 1.5 mM KH2PO4, pH 7.3) before the ischemia-reperfusion 
experiment. The cells in ischemia plates received ischemia-mimetic solution containing 140 
mM NaCl, 1.25 mM CaCl2, 1 mM MgCl2, 8 mM KCl, and 6 mM HEPES, pH 6 (Maddaford 
et al., 1999). The concentration of potassium was higher and the pH was lower than 
physiological conditions to simulate the in vivo conditions during ischemia. The ischemia 
solution was bubbled with 100% nitrogen gas for at least 30 min before adding to the cells. 
The ischemia group was placed in a modular hypoxia chamber which was flushed with 
nitrogen gas for 1.5 h and kept sealed for the period of ischemia at 37ºC. The time-course of 
flushing (1.5 h) was chosen according to the initial experiments when the atmosphere of the 
chamber was tested with the oxygen indicator methylene blue (Eigel et al., 2004). 
Methylene blue is a redox indicator which has blue colour in oxidizing environment (air) 
and turns colourless when reduced (by a reductant in the absence of oxygen). The period of 
ischemia was examined with relatively short (3-5.5 h) or long (9-10 h) episodes.  
After ischemia, the ischemia solution was replaced with DMEM containing 300 mg/l 
NaHCO3 and polyphenols (if any) and the plates were placed in the same chamber as the 
control plates. Control (non-ischemic) plates were given DMEM (with 2% FBS) containing 
300 mg/l NaHCO3 to keep pH at 7.4 in room atmosphere (with <0.1% CO2), and kept at 
37ºC in a humidified chamber throughout the experiment. Those wells in the control plate 
which had been treated with polyphenols were treated the same during the experiment. 
Control and reperfusion plates were occasionally placed in separate chambers during the 
reperfusion time as the reperfusion chamber needed to be flushed with 100% oxygen for 15-
20 min at the beginning of the reperfusion period.  
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3.2.4. Cell viability measurements 
 
3.2.4.1. MTT reduction assessment 
 
 MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide) is a yellow 
coloured salt which is reduced by mitochondrial reductase enzymes of living cells to purple-
coloured formazan crystals. The method used was a modification of the method used by 
Denizot & Lang (1986). Briefly, after reperfusion the medium was removed and the cells 
were washed twice with PBS to remove residual polyphenols. The medium was replaced 
with fresh reperfusion solution (140 mM NaCl, 1.25 mM CaCl2, 1 mM MgCl2, 6 mM KCl, 
10 mM glucose, and 6 mM HEPES, pH 7.4 (Maddaford et al., 1999)), and MTT (in PBS) to 
a final concentration of 0.5 mg/ml (1.2 mM) was added and the cells were incubated for 1 h 
at 37ºC. Then, the solution was removed, purple formazan crystals were solubilized in 
DMSO (100 µl for 96-well plates) for 15 min, and the absorbance was determined at 570 nm 
using an absorbance spectrophotometer.  
 
3.2.4.2. Microscopic determination of cell viability 
 
 Acridine orange is a membrane-permeable fluorescent dye which interacts with DNA 
and RNA via electrostatic attraction, and can be used for staining both dead and viable cells. 
When bound to DNA, it fluoresces 525 nm light if excited at 502 nm. The cells were 
incubated for 1 h with a final concentration of 4 µg/ml (10.8 µM) acridine orange (in PBS) 
added to the medium (Vashishtha et al., 1998). After staining, the medium was aspirated, 
cells were washed with PBS, reperfusion solution containing glucose (described above) was 
added, and the cells were visualized using a fluorescence microscope. H9c2 cells are 
normally attached to the culture dish. When they die they are detached and therefore washed 
away during washing processes. Thus, the only cells observed on the microscope are live 
cells. However, because the cells are stained, unhealthy cells which still remain in the plate 
can easily be detected and excluded from counting. A specific area from each well with a 
magnification of 10X was chosen for imaging. A picture was taken and the number of cells 
in the field of view (3.1 mm2) was counted.  
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3.3. Statistics 
 
Data represent means ± SEM. Statistical analyses were carried out with SPSS software 
using one-way analysis of variance (ANOVA). As a post hoc test, 2-sided Dunnett was used 
where comparisons were with either control or ischemic-reperfused (named as IR in graphs) 
groups. In the absence of ischemia-reperfusion, polyphenol-treated groups were compared 
with the Control, while in ischemia-reperfusion conditions, polyphenol-treated groups were 
compared with the IR. Tukey’s post-hoc test was applied where the comparisons were 
performed in the presence and absence of ascorbic acid. Adjustments were carried out where 
treatments with polyphenols and ascorbate increased cell viability in the control groups. The 
calculations were made based on the percentage of cell viability elevation in the control 
groups treated with antioxidants, and subtracting the same percentage from the 
corresponding antioxidant-treated group in the IR groups. A p value less than 0.05 was 
considered significant.  
 
3.4. Results  
 
3.4.1. Hypoxia contribution in cell death induced by ischemia-reperfusion 
 
Since we aimed to compare the extent to which antioxidants, mainly polyphenols and 
ascorbic acid, alleviate the damage caused by oxidative stress in ischemia and reperfusion, 
the proportion of the harm produced by temporary hypoxia (lack of oxygen), relative to 
temporary ischemia (lack of oxygen, glucose, and serum), was evaluated (Figure 3.1). The 
hypoxia induced in our study produced moderate cell death in H9c2 cells after long (9-10 h) 
periods of ischemia, as about one-third of cell loss in the ischemia-reperfusion (IR) group 
was due to oxygen shortage and two thirds due to lack of FBS and glucose.  
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Figure 3.1. Contributions of oxygen, glucose, and serum removal on cell death after 
exposure to 10 h ischemia and 13 h reperfusion.  
 
To determine the amount of cell death resulting from lack of oxygen, glucose, and FBS, cell 
viability was assessed in different experimental conditions using the MTT assay. The condition 
of the experiment for different groups was as follows:  
Control (DMEM), cells in the control plate (access to oxygen) which received DMEM plus FBS 
throughout the experiment.  
Control (ischemia sol’n), cells in the control plate (with oxygen) which received ischemia 
solution during the time of ischemia and DMEM plus FBS during the time of reperfusion.  
Hypoxia (reperfusion sol’n), cells in the ischemia-reperfusion (IR) plate (flushed with nitrogen) 
which received reperfusion solution (containing glucose) during the time of hypoxia and DMEM 
plus FBS during the reperfusion time.  
IR (ischemia sol’n), cells in the IR plate (flushed with nitrogen) which received ischemia 
solution during ischemia and DMEM plus FBS during reperfusion.  
Hypoxia (DMEM), cells in the IR plate (flushed with nitrogen) which received DMEM plus 
FBS throughout the experiment. The ischemia and reperfusion time-courses were 10 and 13 h, 
respectively. Bars represent means of 3-6 wells ± SEM. a-d Letters that are different indicate a 
significant difference at p<0.05. 
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3.4.2. Testing polyphenols 
 
3.4.2.1. Quercetin 
 
With short-term (3-4 h) ischemia, quercetin exhibited either mild or no protection 
against ischemia-reperfusion. Treatment with 5 to 20 µM quercetin for 3 days prior to 
ischemia and during reperfusion could not significantly improve cell viability after 3 h 
ischemia (Figure 3.2). In control groups, 10 µM quercetin showed elevated MTT reduction 
that could be due to increased cell proliferation, while 40 µM quercetin showed some 
toxicity.   
With 4 h ischemia and 5 µM quercetin the experiment was repeated 4 times (Figure 
3.3). A slight (13%) but significant protection was observed under these conditions.  
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Figure 3.2. Cell viability after 3 h ischemia and 22 h reperfusion in cells pre-treated with 
quercetin (Quer) for 3 days.  
 
Confluent cells were kept in 2% FBS-DMEM for 5 days including 3 days pre-treatment with 
different concentrations of quercetin, and then cells in the ischemia-reperfusion (IR) groups were 
exposed to ischemia for 3 h followed by reperfusion for 22 h. Quercetin was available to the 
cells during the reperfusion time. The number of live cells was detected by the MTT assay. Bars 
are the outcome of two independent experiments, each containing 5 wells. † is for p<0.05 
compared to Control. * is for p<0.05 compared to the IR group. 
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Figure 3.3. Cell viability after 4 h ischemia and 24 h reperfusion in cells pre-treated with 
quercetin (Quer) for 3 days.  
 
Confluent cells were kept in 2% FBS-DMEM for 10 days including 3 days treatment with 5µM 
quercetin. Ischemia was established for 4 h followed by 24 h reperfusion. Quercetin was 
available to the cells during the reperfusion time. The number of live cells was detected with the 
MTT assay. Bars are means of four independent experiments, each assessing 4-5 wells. * is for 
p<0.05 compared to the ischemia-reperfusion (IR) group. 
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With long (9-10 h) duration of ischemia, a similar situation was observed in quercetin-
treated cells where quercetin exhibited either mild or no protection. In one experiment, 
concentrations of 0.1 to 15 µM quercetin exhibited no protection after 9.5 h ischemia 
(Figure 3.4). In another experiment, 5 to 40 µM quercetin increased cell viability by 18 to 33 
percent after 9 h ischemia, while 100 µM was cytotoxic (Figure 3.5).  
Higher concentrations of quercetin showed cytotoxicity. At 40 µM, quercetin 
exhibited a significant cytotoxicity in both control and IR-treated cells, causing 24 and 30 
percent decreases in cell viability as assessed by MTT reduction, respectively (Figure 3.2). 
Similarly, at 100 µM quercetin exacerbated cell death in both control and IR groups by 33 
and 28 percent, respectively (Figure 3.5). 
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Figure 3.4. Cell viability after 9.5 h ischemia and 14 h reperfusion in cells pre-treated 
with quercetin (Quer) for 19 h.  
 
Confluent cells were kept in DMEM with 2% FBS for 6 days before they were treated with 
various concentrations of quercetin for 19 h. Ischemia was induced for 9.5 h followed by 
reperfusion for 14 h. Quercetin was present during the reperfusion time. Cell viability was 
assessed by the MTT assay. Bars represent means of 4 wells ± SEM. † is for p<0.05 
compared to Control. There was no difference between the ischemia-reperfusion (IR) groups 
before or after considering adjustments according to the controls. 
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Although was attempted to keep the concentration of DMSO, the solvent of 
polyphenols, in the DMEM to less than 0.05% v/v, it is yet possible that some of the toxicity 
of higher concentrations of polyphenols tested herein is in fact due to the higher level of 
DMSO rather than the higher concentration of polyphenols themselves.  
Glutathione at 200 µM did not exert any protective or damaging effect (Figure 3.5). It 
seems reasonable that the cells may not have been able to uptake this three-amino acid 
compound, and for this reason many researchers use the cell-permeable precursor N-acetyl 
cysteine (Borger & Essig, 1998).   
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Figure 3.5. Cell viability after 9 h ischemia and 15 h reperfusion in cells pre-treated with 
quercetin (Quer) or glutathione (GSH) for 22 h.  
 
Confluent cells were kept in DMEM with 2% FBS for 5 days before they treated with various 
concentrations of quercetin or 200 µM glutathione for 22 h. Ischemia was induced for 9 h 
followed by reperfusion for 15 h. Quercetin and glutathione were accessible to the cells during 
the reperfusion time. Cell viability was assessed by the MTT assay. Bars are means of 4 wells ± 
SEM. † shows p<0.05 vs. Control. * shows p<0.05 vs. ischemia-reperfusion (IR) with or without 
adjustments according to the corresponding controls.  
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3.4.2.2. Resveratrol 
 
Increasing concentrations of resveratrol appeared to exhibit improvements in cell 
viability ranging from 12 to 25 percent, but none was statistically significant (Figure 3.6). In 
control groups, resveratrol at 5 and 10 µM showed significant toxicity by 9 and 10 percent, 
respectively.  
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Figure 3.6. Cell viability after 9 h ischemia and 15 h reperfusion in cells pre-treated with 
resveratrol (Res) for 20 h.  
 
Confluent cells were maintained in DMEM with 2% FBS for 6 days and incubated with various 
concentrations of resveratrol for 20 h. Resveratrol was present during the reperfusion time. Cells 
in the ischemia-reperfusion (IR) groups were subjected to 9 h ischemia and 15 h reperfusion. 
Cell viability was tested using the MTT assay. Bars indicate means of 4 wells ± SEM. * shows 
p<0.05 compared to Control. There was no significant difference between the IR groups. 
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3.4.2.3. Anthocyanins 
 
Of flavonoids tested from the anthocyanin class, cyanidin did show significant but 
mild protection. Cyanidin in the concentration range of 3 to 40 µM increased cell viability 
assessed with MTT reduction by up to 16 percent, being statistically significant at 5 and 20 
µM (Figure 3.7).  
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Figure 3.7. Cell viability after 9.5 h ischemia and 14 h reperfusion in cells pre-treated with 
cyanidin for 3 days.  
 
Confluent cells were kept in DMEM with 2% FBS for 5 days including 3 days incubation with 
various concentrations of cyanidin before induction of ischemia for 9.5 h and reperfusion for 14 
h. Cyanidin was present during the reperfusion time. Cell viability was measured by the MTT 
assay. Bars are means of 5 wells ± SEM. * is for p<0.05 vs. the ischemia-reperfusion (IR). 
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Delphinidin did not show any protection; instead, concentrations of 50 and 100 µM 
displayed toxicity (Figure 3.8). These concentrations caused 55 and 92 percent significant 
cell loss in control and 79 and 99 percent cell demise in the IR groups, respectively.  
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Figure 3.8. Cell viability after 5 h ischemia and 18 h reperfusion in cells pre-treated with 
delphinidin (Del) for 3 days. 
 
Confluent cells were kept in 2% FBS-DMEM for 6 days including 3 days pre-treatment with 
various concentrations of delphinidin, and then ischemia-reperfusion (IR) groups were exposed 
to 5 h ischemia and 18 h reperfusion. Delphinidin was present during the reperfusion time. The 
number of live cells was counted after staining cells with acridine orange. Bars represent means 
of 3-4 wells + SEM. * shows p<0.05 vs. Control. There was no significant difference between 
the IR groups. 
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3.4.2.4. Catechins  
 
Catechins, including (+)-catechin, and (-)-epigallocatechin gallate and 
proanthocyanidins, which have a basic structure similar to catechin, exhibited good 
protection on the cells against damage caused by ischemia-reperfusion. In long-term pre-
treatment, concentrations of 5 to 100 µM catechin improved cell viability by 21 to 58 
percent, with concentrations of 5 to 50 µM being statistically significant (Figure 3.9). 
Similar to our results, Chang and colleagues (2007) found that 3 days pre-treatment with 25 
µM catechin decreased chick cardiomyocyte death induced by ischemia-reperfusion by 
22%.  
Whereas in long-term (2-3 days) treatments concentrations from 5 to 50 µM catechin 
exhibited almost 50% protection (Figure 3.9 and 3.10), in short-term (1 h) treatment 50 µM 
catechin gave a 98% elevation in cell viability (Figure 3.10). Interestingly, no cytotoxic 
effect of catechin was observed in control and IR groups in either short- or long-term pre-
treatments (Figures 3.9 and 3.10).  
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Figure 3.9. Cell viability after 5 h ischemia and 18 h reperfusion in cells pre-treated with 
catechin (Cat) for 3 days. 
 
Confluent cells were kept in 2% FBS-DMEM for 6 days including 3 days pre-treatment with 
various concentrations of catechin, and then ischemia-reperfusion (IR) groups were exposed to 5 
h ischemia followed by 18 h reperfusion. Catechin was present during the reperfusion time. The 
number of live cells was counted after staining cells with acridine orange. Bars represent means 
of 3-4 wells ± SEM. * shows p<0.05 vs. IR. No significant difference was present between 
control groups. 
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Figure 3.10. Cell viability after 5 h ischemia and 18 h reperfusion in cells pre-treated with 
catechin (Cat) for either 1 h or 2 days. 
 
Cells were kept in DMEM with 2% FBS for 2 days and treated with either 10 or 50 µM catechin 
(Cat) for either 1 h (short-term) or 2 days (long-term) before establishment of ischemia for 5 h 
and reperfusion for 18 h. Catechin was present during the reperfusion time. Live cells were 
counted by a microscope after staining cells with acridine orange. Columns are means of 8 wells 
± SEM. * shows p<0.05 compared to the corresponding ischemia-reperfusion (IR) group. 
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Concentrations of 5 to 100 µM epigallocatechin gallate and proanthocyanidins gave 28 
to 49 and 22 to 44 percent protection, respectively, which in some concentrations were 
statistically significant (Figure 3.11). Consistent with our finding, Townsend et al. (2004) 
documented the anti-apoptotic effect of epigallocatechin gallate on neonatal primary 
cardiomyocytes against ischemia-reperfusion-induced cell death. 
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Figure 3.11. Cell viability after 4.5 h ischemia and 18 h reperfusion in cells pre-treated 
with epigallocatechin gallate (EGCG) or proanthocyanidins (PC) for 3 days. 
 
Confluent cells were maintained in DMEM with 2% FBS for 6 days including 3 days incubation 
with various concentrations of epigallocatechin gallate or proanthocyanidins. The ischemia-
reperfusion (IR) groups then were subjected to 4.5 h ischemia and 18 h reperfusion. 
Epigallocatechin gallate and proanthocyanidins were present during the reperfusion time. Viable 
cells were detected using a microscope following staining with acridine orange. Data are means 
of 3 wells ± SEM. * indicates p<0.05 vs. Control. † shows p<0.05 vs. IR after considering 
adjustments according to the controls.  
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3.4.2.5. Ascorbic acid 
 
A previous report (Guaiquil et al., 2004) stated that dehydroascorbic acid is the form 
of vitamin C transported into both rat myocardial cells and rat primary cardiomyocytes, and 
after being transformed to ascorbic acid intracellularly can elicit protection against ischemia-
reperfusion and hypoxia-reoxygenation. However, our results revealed the opposite in rat 
embryonic H9c2 cells. None of the concentrations of dehydroascorbic acid protected cells 
from ischemia-reperfusion (Figure 3.12), whereas sodium ascorbate gave remarkable 
protection at all concentrations tested, promoting cell viability by 57 to 92 percent (Figure 
3.13). 
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Figure 3.12. Cell viability after 9.5 h ischemia and 14 h reperfusion in cells pre-treated 
with dehydroascorbic acid (DHA) for 3 days.  
 
Confluent cells were kept in 2% FBS-DMEM for 5 days including 3 days pre-treatment with 
dehydroascorbic acid. Then, ischemia-reperfusion (IR) groups were exposed to 9.5 h ischemia 
and 14 h reperfusion. dehydroascorbic acid was present during the reperfusion time. The MTT 
assay was used to measure viable cells. Bars show means of 5 wells ± SEM. There was no 
significant difference between either control or IR groups. 
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Figure 3.13. Cell viability after 5 h ischemia and 18 h reperfusion in cells pre-treated with 
sodium ascorbate (Na asc) for 3 days. 
 
Confluent cells were maintained in 2% FBS-DMEM for 6 days including 3 days pre-treatment 
with various concentrations of sodium ascorbate, and then ischemia-reperfusion (IR) groups 
were exposed to 5 h ischemia followed by 18 h reperfusion. Sodium ascorbate was present 
during the reperfusion time. The number of live cells was counted after staining cells with 
acridine orange. Bars are means of 3-4 wells ± SEM. * indicates p<0.05 compared to the IR 
regardless if adjustments were or were not made. No significant difference was detected between 
the control groups.  
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3.4.2.6. Comparison between polyphenols in the presence and absence of ascorbic acid 
 
In spite of protection that was observed by some polyphenols especially catechin, 
epigallocatechin gallate, proanthocyanidins, and ascorbic acid, a subsequent experiment 
revealed no protection by any of these and other polyphenols with or without the presence of 
ascorbic acid (Figure 3.14). The reason of this discrepancy is not clear, but in comparison 
with other experiments that showed protection by polyphenols and ascorbic acid this 
experiment had a lower difference between the Control and IR groups, and so the extent of 
oxidative stress may not have been sufficient to allow antioxidants to protect.    
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Figure 3.14. Cell viability after 5.5 h ischemia and 17 h reperfusion in cells pre-treated 
with a number of polyphenols in the presence or absence of sodium ascorbate (asc) for 3 
days. 
 
Confluent cells were maintained in DMEM with 2% FBS for 6 days including 3 days pre-
treatment with either 300 µM sodium ascorbate or 5 µM of a polyphenol. Ischemia was induced 
for 5.5 h followed by reperfusion for 17 h. Cells were treated with the corresponding 
polyphenols with or without ascorbate during the reperfusion time. Viable cells were counted 
using a microscope after staining cells with acridine orange. Bars are means of 3-4 wells ± SEM. 
No significant difference was observed between either control or ischemia-reperfusion (IR) 
groups either before or after performing adjustments. Cyan, cyanidin; Del, delphinidin; Cat, 
catechin; EGCG, epigallocatechin gallate; PC, proanthocyanidins; Quer, quercetin; Res, 
resveratrol; Myric, myricetin; Caff, caffeic acid; Gallic, gallic acid.  
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3.5. Discussion 
 
The objective of these studies was to compare the effect of selected polyphenols, 
mainly flavonoids, on cell death caused by a model of ischemia-reperfusion in cultured 
H9c2 rat embryonic ventricular cells. Most of the cell death in this model was due to glucose 
and FBS removal, and merely one third of cells died due to hypoxia (Figure 3.1). However, 
oxidative stress may have been involved to a larger extent in the death of cells. It has been 
reported that serum withdrawal initiates apoptosis in a number of cell types (King et al., 
2003; Maestre et al., 2003; Fernandez-Marinez et al., 2006; Voccoli et al., 2007). The 
process of death caused by serum removal involves mitochondrial dysfunction (Maestre et 
al., 2003) that leads to increased production of reactive oxygen species (Maestre et al., 2003; 
King et al., 2003), as well as depletion of endoplasmic reticulum Ca2+ stores (Voccoli et al., 
2007) that results in cellular Ca2+ overload. These changes in Ca2+ and reactive oxygen 
species with serum withdrawal are similar to those that occur in in vivo models of ischemia-
reperfusion. On the other hand, up to 76% of death after long ischemia has been due to FBS 
and oxygen deprivation and so to some degree involves oxidative stress, and the rest (24%) 
has been the result of glucose (and thus energy) deprivation (Figure 3.1). Interestingly, 
hypoxia alone did not decrease cell number (last bar in Figure 3.1). However, this does not 
necessarily mean that no cell death occurred in the hypoxic group, as with hypoxia both 
apoptosis and cell proliferation can be stimulated (Ray et al., 2008).  
Quercetin in both short and long episodes of ischemia showed either mild or no 
protection (Figures 3.2 through 3.5). It is unclear why only in some, but not all, experiments 
quercetin showed protection. However, what is conspicuous is that protection, if any, by 
quercetin against cell death caused by the type of ischemia-reperfusion used in our study, 
was rather mild. Quercetin has been shown to induce phase 1 and more so phase 2 enzymes, 
including glutathione S-transferase, quinone reductase, glutamate cysteine ligase, and heme 
oxygenase, in 6 to 24 h incubation of rat primary cardiomyocytes with 30 µM quercetin 
(Angeloni et al., 2008). Whether quercetin also induces such enzymes in H9c2 cells, and 
whether the occasional mild protection exhibited by quercetin herein is partially due to this 
induction is not clear. 
Similar to quercetin, resveratrol did not show a notable benefit. However, its toxicity 
merits attention, as it seemed to cause toxicity at lower concentrations compared to the other 
polyphenols tested herein (Figure 3.6). Nevertheless, the cytotoxicity of resveratrol was not 
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seen in the IR groups. This suggests that there may not be a serious concern for the toxicity 
of resveratrol in conditions of oxidative stress for which a benefit of resveratrol is validated.  
The ability of resveratrol to induce antioxidants and phase 2 enzymes has been 
reported in H9c2 cells in 1 to 3 days incubation with 50 and 100 µM resveratrol (Cao & Li, 
2004). Moreover, resveratrol attenuated cell death and oxidative stress caused by xanthine 
oxidase and 4-hydroxyl-2-nonenal through a mechanism apart from its direct antioxidant 
effect. It is unlikely that resveratrol in our study has induced any of the antioxidant enzymes 
as both the concentrations and the incubation time used for resveratrol were too low to 
provide possibility of induction of phase 2 and antioxidant enzymes (Cao & Li, 2004). 
Surprisingly, the toxicity did not seem to be a concern in the study by Cao and Li. However, 
Leong et al. (2007) reported that resveratrol in concentrations ranging from 30 to 120 µM 
inhibited cell proliferation and promoted differentiation in H9c2 cells without causing cell 
damage. Therefore, it is likely that the reduced cell viability in control cells treated with 5 
and 10 µM resveratrol in the current study has been in fact a result of inhibition of cell 
proliferation rather than causing cell injury. The mild reduction (5 to 10 percent) in cell 
viability at 5 and 10 µM resveratrol confirms this speculation (Figure 3.6). 
The cytotoxicity of delphinidin also deserves attention as it seemingly is more 
destructive than other polyphenols tested in our study (Figure 3.8). For instance, quercetin at 
toxic concentrations tested caused approximately 30% cell death in both control and IR 
groups (Figures 3.2 and 3.5), while delphinidin caused 55% cell death at the lowest toxic 
concentration tested (Figure 3.8). 
We did not find considerable protection by cyanidin (Figure 3.7) and delphinidin 
(Figure 3.8) in H9c2 cells exposed to ischemia-reperfusion, except for mild (12 to 16 
percent) protection with 5 and 20 µM cyanidin. In this regard, our results are in contrast with 
those of other investigators who found a 30 to 40 percent decrease in H9c2 cell death 
induced by the anticancer agent, doxorubicin, after 24 h incubation with 50 and 100 µM 
cyanidin and delphinidin (Choi et al., 2007). The discrepancy could be due to different 
mechanisms of cell death caused by doxorubicin and ischemia-reperfusion. 
Of the polyphenols tested, catechins gave the most notable protection. Both long- and 
short-term treatments with catechin showed significant protection (Figures 3.9 and 3.10). 
Low concentrations (e.g. 10 µM) of catechin seemed to work better if left with the cells for 
prolonged incubation times (in the range of days), while higher concentrations (e.g. 50 µM) 
were capable of protection even over short-term (1 h) pre-treatment. The reason for such a 
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strong protection in short-term pre-treatment could be a direct antioxidant effect of catechin, 
as in long-term pre-treatments most of the catechin may have been oxidized during the 
regular cellular metabolism and due to factors such as transition metals present in the 
medium (Wee et al., 2003). If not much antioxidant activity remained after 3 days pre-
treatment, why were such protections observed? The answer could be that catechins might 
have acted indirectly through signaling pathways to activate the antioxidant response 
element (ARE) and induce expression of antioxidant enzymes (Chen et al., 2000). 
Consistent with this supposition, Du and colleagues (2007) indicated that 24 h incubation of 
H9c2 cells with 50 µM and more substantially 100 µM catechin or proanthocyanidin B4 
increased activities of a number of cellular antioxidants and antioxidant enzymes and 
mitigated cell death caused by the xanthine oxidase system (Du et al., 2007).  
Similar to catechin, epigallocatechin gallate and proanthocyanidins conferred 
considerable (up to 49%) protections (Figure 3.11). The protection exhibited by 
epigallocatechin gallate and proanthocyanidins is intriguing as the ischemia-reperfusion in 
the corresponding experiment was so intense that almost no cells remained in the IR group. 
This suggests that epigallocatechin gallate and proanthocyanidins may be appropriate 
flavonoids to work against severe states of oxidative stress. Furthermore, it has been 
reported that epigallocatechin gallate may be capable of inhibiting apoptosis induced by 
serum removal in cultured cells (Mandel et al., 2003), suggesting that this flavonoid may be 
capable of inhibiting or rectifying calcium disturbances following ischemia-reperfusion 
(Voccoli et al., 2007). Of note in the current study was that the protection by the catechins in 
long term pre-treatments (Figures 3.9 and 3.11) was dose-independent for the concentration 
range tested, suggesting protection by mechanisms other than direct antioxidant activities 
because one might expect increasing competition for ROS at increasing concentrations.  
Although both epigallocatechin gallate and proanthocyanidins appeared to decrease 
the number of live cells at higher concentrations, no significant toxicity was detected (Figure 
3.11). A pro-oxidant effect of proanthocyanidins has been reported for concentrations more 
than 100 µM on chick cardiomyocytes (Shao et al., 2003). 
The beneficial effect of ascorbic acid seen in our study (up to 92% protection with 3 
days pre-treatment, Figure 3.13) is in accordance with previous observations from other 
investigators. For instance, ascorbic acid (100 µM) improved cell survival by 40% in HL-1 
mouse cardiac cell line subjected to hypoxia induced by cobalt chloride (Vassilopoulos & 
Papazafiri, 2005). A part of the ascorbic acid protection could be due to induction of phase 2 
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enzymes as the ability of ascorbic acid to induce phase 1 as well as phase 2 enzymes has 
been demonstrated in guinea pig liver after supplementing diets with ascorbic acid (Roomi 
et al., 1998). Ascorbic acid can auto-oxidize in the growth media (Wee et al., 2003) and a 
part of the observed protection could have been due to the mild oxidative stress produced by 
ascorbate auto-oxidation which might have induced phase 2 enzymes. In this way, pre-
treatment with ascorbate may provide a form of preconditioning which can be clinically 
useful. 
The toxicity of flavonoids may result from their pro-oxidant effect and oxidation 
products. As discussed earlier, as a part of their scavenging activity, flavonoids donate 
electrons and are concomitantly oxidized. The oxidized forms should be detoxified by other 
antioxidants, such as ascorbic acid (Blokhina et al., 2003) and glutathione (Galati et al., 
2001), in order to be reduced or excreted in conjugated forms, respectively. If such 
detoxification is not performed, the oxidized forms of flavonoids can trigger oxidative 
reactions or react covalently with biomolecules (Galati & O’Brien, 2004).  
On the other hand, flavonoids such as quercetin can reduce iron and copper and 
undergo metal-catalyzed oxidation to produce hydrogen peroxide and possible Fenton 
reactions (El Hajji et al., 2006). Since transition metals are sequestered by proteins in vivo, 
such reactions may not be of much concern in animal and human models, but they could be 
the underlying reason of toxicity exhibited by flavonoids in cell culture as both flavonoids 
and transition metals are together in the culture medium. Several flavonoids including 
catechin, epigallocatechin gallate, and quercetin have shown to undergo oxidation in cell 
culture media to produce hydrogen peroxide (Long et al., 2000). However, as catechins 
(Long et al., 2000) and ascorbate (Peterkofsky & Prather, 1977; Arakawa et al., 1994; 
Clément et al., 2001; Wee et al., 2003) have also been shown to produce hydrogen peroxide 
in culture medium, although mostly in concentrations much higher than what were used in 
the current study, and since catechins and ascorbate showed no toxicity in either control or 
ischemic-reperfused cells in our study, the involvement of hydrogen peroxide generated by 
metal-catalyzed oxidation of flavonoids can be ruled out. However, metal-catalyzed 
oxidation of flavonoids such as quercetin produces several degradation products (El Hajji et 
al., 2006) which may explain the cytotoxicity of flavonoids relative to ascorbate. 
Further evidence that the cytotoxic effects of flavonoids may not have originated from 
reactive oxygen species generated during or after flavonoid oxidation are studies where 
antioxidants have failed to prevent cytotoxic and DNA-damaging effect of flavonoids 
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(Sasaki et al., 2007; Watjen et al., 2005). As an example, Sasaki and coworkers (2007) 
reported that quercetin at moderate concentrations (33 µM) induced death in PC12 neuronal 
cell line, and N-acetylcysteine and glutathione could not inhibit its toxicity although they 
prevented hydrogen peroxide-induced cell death. Interestingly, quercetin did not protect the 
cells against hydrogen peroxide cytotoxicity but rather it exacerbated it.  
Other possible explanations for flavonoid cytotoxicity could be perturbation in normal 
cellular metabolism including inhibition of enzymes such as protein kinases and DNA 
topoisomerases (Middleton et al., 2000). Spencer et al. (2003) reported that a neurotoxic 
effect of quercetin was mediated via inhibition of protein kinase B (Akt) and extracellular 
signal-regulated protein kinase (ERK). Moreover, inhibition of protein kinase C (Birt et al., 
1996; Lin et al., 1997; Kang & Liang, 1997), mitogen-activated protein kinases (MAPKs) 
(Hou et al., 2004; Chen et al., 2004), and protein tyrosine kinases (Kandaswami et al., 2005; 
Lee et al., 2002; Kang & Liang, 1997) have been recognized among the mechanisms of 
chemopreventive, anti-proliferative and anti-tumor properties of flavonoids. The inhibitions 
are probably mediated through competition with ATP for binding to the active site of the 
enzymes (Lin et al., 1997; Stewart et al., 1999). 
However, protein kinase signaling pathways possess many complexities. For instance, 
relatively low concentrations (25-50 µM) of epigallocatechin gallate activated the apoptotic 
pathway in human breast cancer cells associated with elevation of cellular oxidative stress 
and activation of c-Jun N-terminal kinase (JNK), while higher concentrations (100-400 µM) 
triggered necrosis without changes in cellular redox status or activation of JNK (Hsuuw & 
Chan, 2007). On the other hand, inhibition of protein kinases may contrarily confer benefits 
which could be of relevance to ischemia-reperfusion situations. For instance, it has been 
reported that inhibitions of MAPKs and nuclear factor-kappa B (NF-κB) (Chae et al., 2007; 
Hong et al., 2007; Shin et al., 2007) and protein tyrosine kinases and serine/threonine 
kinases (including protein kinase B) (Maeda-Yamamoto et al., 2004) are involved in the 
anti-inflammatory and anti-allergic effects of epigallocatechin gallate and also delphinidin 
(Hou et al., 2005). Similar inhibition of protein kinase C and MAPKs has also been 
suggested as the mechanisms of anti-platelet activities of quercetin plus catechin (Pignatelli 
et al., 2006) and resveratrol (Yang et al., 2008). Therefore, with all of the intricacies around 
protein kinase signaling pathways it is hard to make any speculation on whether flavonoids 
in our study have interacted with such pathways, and whether the observed protection, 
absence of protection, or toxicity can be attributed to such interactions.  
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3.6. Conclusions 
 
1. In this model of ischemia-reperfusion in H9c2 cells, cell death resulted from the 
combined lack of oxygen, glucose, and serum, and is most likely to have occurred through 
mechanisms associated with oxidative stress. 
2. Ascorbic acid, catechin, epigallocatechin gallate, and proanthocyanidins were the 
most protective compounds against ischemia-reperfusion-induced cell death.  
3. A low concentration (10 µM) of catechin was more effective when incubated with 
the cells for a longer time (2 days), while a higher concentration (50 µM) could exert benefit 
even after 1 h incubation.  
4. Quercetin showed either mild or no protection. Resveratrol, cyanidin, and 
delphinidin displayed no protection.  
5. Higher concentrations (e.g. 50-100 µM) of some polyphenols including delphinidin, 
resveratrol, and quercetin in long-term treatments (1-3 days) exhibited toxicity. The toxicity 
was more pronounced in the control than in the ischemic-reperfused cells.  
In conclusion, flavonoids from the catechin family and ascorbic acid may protect heart 
cells against ischemia-reperfusion. Direct antioxidant activity as well as induction of 
antioxidant and phase 2 enzymes may be implicated in the mechanisms of protection. 
Caution should be taken when using high concentrations of polyphenols, especially in long-
term treatments and non-oxidative conditions. 
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CHAPTER 4 
 
PROTECTIVE EFFECT OF FLAVONOIDS ON RAT EMBRYONIC 
VENTRICULAR H9c2 CELLS EXPOSED TO HYDROPEROXIDES 
 
 
4.1.   Introduction 
 
Reactive oxygen species (ROS) are forms of oxygen with more positive reduction 
potential and more reactivity than molecular oxygen. ROS are key factors in cell signaling 
pathways, working as second messengers for a wide range of activities including cell growth 
and apoptosis (Filomeni & Ciriolo, 2006). Targets of ROS in such pathways are redox-
sensitive proteins such as protein tyrosine phosphatases, phospholipases, and calcium 
channels (Genestra, 2007). However, as the concentration of ROS increases in the cell the 
role that they play in regulation of signaling pathways shifts from a maintenance physiologic 
role to a pathologic deleterious action (Kamata & Hirata, 1999). In the pathologic mode of 
action, ROS impose cell oxidative stress which can lead to cell demise. Cells, however, 
possess an antioxidant network to help fight against oxidative stress. The network comprises 
enzymatic antioxidants such as superoxide dismutase and glutathione peroxidase and non-
enzymatic antioxidants such as glutathione and thioredoxin. Nevertheless, when oxidative 
stress overwhelms the cellular antioxidant capacity, the cells will fall into a death program; a 
moderate oxidative stress may activate apoptosis whereas an extreme insult can block 
apoptosis and proceed to necrosis.   
Polyphenols, especially flavonoids, have antioxidant activity. They have shown 
inhibitory effects against a variety of ROS including hydrogen peroxide (Dajas et al., 2003) 
and peroxynitrite (Sadeghipour et al., 2005). Other than a direct scavenging effect, 
numerous mechanisms have been suggested for the antioxidant potential of flavonoids, one 
of which is sequestration of transition metals such as iron (Morel et al., 1993). For example, 
a part of the protective effect of flavonoids against hydrogen peroxide may originate from 
this metal chelating activity (Melidou et al., 2005). Furthermore, the induction of antioxidant 
and phase 2 enzymes has recently been acknowledged as one of the indirect mechanisms of 
antioxidant activity of flavonoids (Angeloni et al., 2008; Moskaug et al., 2005). Flavonoids 
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may also render their antioxidant effect by reinforcement of other cellular antioxidants, 
either working in an orchestrated manner with them (Haramaki et al., 1998) or by being 
preferentially oxidized preserving lipid soluble antioxidants (Lotito & Fraga, 2000). The 
ability of polyphenols to reduce oxidative stress may be enhanced in the presence of 
ascorbic acid even when ascorbic acid or polyphenols alone affords no cytoprotection 
(Skaper et al., 1996; Ferroni et al., 2004; Chen et al., 2004). Moreover, flavonoids have been 
suggested to work synergistically with ascorbate to protect membranes (Bandy & Bechara, 
2001). 
Whereas many studies on polyphenols have investigated antitumor activities of these 
compounds, there are also many that have focused on their protective and anti-apoptotic 
capacities which are mainly exerted through their antioxidant activities. The goal of the 
current study was to compare the effects of various polyphenols, mostly flavonoids, on H9c2 
cell viability after exposure to hydroperoxides, and to examine whether the presence of 
ascorbate could improve the protection.    
 
4.2. Materials and Methods 
 
4.2.1. Cell culture and treatments  
 
Cells were cultured according to the protocol described in Chapter 3. In brief, H9c2 
cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 1.5 g/l 
NaHCO3 and 1.0 g/l glucose, 100 U/ml penicillin, and 100 U/ml streptomycin. Cells grew in 
flasks containing DMEM supplemented with 10% fetal bovine serum (FBS) at 37ºC in a 
humidified atmosphere of 5% CO2. For experiments, cells were cultured on 96 well plates, 
kept in DMEM with 10% FBS until they became confluent, and they were then switched to 
DMEM with 2% FBS.  
Cells were treated with polyphenols and/or ascorbate for either short (1-2 h) or 
prolonged (1-3 days) periods prior to addition of tert-butyl hydroperoxide (t-buOOH). The 
cells were then incubated in t-buOOH for 24 h followed by assessment of cell viability.  
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4.2.2. Cell viability measurements 
 
 Cell viability was measured by either reduction of MTT (3-(4,5-Dimethyl-2-
thiazolyl)-2,5-diphenyltetrazolium bromide) or counting cells after staining with acridine 
orange as described in Chapter 3. For the MTT assay, after incubation with t-buOOH, cells 
were washed twice with phosphate-buffered saline (PBS), and MTT was added in a final 
concentration of 1.2 mM to a glucose-containing solution (140 mM NaCl, 1.25 mM CaCl2, 1 
mM MgCl2, 6 mM KCl, 10 mM glucose, and 6 mM HEPES, pH 7.4) (Denizot & Land, 
1986). After 1 h incubation at 37ºC, the solution was removed and purple formazan crystals 
were solubilized in 100 µl DMSO for 15 min, and the absorbance was detected at 570 nm 
using an absorbance spectrophotometer. 
For the acridine orange staining method, the cells were incubated for 1 h in a final 
concentration of 11 µM acridine orange added to the medium (Vashishtha et al., 1998). 
Then, the medium was removed, the cells were rinsed with PBS, the above-mentioned 
glucose-containing solution was added, and the cells were imaged using a fluorescence 
microscope.  
The activity of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) released into 
the medium was used as another indication of cell death. GAPDH activity was measured 
using acella-TOX kit according to the manufacturer’s instructions. GAPDH is an important 
enzyme in the glycolysis pathway that catalyzes the oxidative phosphorylation of 
glyceraldehyde-3-phosphate to 1,3-diphosphoglycerate in the presence of the NAD+ cofactor 
and inorganic phosphate. In the acella-TOX kit, the activity of GAPDH is coupled to that of 
the enzyme 3-phosphoglyceric phosphokinase to produce ATP, which is detected via the 
luciferase/luciferin bioluminescence methodology. 
 
4.3. Statistics 
 
Data are means ± SEM. Statistical analyses were performed with SPSS software using 
one-way analysis of variance (ANOVA). As post hoc tests, the 2-sided Dunnett’s test was 
used where comparisons were made between either control or t-buOOH groups where 
ascorbic acid was not included in the experiment, while Tukey’s test was applied where the 
comparisons were assessed in the presence and absence of ascorbic acid. In the statistical 
analysis, adjustments were made where treatments with polyphenols and ascorbate increased 
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cell viability in the control groups. The adjustments were made by calculating the 
percentage of cell viability elevation in the control groups treated with antioxidants, and 
subtracting the same percentage from the corresponding antioxidant-treated group in the t-
buOOH category. A p value less than 0.05 was considered significant.  
 
4.4. Results  
 
Consistent with the results from the ischemia-reperfusion experiments (Figure 3.11), 
epigallocatechin gallate showed protection against t-buOOH (Figure 4.1). Cells treated with 
100 µM epigallocatechin gallate for 1 h had 54% more survival than cells treated with t-
buOOH alone, although a lower concentration of epigallocatechin gallate (50 µM) was 
ineffective. Resveratrol at the concentrations examined gave no protection.  
One hour treatment with 50 and 100 µM epigallocatechin gallate and resveratrol did 
not cause any significant damage in the control groups (Figure 4.1), but the same 
concentrations over 3 days revealed strong cytotoxicity (Figure 4.2). After 3 days treatment 
with such high concentrations of epigallocatechin gallate and resveratrol there likely were 
not many cells remaining in the plate before the cells were treated with t-buOOH, and so no 
protection by the flavonoids could be seen. Cytotoxicity of epigallocatechin gallate seemed 
to be more potent than resveratrol as at 50 µM for example it caused 237% more cell death 
than resveratrol (Figure 4.2).  
In contrast to the ischemia-reperfusion experiments where flavonoids were more 
beneficial over 3-day rather than 1 day treatments (Chapter 3), in the t-buOOH experiments 
more benefit was observed in 1 h treatments, and 3-day treatments revealed cytotoxicity of 
some polyphenols (Figures 4.1 and 4.2). 
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Figure 4.1. Effects on cell viability of epigallocatechin gallate (EGCG) and resveratrol 
(Res) added 1 h prior to t-buOOH. 
 
Confluent cells were kept for 4 days in DMEM with 2% FBS before treating with 50 or 100 µM 
of epigallocatechin gallate or resveratrol for 1 h and then with 400 µM t-buOOH (shown as t-
booh in the figure) for 24 h. Live cells were counted after staining with acridine orange. Bars are 
means of 3-4 wells ± SEM. * shows p<0.05 vs. t-booh.  There was no significant difference 
between the control groups.  
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Figure 4.2. Effects on cell viability of epigallocatechin gallate (EGCG) and resveratrol 
(Res) added 3 days prior to t-buOOH. 
 
Confluent cells were kept in DMEM with 2% FBS for 7 days including 3 days pre-treatment 
with either 50 or 100 µM of epigallocatechin gallate or resveratrol. Then, cells were incubated 
with 400 µM t-buOOH (shown as t-booh in the figure) for 24 h. Live cells were counted after 
staining with acridine orange. Bars are means of 3-4 wells ± SEM. * shows p<0.05 vs. Control.   
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Catechin also showed a significant 28% protection at 100 µM added 1 h before t-
buOOH, but lower concentrations (10 and 50 µM) did not exert significant protection 
(Figure 4.3). The ability of catechin to protect cells against t-buOOH was less than that of 
epigallocatechin gallate, as catechin at 10 and 50 µM concentrations increased cell survival 
by 6 and 6.5 percent (both non-significant), respectively, but epigallocatechin gallate at the 
same concentrations respectively produced 24 and 57 percent significant improvement in 
cell viability (Figure 4.3). The presence of 100 µM ascorbic acid lessened the cytoprotective 
effects of both flavonoids (Figure 4.3). Control groups treated with the same concentrations 
of catechin and epigallocatechin gallate with or without ascorbic acid were not adversely 
affected by the treatments. 
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Figure 4.3. Effects on cell viability of catechin (Cat) and epigallocatechin gallate (EGCG) 
with or without ascorbate (Asc) added 1 h prior to t-buOOH. 
 
Confluent cells were kept in DMEM with 2% FBS for 7 days and treated with different 
concentrations of catechin or epigallocatechin gallate alone or in combination with 100 µM 
sodium ascorbate for 1 h. Cells were then treated with 350 µM t-buOOH (shown as tbooh in the 
graph) for 24 h. Live cells were counted after staining with acridine orange. Data are means of 3-
4 wells ± SEM. † is for p<0.05 vs. Control. * shows p<0.05 vs. tbooh and Asc,tbooh. There was 
no significant difference between control groups.  
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Because higher concentrations of polyphenols were cytotoxic in 3-day treatments 
(Figure 4.1), lower concentrations (10 and 25 µM) were evaluated for their ability to protect 
and to cooperate with ascorbate. At 10 µM, none of polyphenols alone or in combination 
with ascorbate protected cells against t-buOOH (Figure 4.4-B). At this concentration, 
myricetin, epigallocatechin gallate + ascorbate, and quercetin + ascorbate revealed cytotoxic 
effects in the control groups (Figure 4.4-A).  
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Figure 4.4. Effects on cell viability of 10 µM of different polyphenols with or without ascorbate 
added 3 days prior to treatment with t-buOOH. 
 
Confluent cells were kept in DMEM with 2% FBS for 5 days including 3 days pre-treatment with 10 
µM of polyphenols alone or in combination with 100 µM sodium ascorbate. Then, cells were treated 
with 350 µM t-buOOH (shown as tbooh) for 24 h. Live cells were counted after staining with 
acridine orange. Asc, ascorbic acid; Cyan, cyanidin; Del, delphinidin; Cat, catechin; EGCG, 
epigallocatechin gallate; PC, proanthocyanidins; Quer, quercetin; Res, resveratrol; Myric, myricetin; 
Gall, gallic acid; Caff, caffeic acid. A. Cells in control groups (untreated with t-buOOH). Data are the 
mean of 3 wells ± SEM. * indicates p<0.05 vs. Control. B. Cells treated with t-buOOH. Bars are 
from two independent experiments each containing 4 wells. There was no significant difference 
between any of the conditions in the t-buOOH-treated cells.  
A 
B 
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Examination of 25 µM of the same compounds also did not show protection except for 
quercetin which revealed the same protection (39 to 46 percent) in the presence and absence 
of ascorbate (Figure 4.5). In contrast to the previous experiments, here ascorbate did not 
show a pro-oxidant effect in the presence of t-buOOH, although considering the required 
statistical adjustments according to the ascorbate-treated control group it also did not 
significantly protect cardiomyocytes against t-buOOH. The toxicity of polyphenols in t-
buOOH-treated cells appeared more pronounced at 25 µM (Figure 4.5) compared to 10 µM 
(Figure 4.4). However, it was only quercetin which in combination with ascorbic acid 
significantly decreased cell viability in control groups. Nevertheless, the toxicity of 
quercetin in control cells implies that it should not be used for prolonged applications, and 
should be used only in conditions of oxidative stress.   
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Figure 4.5. Effects on cell viability of 25 µM of different polyphenols with or without 
ascorbate added 3 days prior to treatment with t-buOOH. 
 
Cells were maintained in DMEM with 2% FBS containing 25 µM of polyphenols alone or in 
combination with 100 µM sodium ascorbate for 3 days. Cells were then treated with 350 µM t-
buOOH (shown as tbooh) for 24 h. Live cells were counted after staining with acridine orange. 
Columns are means of 3-4 wells ± SEM. * shows p<0.05 vs. Control. † indicates p<0.05 vs. 
tbooh (with or without adjustments according to the corresponding controls). § indicates p<0.05 
vs. Asc,tbooh. Asc, ascorbic acid; Cyan, cyanidin; Del, delphinidin; Cat, catechin; EGCG, 
epigallocatechin gallate; PC, proanthocyanidins; Quer, quercetin; Res, resveratrol; Gall, gallic 
acid; Caff, caffeic acid.  
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To investigate whether any of the examined compounds is advantageous with short-
term treatment, the pre-treatment time course was decreased to 1 h with 50 µM of each 
polyphenol, with or without ascorbate. Epigallocatechin gallate and quercetin in the 
presence or absence of ascorbate were the only compounds that inhibited t-buOOH-induced 
cell death, increasing cell survival by 66 to 95 percent (Figure 4.6). Addition of ascorbate 
improved the cytoprotection exhibited by epigallocatechin gallate, while the quercetin effect 
did not change in the presence of ascorbate. 
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Figure 4.6. Effects on cell viability of different polyphenols with or without ascorbate 
added 1 h prior to treatment with t-buOOH. 
 
Cells were kept for 2 days in DMEM with 2% FBS and treated with 50 µM of polyphenols alone 
or in combination with 100 µM sodium ascorbate for 1 h before treatment with 450 µM t-
buOOH (tbooh) for 24 h. Live cells were counted after staining with acridine orange. Bars show 
means of 3-4 wells ± SEM. * shows p<0.05 vs. tbooh (with or without adjustments according to 
the corresponding controls). † shows p<0.05 vs. EGCG,tbooh. Asc, ascorbic acid; Cyan, 
cyanidin; Del, delphinidin; Cat, catechin; EGCG, epigallocatechin gallate; PC, 
proanthocyanidins; Quer, quercetin; Res, resveratrol; Gall, gallic acid; Caff, caffeic acid.  
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The protective effect of 50 µM epigallocatechin gallate and quercetin with short-term 
pre-treatment was confirmed in a separate experiment which revealed 73 to 94 percent 
elevation in cell viability (Figure 4.7). Unlike in the previous experiment with 
epigallocatechin (Figure 4.6), no significant difference was observed in co-treatment of 
ascorbic acid with epigallocatechin gallate or quercetin. The supernatants of the same cells 
was used to detect glyceraldehyde-3-phosphate dehydrogenase (GAPDH) released from 
dead cells. The amount of GAPDH in the medium was increased by 240% in t-buOOH-
treated cells (Figure 4.8). Ascorbic acid did not cause a significant reduction, but 
epigallocatechin gallate and quercetin gave significant declines of 77 and 124 percent in the 
absence of ascorbate, and 78 and 114 percent in the presence of ascorbate, respectively.  
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Figure 4.7. Effects on cell viability of epigallocatechin gallate (EGCG) and quercetin 
(Quer) with or without ascorbate added 1 h prior to t-buOOH. 
 
Cells were treated with 50 µM EGCG or Quer alone or combined with ascorbate (Asc) for 1 h 
before incubation with 450 µM t-buOOH (tbooh) for 24 h. Viable cells were counted under a 
microscope after staining cells with acridine orange. Bars are means of 4 wells ± SEM. * is for 
p<0.05 vs. tbooh. 
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Figure 4.8. Effects on glyceraldehyde-3-phosphate dehydrogenase (GAPDH) release of 
epigallocatechin gallate (EGCG) and quercetin (Quer) with or without ascorbate added 1 h 
prior to t-buOOH. 
 
Cells were treated with 50 µM EGCG or Quer alone or combined with ascorbate (Asc) for 1 h. 
Cell viability was tested by measuring glyceraldehyde diphosphate dehydrogenase in the 
supernatants of the cells 24 h after treating cells with 450 µM t-buOOH (tbooh). Bars are means 
of 3-4 wells ± SEM. * shows p<0.05 vs. tbooh. 
 
 
 
 
4.5. Discussion 
 
The goal of this study was to compare the protective effects of polyphenols, alone and 
in combination with ascorbate, on H9c2 cells in conditions where cell death is more 
completely due to oxidative stress than was the case in the ischemia-reperfusion model. 
Compared to ischemia-reperfusion, in t-buOOH oxidative conditions long-term (3 days) pre-
treatments with polyphenols exhibited less protection and more toxicity. In short-term (1 h) 
pre-treatments, 50 µM quercetin and epigallocatechin gallate and less effectively 100 µM 
catechin showed up to 95% protection. Ascorbate alone did not prevent the cytotoxicity of t-
buOOH, and in combination with polyphenols, in most cases, did not improve the 
protection. 
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It is worthwhile to note that the micromolar concentrations of polyphenols 
administered in the current study are not achievable in vivo by means of a regular diet 
(Hertog et al., 1995), and therefore the amounts that are received by a regular diet may not 
induce a cytotoxic effect. Feeding with 50 mg/kg quercetin per day (that is higher than the 
average daily consumption of quercetin through a regular diet) for 11 weeks elevated plasma 
levels of quercetin in rats to 7.7 µM (de Boer et al., 2005). However, the concentration of 
quercetin in a variety of tissues was lower, with an average of 0.5 to 1 µM in tissues like 
liver, heart, kidney, and lung. In pigs, however, the concentrations of quercetin achieved in 
plasma and tissues were even lower (de Boer et al., 2005). Therefore, tissue achievable 
levels of flavonoids vary between different species.   
Protection by quercetin and epigallocatechin gallate of cardiomyocytes against 
hydrogen peroxide has already been demonstrated. For instance, Park et al. (2003) found 50 
to 87 percent improvement in H9c2 cell survival from 150 µM hydrogen peroxide following 
30 min incubation with various concentrations of quercetin effective from 37 to 300 µM. 
Reduction of intracellular ROS, preservation of mitochondrial normal morphology, and 
induction of Bcl-2 proteins were among mechanisms of quercetin protection of H9c2 cells 
against hydrogen peroxide. Likewise, Choi et al. (2003) reported a 50% decrease in cell 
death from hydrogen peroxide following 30 min pre-incubation of human vascular 
endothelial cells with 50 µM epigallocatechin gallate or quercetin, while other flavonoids 
tested in their study were ineffective or damaging. Toschi et al. (2000) also found that 24 h 
treatment of neonatal rat cardiomyocytes with green tea extract prevented release of lactate 
dehydrogenase and formation of conjugated dienes during exposure to a free radical-
generating system. 
Regarding the best pre-treatment time-course for quercetin, our results are inconsistent 
with those from Angeloni et al. (2007) who reported 100% prevention of 150 µM hydrogen 
peroxide-induced death in H9c2 cells after 24 h pre-treatment with 30 µM quercetin, but not 
much protection after shorter incubation times (e.g. 18 h) with quercetin. The authors 
suggested induction of cellular antioxidants as one of the indirect mechanisms of protection 
displayed by quercetin (Angeloni et al., 2008). In contrast to them, we found the same 
magnitude of protection (92 to 94 percent) by quercetin (50 µM) after 1 h incubation 
(Figures 4.6 to 4.8), while with 3 days pre-treatment cell viability was improved by 46% 
with 25 µM quercetin (Figure 4.5) and showed no improvement with 10 µM quercetin 
(Figure 4.4). Although with a different cardiomyocyte cell type and using catechins, Dreger 
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et al. (2008), in agreement with us, reported that 1 h pre-treatment of rat neonatal 
cardiomyocytes with 50 µM epigallocatechin gallate or 20 µM theaflavin digallate inhibited 
cell death caused by 30 min incubation with 100 µM hydrogen peroxide. They indicated that 
with increasing pre-treatment time the protective effects of the flavonoids decreased, 
suggesting the involvement of a direct antioxidant effect rather than indirect antioxidant 
induction. They documented that as a result of administration of epigallocatechin gallate, 
protein expression of heme oxygenase-1, but not glutathione peroxidase 3, superoxide 
dismutase 1 or catalase, was induced, but heme oxygenase-1 was not implicated in the 
cytoprotection exhibited by epigallocatechin gallate. They validated the involvement of a 
direct antioxidant effect of epigallocatechin gallate by observing reduction of intracellular 
ROS measured by dichlorofluorescein (Dreger et al., 2008).  
In summary, the current study compared the ability of a number of different 
polyphenols and ascorbate to protect H9c2 cardiomyocytes against cytotoxicity of t-buOOH. 
Most other studies have not compared different polyphenols (and have used H2O2 instead of 
t-buOOH). Among the different polyphenols tested, only quercetin, epigallocatechin gallate 
and catechin were effective under the conditions tested, and only with short-term pre-
treatment. This study was unable to confirm cooperation between ascorbate and flavonoids, 
as has been found previously in other systems (Skaper et al., 1996; Bandy & Bechara, 2001; 
Chen et al., 2004; Ferroni et al., 2004), except with epigallocatechin gallate. However the 
relative concentration of t-buOOH to the polyphenols may not have been optimal to detect 
this interaction.  
 
4.6. Conclusions 
 
In this model, unlike with ischemia-reperfusion (Chapter 3), 3 days pre-treatment with 
different polyphenols did not give protection and in many cases gave cytotoxicity. However, 
short-term (1 h) pre-treatment with some polyphenols gave protection. The best protection 
was observed in 1 h pre-treatment with 50 µM quercetin followed by 50 µM 
epigallocatechin gallate and 100 µM catechin. Lower concentrations in the short-term were 
ineffective. Pre-treatment with ascorbic acid (100 µM) did not prevent cytotoxicity of t-
buOOH. Similarly, co-treatment of ascorbate with polyphenols in most cases did not 
improve cell survival upon treatment with t-buOOH, except in one case that ascorbic acid 
enhanced cytoprotection by epigallocatechin gallate. 
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CHAPTER 5 
 
PROTECTIVE EFFECTS OF SASKATOON BERRIES, GREEN TEA 
EXTRACT, AND BROCCOLI SPROUTS AGAINST ISCHEMIA-
REPERFUSION INJURY IN ISOLATED RAT HEARTS 
 
 
5.1. Introduction 
 
Myocardial ischemia-reperfusion injury is the major cause of affliction, disability, and 
mortality after cardiac events such as heart attack and angioplasty. Following 
discontinuation of blood flow, delivery of nutrients and oxygen to the myocardial cells fails. 
As a result, mitochondrial oxidative phosphorylation is blocked but glycolysis primarily 
continues to supply energy (Solaini & Harris, 2005; Powers et al., 2007). Activation of 
anaerobic glycolysis is associated with production of lactate and consequently decline of 
intracellular pH, which initiates a succession of events that continues until reperfusion. By 
re-introduction of blood to the tissue at reperfusion, the already initiated ischemic damage is 
accelerated. In the first minutes of reperfusion, major changes in cytosolic and 
mitochondrial ionic concentrations occur, and substantial ROS are generated in the 
myocardial and surrounding non-myocardial cells, leading to activation of signaling 
pathways and eventually destruction of cells.  
As elevation of ROS and the resultant oxidative stress is an important trigger of 
ischemia-reperfusion injury, one of the preventive interventions for this pathological 
circumstance is to reduce the magnitude of oxidative stress. One strategy could be 
administration of antioxidants such as superoxide dismutase and N-acetyl cysteine 
(Makazan et al., 2007). An alternative solution is to stimulate cells to produce more 
endogenous antioxidants, for example to express more superoxide dismutase (Tanaka et al., 
2004). This enhancement may be achieved by activation of the Nrf2-ARE pathway which 
results in coordinated expression of phase 2 detoxification proteins, a group of proteins 
which are implicated in defence against xenobiotics and oxidative stress (Chen & Kunsch, 
2004). The Nrf2-ARE pathway can be activated by various stimuli, among which are ROS 
and ischemia-reperfusion itself.  
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Flavonoids, a class of plant polyphenols for which health promoting properties have 
been appealing to many investigators for decades, have recently been identified for their 
potential to induce phase 2 enzymes, although they seem to work tissue and cell type-
dependently (Moon et al., 2006). No study has yet attempted to investigate their phase 2 
enzyme induction capacities in heart, especially under conditions of ischemia-reperfusion. 
As strong antioxidants, flavonoids might attenuate oxidative stress caused by ischemia-
reperfusion, but they may also simultaneously stimulate Nrf2 and other possible 
transcription factors involved in the induction of cellular antioxidant proteins. Flavonoids 
also have other properties that are prophylactic for cardiovascular diseases such as anti-
inflammatory, anti-apoptotic, and vasodilatory effects (Naruszewicz et al., 2007; Stangl et 
al., 2006). There are numerous reports available in the literature showing the protective 
effect of flavonoids against cardiac ischemia-reperfusion injury (Toufektsian et al., 2008; 
Ikizler et al., 2007; Bak et al., 2006).  
Most of the interventions that are being suggested to alleviate heart ischemia-
reperfusion injury are generally effective if introduced before ischemia (Bolli et al., 2004). 
However, introducing treatments before ischemia is sometimes hard to achieve especially in 
unexpected ischemic incidents such as myocardial infarction or heart arrest. Therefore, 
preferences are given to those interventions that are applicable in daily life. As an 
endogenous component of fruit and vegetables, flavonoids are present in our daily diet. By 
including plant materials rich in flavonoids in our daily diet, one can be prepared for 
possible unforeseen cardiac events. The objective of the present study was to investigate 
whether introducing flavonoid-rich foods in the diet can ameliorate biochemical indicators 
of ischemia-reperfusion injury. 
Three feeding groups were included in our study. The diets were supplemented with 
either saskatoon berries, green tea extract, or broccoli sprouts. Berries were chosen as a 
source of anthocyanins (Clifford, 2000). They have been claimed to possess some of the 
highest amounts of antioxidants (Halvorsen et al., 2002) and phenolic acids (Mattila et al., 
2006) among foods. Berries have shown the capability to reduce oxidative stress-induced 
cardiomyocyte cell death (Shao et al., 2004) and to protect cultured human endothelial cells 
against oxidative stress (Miranda-Rottmann et al., 2002). However, they have not been 
examined in heart ischemia-reperfusion. Jones et al. (1998) have tested the effects of Juniper 
berry oil on hepatic ischemia-reperfusion and observed a decrease in tissue damage and cell 
death, and improvement in hepatic microcirculation over a 2-week feeding period. There are 
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a few reports pointing to the effects of anthocyanins in heart ischemia-reperfusion. 
Toufektsian et al. (2008) fed rats with an anthocyanin-rich diet from maize kernels for 8 
weeks and found higher levels of reduced glutathione in pre-ischemic hearts and lower 
infarct size in ischemic hearts. Kim et al. (2006) tested anthocyanins from black soybean 
seed coat and found reduced infarct size after oral administration of anthocyanin extract to 
rats 24 h before coronary artery occlusion. Amorini and colleagues (2003) reperfused 
isolated rat hearts with a synthetic derivative of cyanidin and reported decreased lipid 
peroxidation and preserved energy resources in treated myocardium. One aim of the present 
study was to examine whether feeding with berries in dietary achievable amounts could 
protect hearts against ischemia-reperfusion. This is important because the amount of 
anthocyanins consumed via food is generally far lower than their concentration when they 
are administered in a pure synthetic or extracted form. 
A number of studies have already examined green tea extract or various forms of 
catechins. Townsend et al. (2004) administered green tea extract in drinking water to rats for 
one week before isolation of hearts for ischemia-reperfusion and observed reduced infarct 
size and apoptosis and improved cardiac function. The benefits of catechins on heart 
ischemia-reperfusion have also been demonstrated (Modun et al., 2003; Hirai et al., 2007; 
Aneja et al., 2004; van der Kraaij et al., 1989). However, the induction of phase 2 enzymes, 
as one of the possible mechanisms of catechin protection of heart against ischemia-
reperfusion injury, has not been investigated.  
Health benefits of broccoli sprouts have recently been claimed, and are postulated to 
be mainly due to isothiocyanates such as sulforaphane. Sulforaphane has been widely 
recognized as an anticancer agent by causing cell cycle arrest and apoptosis in cancer cells 
and as a chemopreventive agent through induction of phase 2 enzymes involved in 
detoxification mechanisms (Myzak & Dashwood, 2006; Zhang et al., 1992) and possibly 
inhibition of phase 1 enzymes implicated in activation of carcinogens (Myzak & Dashwood, 
2006). It has been found that broccoli seeds, broccoli sprout extract, and sulforaphane 
induce the activities of quinone reductase, glutathione S-transferase, and glutamate cysteine 
ligase, and elevate intracellular glutathione levels in a number of cell and tissue types 
(Brooks et al., 2001; McWalter et al., 2004). No study has yet tested the effects of broccoli 
sprouts on hearts against ischemia-reperfusion injury.  
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The current study had two objectives. The first objective was to compare the effects of 
diets containing saskatoon berries, green tea extract, or broccoli sprouts on ischemia-
reperfusion in isolated rat hearts. The second objective was to investigate if the effects were 
associated with alterations in phase 2 enzymes.  
 
5.2. Materials and Methods    
 
5.2.1. Animals, diets, and experimental groups 
 
Animals were male Wistar rats weighing 250-300 g. All animals were maintained and 
handled under humane care in compliance with the national standards and guidelines of the 
Canadian Council on Animal Care (CCAC) and with approval of the University Committee 
on Animal Care and Supply (UCACS). The animals received food and water ad libitum until 
the start of the experiment (surgery). The animals were randomly assigned to one of the 
following feeding groups:  
 
Sham (5 rats): AIN-93G diet 
Control (8 rats): AIN-93G diet  
Berries (6 rats): AIN-93G diet supplemented with 5% dried saskatoon berry  
Tea (6 rats): AIN-93G diet supplemented with 0.25% green tea extract  
Sprouts (10 rats): AIN-93G diet supplemented with 2% dried broccoli sprouts 
 
The doses of saskatoon berries, green tea extract, and broccoli sprouts were chosen 
according to the previous works done by other investigators (Casto et al., 2002; Modun et 
al., 2003; Townsend et al., 2004; Wu et al., 2004b). The AIN-93G diet without tert-
butylhydroquinone (an antioxidant and potential phase 2 enzyme inducer) was prepared in 
powder form and packaged under nitrogen by Dyets Inc. (Bethlehem, PA). The different 
experimental diets were prepared by mixing the powder form ingredients in a V-shell 
blender under 100% nitrogen and stored at -20ºC until the time of serving to the animals. 
Saskatoon berries (a donation from Riverbend Plantations, Saskatoon, SK, Canada) were 
freeze-dried (final shelf temperature 40-50ºC) for 48 h. Green tea extract was a commercial 
product called Polyphenon 60 (Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) 
containing 63.9% of total catechins including 28.5% epigallocatechin gallate, 20.2% 
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epigallocatechin, 8.2% epicatechin gallate, and 7% epicatechin. Broccoli seeds (donated 
from Dr. Juurlink’s laboratory, University of Saskatchewan) were of the calabrese cultivar 
which are high in glucoraphanin. Broccoli sprouts were grown for 6 days and air-dried for 1 
week at room temperature.  
All animal groups received the corresponding diets for 10 days before surgery. All the 
groups except sham were subjected to ischemia-reperfusion; hearts in the sham group 
underwent sham surgery (see below). The animals were weighed at the beginning of the 10-
day feeding and before going for the surgery (Table 5.1).  
 
5.2.2. Ischemia-reperfusion  
 
The animals were anaesthetized with an initial flow of 5% and maintenance flow of 
2.5% isoflurane in 1 L/min of 100% oxygen. The animals were first heparinized through the 
femoral vein with 350 IU/kg heparin, then the abdomen under the diaphragm was opened 
and the median lobe of the liver was excised and snap-frozen in liquid nitrogen. Then the 
chest was fully opened and the heart was removed, immediately immersed in cold perfusate, 
and cannulated through the aorta on a Langendorff apparatus in the quickest time possible. 
The hearts were perfused in the retrograde mode with modified Krebs-Henseleit buffer 
containing 118 mM NaCl, 1.2 mM KH2PO4, 4.7 mM KCl, 1.7 mM CaCl2, 1.2 mM MgSO4, 
20 mM sodium acetate, and 10 mM glucose, pH 7.4 (Imahashi et al., 1999). To remove any  
 
Table 5.1. Weight of animals before and after 10 days feeding1  
   
      Before        After  Difference* 
 
 Sham 384.0±5.6  428.0±10.0  44.2±4.7 
      Control                          368.5±5.3        418.0±9.5                    49.5±7.0  
 Berries 372.7±2.7 419.5±6.1  46.8±5.5 
 Tea 371.0±2.9 418.2±6.7  47.2±4.5 
 Sprouts 373.3±1.8 418.3±4.3  41.0±4.7 
 
1 Data are the mean ± SEM. 
* There was no significant difference between groups either before or after 10 days 
feeding, or in the weight gained. 
 165
particulate contaminants the buffer was filtered and kept at 2-8ºC until the time of use. The 
perfusate was continuously bubbled with 100% oxygen, and warmed to 37ºC using a heating 
coil connected to a circulating water bath. The temperature of the heart was maintained at 
37ºC by the warm buffer as well as a small water-jacketed chamber. The hearts were 
perfused at a constant pressure of 110 cm H2O. A stabilization period of 15 min was used 
before ischemia. The initial flow rate during the stabilization period was set between 10-15 
ml/min. After the period of stabilization, global ischemia was induced for 20 min by 
clamping one of the upper tubes of the apparatus at two places to ensure complete blockade 
of the perfusion, and then the perfusion was restored for 2 h by rapid unclamping of the 
above-mentioned tubes. At the end of reperfusion, the hearts were harvested, the weight of 
the whole heart and both ventricles was determined and the ventricles were snap-frozen in 
liquid nitrogen and kept at -70ºC for later analysis. The hearts from the sham group were 
weighed and frozen at the end of the stabilization period.  
      
5.2.3. Tissue crushing  
 
Frozen ventricles were crushed to a powder using a tissue pulverizer prechilled in 
liquid nitrogen. For tissue analyses, weighed amounts of pulverized frozen tissues were 
homogenized in the appropriate buffer using a microcentrifuge tube homogenizer. 
 
5.2.4. Assessment of protein content   
 
Protein concentration was determined by the Bradford technique. Bradford reagent 
required for the assay was prepared using 100 ml of 85% phosphoric acid, 50 ml of 95% 
ethanol, and 100 mg of the dye. The solution was brought to 1 L with water, mixed 
thoroughly (left overnight while stirring), and filtered to remove undissolved dye particles. 
Generally, 5 µl of sample supernatants from tissues 10 times diluted with lysis buffer was 
added to 995 µl of the Bradford reagent in cuvettes. The absorbance of the dye was read at 
590 and 450 nm, and the protein was quantified by dividing the absorbance at 590 nm by 
that at 450 nm (Zor & Selinger, 1996). To construct a protein standard curve, bovine serum 
albumin was used as the standard.  
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5.2.5. Flow rate and lactate dehydrogenase  
 
To determine the coronary flow rate and lactate dehydrogenase released from the 
myocardial cells, heart effluents were collected for 1 minute at minutes 5 and 15 of the 
stabilization period, and minutes 1, 3, 5, 7, 10, 15, 20, 30, 60, 90, and 120 of the reperfusion 
time. For the sham hearts, the effluents were only collected from minutes 5 and 15 of the 
perfusion. Aliquots of the coronary effluents were kept refrigerated, and later in the day of 
the operation, 200 µl of the effluent was mixed with 800 µl of pyruvate solution containing 
50 mM potassium phosphate, pH 7.4, 2.5 mM pyruvate, and 180 µM NADH (added 
immediately before the assay), and the kinetics of the NADH consumption by the lactate 
dehydrogenase was recorded for 30 seconds at 340 nm. Lactate dehydrogenase activity was 
expressed as units of lactate dehydrogenase released into the perfusate/ml of coronary 
flow/wet weight of the heart.  
 
5.2.6. Caspase-3 activity 
 
Caspase-3 activity was assessed by incubation of tissue homogenates with a caspase-3 
substrate and colorimetric detection of the cleaved substrate as a result of digestion by 
caspase-3 in cell lysates (Masini et al., 2003). Briefly, 30 mg of the frozen tissue was 
homogenized in 500 µl cold lysis buffer containing 10 mM Hepes, 50 mM KCl, 5 mM 
MgCl2, 0.5% CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate), 10 
mM dithiothreitol (DTT), 1 mM phenylmethylsulphonyl fluoride (PMSF), 2 µg/ml 
leupeptin, and 2 µg/ml aprotinin, pH 7.4. The homogenates were incubated on ice for 15 
min, and centrifuged at 10,000 g for 10 min at 4ºC. A 170 µl sample of the supernatant was 
incubated with 6 µl of 10 mM caspase-3 substrate Ac-DEVD-p-nitroanilide (Sigma-Aldrich 
Canada Ltd., Oakville, ON, Canada) (340 µM final) for 1 h at 37ºC, and the absorbance of 
the cleaved substrate, p-nitroanilide, was measured at 405 nm. The extinction coefficient of 
8300 M-1cm-1 (Jacques et al., 2000) was used for determination of p-nitroanilide 
concentration. Data were expressed as µmol of p-nitroanilide/min/mg of protein. 
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5.2.7. DNA fragmentation   
 
DNA was extracted from the tissues and subjected to agarose gel electrophoresis 
(Fliss & Gattinger, 1996). About 100 mg of the frozen tissue was homogenized with 800 µl 
lysis buffer containing 10 mM Tris-HCl, 100 mM NaCl, 25 mM EDTA, 1% sodium dodecyl 
sulfate (SDS), pH 8.0, incubated for 15 min and centrifuged at 13,000 g for 15 min, both at 
room temperature. From the upper part of the supernatant which contained fragmented DNA 
450 µl was taken without disturbing the viscous lower part containing intact high molecular 
weight DNA. The supernatant was incubated with 100 µg/ml final concentration of 
proteinase K (EMD Chemicals, Inc., Gibbstown, NJ, USA) for 30 min at 50ºC. To 
precipitate DNA, 60% final concentration of ethanol and 500 mM final concentration of 
NaCl were added to the proteinase-treated samples and the samples were left overnight at -
20ºC. To obtain DNA, samples were centrifuged at 13,000 g for 15 min at 4ºC, and the 
pellet was resuspended in 500 µl TE buffer containing 10 mM Tris-HCl and 1 mM EDTA, 
pH 8.0. Then, 500 µl phenol/chloroform saturated with TE buffer (1/1/2) was added, and the 
DNA was extracted by centrifugation at 20,000 g for 1 min at 4ºC. The supernatant was 
treated with an equal volume of chloroform and again centrifuged at 20,000 g for 1 min at 
4ºC. The supernatant was taken and treated with final concentrations of 60% ethanol and 
500 mM NaCl for 1 h at -20ºC to precipitate DNA. DNA was obtained by centrifugation at 
13,000 g for 15 min at 4ºC and dried overnight at room temperature. Next day, the DNA was 
resuspended in 50 µl of TE buffer. To determine the concentration of DNA in the samples, a 
10 µl aliquot of DNA in TE buffer was treated with a final concentration of 100 µg/ml 
RNase (Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) for 30 min at 37ºC, then 50 
µg/ml final concentration of ethidium bromide was added and DNA concentration was 
determined by measuring ethidium bromide emission at 595 nm with excitation at 510 nm 
and using pure plasmid DNA as standard. Then, the rest of the samples were treated with a 
final concentration of 100 µg/ml RNase for 30 min at 37ºC. An aliquot containing 2 µg of 
the RNase-treated DNA was mixed with 6X loading buffer containing 50% (v/v) glycerol, 
50 mM EDTA, and 0.25% bromophenol blue, immediately loaded on a 1% agarose gel in 
TAE buffer (40 mM Tris-HCl, 30 mM acetic acid, and 2 mM EDTA, pH 8.0) containing 0.5 
µg/ml ethidium bromide, and electrophoresed at 150 volts. Hind III-digested bacteria phage 
Lambda DNA was used as the standard DNA marker. The gels were then imaged with an 
Alpha Innotech digital imaging system, and the bands were densitometrically analyzed using 
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the AlphaEase (Alpha Innotech) software. The software measured the intensity of the 
fluorescence in the centre of the non-fragmented DNA band and of fragmented DNA at a 
fixed distance from this, and the data were expressed as the ratio of fragmented to non-
fragmented DNA (Noda et al., 2001). 
 
5.2.8. Thiobarbituric acid reactive substances (TBARS) 
 
Peroxidation in tissues was measured by the TBARS assay based on the reaction of 
thiobarbituric acid with reactive aldehydes present in the samples, forming a colorimetric 
adduct that could be detected spectrophotometrically (Ohkawa et al., 1979). An approximate 
amount of 50 mg of the frozen tissues was homogenized with 200 µl of RIPA buffer 
containing 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 10 mM EGTA, 1% Triton X-
100, 1% sodium deoxycholate, 0.1% SDS, 1 mM DTT, 0.0002% butylated hydroxytoluene 
(BHT), 1 mM PMSF, 5 µg/ml aprotinin, and 5 µg/ml leupeptin, pH 7.4. The homogenates 
were incubated for 30 min at room temperature, and centrifuged at 15,000 g for 10 min at 
4ºC. The protein content was measured and 100 µl of the supernatant was added to 350 µl of 
thiobarbituric acid solution containing 12% acetic acid, pH 3.5, 0.6% SDS, 0.45% 
thiobarbituric acid, and 0.0002% BHT, and heated for 1 h at 95ºC. The heated samples were 
then cooled, centrifuged at 4,000 g for 10 min, and the absorbance of the supernatant was 
measured at 532 nm. The concentration of malondialdehyde (MDA) was calculated using a 
standard curve of malondialdehyde prepared from tetraethoxypropane by acid hydrolysis 
(Esterbauer & Cheeseman, 1990). The amount of MDA in samples was expressed as 
nmol/mg of protein.   
 
5.2.9. Aconitase activity 
 
Aconitase activity was evaluated by measuring the amount of cis-aconitate produced 
from either citrate or isocitrate (Takemoto et al., 2001). About 20 mg of the frozen tissues 
was homogenized with 200 µl of lysis buffer containing 50 mM Tris-HCl, pH 7.6, 1% 
Triton X-100, 1 mM cysteine, 1 mM citrate, 0.5 mM MnCl2, and 1 mM PMSF, incubated 
for 15 min at room temperature, and centrifuged at 15,000 g for 10 min at 4ºC. Then, 20 µl 
of the supernatant (~ 15 µg of protein) was added to quartz cuvettes with 780 µl water and 
200 µl aconitase reaction buffer containing 50 mM Tris-HCl, pH 7.4, 20 mM isocitrate, and 
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0.5 mM MnCl2, incubated for 2 min, and the absorbance of cis-aconitate was measured at 
240 nm. The amount of aconitase in the samples was determined using a standard curve for 
cis-aconitate and the aconitase activity was reported as µmoles of cis-aconitate 
produced/min/mg of protein. 
 
5.2.10. Glutathione measurements  
 
Tissue glutathione and glutathione disulfide were determined using a method 
described by Tietze (1969). To measure glutathione, 30 mg of tissue was mixed with 300 µl 
meta-phosphoric acid solution containing 1% meta-phosphoric acid. Samples were left on 
ice for 15 min and centrifuged at 10,000 g for 15 min. For glutathione (GSH) measurements, 
40 µl of the protein-precipitated supernatants was added to 160 µl of 50 mM potassium 
phosphate buffer, pH 11, mixed and the background absorbance was measured at 412 nm. 
Then, 10 µl of 5 mM 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) (in methanol) (250 µM 
final) was added, mixed and incubated for 20 min in the dark. A second reading at 412 nm 
was performed and the difference between the two readings was used for determining the 
glutathione level in the tissue. 
For glutathione disulfide (GSSG) measurement, 40 µl of the protein free supernatants 
was added to 160 µl of 50 mM potassium phosphate buffer, pH 11, with 8 µl of 5 mM 
NADPH (200 µM final). The initial absorbance at 340 nm was recorded, and 5 µl of 20 
U/ml glutathione reductase (0.5 U/ml final) was added, mixed, and the samples were 
incubated at room temperature for 40 min and read again. The difference of the first and the 
second reading indicates NADPH consumption, and therefore the amount of glutathione 
disulfide present. Standard curves were plotted using pure glutathione and glutathione 
disulfide. The values for tissue glutathione were calculated according to the standard curves 
and weight of the tissues used.  
For measuring glutathione content in liver tissues, more diluted samples were used. 
For protein precipitation, 400 µl of 3% meta-phosphoric acid solution was used for 30 mg of 
liver tissues. After centrifugation, 20 µl of the supernatants was used for both glutathione 
and glutathione disulfide measurements.  
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5.2.11. Heme oxygenase-1 protein level  
 
To determine heme oxygenase-1 protein level in heart, 30 mg of the tissue was 
homogenized in 300 µl RIPA buffer containing 50 mM Tris-HCl, 150 mM NaCl, 1 mM 
EDTA, 10 mM EGTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM DL-
dithiothreitol (DTT), 1 mM PMSF, 5 µg/ml aprotinin, 5 µg/ml leupeptin, pH 7.4. The 
homogenates were incubated for 20 min on ice, and centrifuged at 15,000 g for 10 min at 
4ºC. The protein content was measured, and homogenates were denatured in sample loading 
buffer (100 mM Tris-HCl, pH 6.8, 4 mM EDTA, 2% SDS, 15% glycerol, 0.03% 
bromophenol blue (in methanol), 2% β-mercaptoethanol) at 95ºC for 10 min (Tron et al., 
2005). Aliquots containing 60 µg of total protein were subjected to sodium dodecyl sulfate - 
polyacrylamide gel electrophoresis (SDS-PAGE) with a 12% resolving gel. Proteins were 
transferred onto nitrocellulose membranes using a semi-dry electrophoretic transfer cell, and 
the membranes were blocked in Tris-buffered saline (20 mM Tris, 125 mM NaCl, 0.1% 
Tween 20) with 5% nonfat-dried milk at 4ºC overnight. The next day, the membranes were 
incubated with goat anti-rat HO-1 polyclonal antibody (R&D Systems, Minneapolis, MN, 
USA) in 1:2000 dilution for 2 h at room temperature. After 4-times washing, the membranes 
were incubated with 1:3000 concentration of peroxidase-conjugated anti-rabbit/goat 
immunoglobulin (Rockland Immunochemicals, Inc., Gilbertsville, PA, USA) as the 
secondary antibody for 1 h followed by washing steps. The membranes were then treated 
with the chemiluminescent substrate luminol (Sigma-Aldrich Canada Ltd., Oakville, ON, 
Canada) and hydrogen peroxide, and the luminescent signals were detected by exposure to 
Kodak BioMax XAR film. To check for equal loading of proteins, the blots were stripped 
off and the membranes were re-probed with rabbit anti-actin antibody (1:5000) (Sigma-
Aldrich Canada Ltd., Oakville, ON, Canada).  
 
5.2.12. Glutamate cysteine ligase activity 
 
The activity of glutamate cysteine ligase was determined by detection of the 
fluorescent product of the reaction of 2,3-naphthalenedicarboxyaldehyde (NDA) with γ-
glutamylcysteine produced as the result of glutamate cysteine ligase activity (White et al., 
2003). Approximately 30 mg tissue was homogenized in 200 µl TES/SB buffer containing 
20 mM Tris, 1 mM EDTA, 250 mM sucrose, 20 mM sodium borate, and 2 mM serine. The 
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homogenates were incubated on ice for 20 min, and centrifuged at 15,000 g for 20 min at 
4ºC. Fifty µl of the supernatants was transferred to a second series of tubes, and 50 µl of 
reaction cocktail containing 400 mM Tris, 2 mM EDTA, 20 mM sodium borate, 2 mM 
serine, 40 mM MgCl2, 20 mM glutamic acid, and 40 mM ATP was added. After a 5 min 
pre-incubation, 50 µl of 4 mM cysteine (a stock solution was diluted in TES/SB) was added 
and samples were incubated for 45 min. Then, 50 µl of 0.8 M sulfosalicylic acid was added, 
the tubes were vortexed, kept on ice for 20 min, and the precipitated proteins were pelleted 
at 700 g for 5 min. Twenty µl of the supernatants were loaded in a black multi-well plate 
and 180 µl of NDA derivatization solution containing 40 mM Tris, 90 mM NaOH, 1.1 mM 
NDA (in DMSO), pH 12.5, (did not vortex, otherwise would be polymerized) was added. 
The plate was incubated for 30 min at room temperature in the dark, and the fluorescence 
emission of NDA-γ-glutamylcysteine was detected at 528 nm with excitation at 472 nm in a 
plate reader.  
For assessment of the enzyme activity in liver, the same procedure as for the heart 
samples was used except that because the amount of the enzyme in liver is much higher than 
that in heart, more diluted samples were used for liver tissues. Twenty mg of tissue was 
homogenized in 500 µl TES/SB buffer, and the supernatants were diluted 1:15 before 
treating with the reaction cocktail. Furthermore, the time course of incubation with the 
reaction cocktail was decreased from 45 min to 10 min. 
 
5.2.13. NAD(P)H quinone oxidoreductase activity  
 
The activity of NAD(P)H quinone oxidoreductase (quinone reductase) was determined 
by assessing the ability of the tissues to reduce 2,6-dichloroindophenol (DCIP) (Spencer & 
Rifkind, 1990). About 30 mg of tissue was homogenized in 200 µl of 50 mM potassium 
phosphate buffer, pH 7.6, containing 1 mM PMSF, 5 µg/ml aprotinin, and 5 µg/ml 
leupeptin, and incubated on ice for 10 min. The homogenates were then centrifuged for 10 
min at 9,000 g at 4 ºC, and 20 µl of the supernatants was added to cuvettes containing 178 µl 
of buffer containing 50 mM Tris-HCl, pH 7.5, 0.07% bovine serum albumin, and 500 µM 
NADPH. The cuvettes were vortexed, and placed in the spectrophotometer. The first 2-3 
seconds were recorded at 600 nm and then, 2 µl of 6 mM sodium DCIP (60 µM final) was 
added to the cuvettes and the kinetics of DCIP reduction was recorded for 2 min. The rate of 
DCIP reduction was also measured in the presence of the quinone reductase inhibitor, 
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dicoumarol, and the activity of the enzyme was determined from the difference of enzyme 
activity in the presence and absence of dicoumarol. Calculations were made using an 
extinction coefficient of 21 mM-1cm-1 for DCIP. 
For liver tissues, the assay was performed by the same protocol except that the lysate 
supernatants were diluted 10 times, and then 30 µl of the diluted supernatants was used in 
the reaction.  
 
5.2.14. Tissue ATP content  
 
The ATP level in heart tissues was determined by a luciferase method using a 
bioluminescence kit (Sigma, Saint Louis, MO, USA). Thirty mg of the tissue was lysed in 
RIPA buffer containing 50 mM Tris-HCl, 1 mM EDTA, 10 mM EGTA, 1% Triton X-100, 
1% Na deoxycholate, 0.1% SDS, 1 mM PMSF, 1mM DTT, 5 µg/ml leupeptin, 5 µg/ml 
aprotinin, pH 7.8, for 30 min on ice, and centrifuged at 12,000 g for 10 min at 4ºC. Then, 70 
µl of the ATP assay mixture containing luciferase, luciferin, MgSO4, DTT, EDTA, bovine 
serum albumin, and tricine buffer salts was added to the wells of a white multi-well plate, 
left for 3 min and then 70 µl of the tissue lysate supernatant was added, mixed, and the 
luminescence light was detected in a luminometer. 
 
5.2.15. Total polyphenol content 
 
Total amount of polyphenols in saskatoon berries, green tea extract, and broccoli 
sprouts was measured based on transfer of electrons in alkaline medium from phenolic and 
other antioxidant compounds present in plant extracts to phosphomolybdic/phosphotungstic 
acid complexes in the Folin-Ciocalteu reagent, forming blue complexes which can be 
detected by a spectrophotometer (Ainsworth & Gillespie, 2007). To extract polyphenols, 
saskatoon berries and broccoli sprouts in power form and green tea extract were mixed 
1/100 (w/v) with 95% methanol and left at room temperature for 48 h in the dark. They were 
centrifuged at 13,000 g for 5 min and the supernatants were transferred to new tubes. The 
tea supernatant was diluted 1/50 with 95% methanol, and 100 µl of the sample supernatants 
and standards (gallic acid in methanol) was taken, 200 µl of 10% Folin-Ciocalteu reagent 
was added, vortexed and left to stand for 1-2 min. Then, 800 µl of 700 mM Na2CO3 was 
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added, mixed, and incubated at room temperature for 2 h, and the developed blue colour was 
measured at 765 nm.  
 
5.3. Statistics 
  
Data shown are means ± SEM. Statistical analysis was performed with SPSS software 
using one-way analysis of variance (ANOVA). For ischemic-reperfused groups, 
comparisons were made between animals in the treatment groups (berries, tea, and sprouts) 
and non-treated ischemic-reperfused animals (control) using 2-sided Dunnett as the post hoc 
test. Comparison between non-treated ischemic-reperfused animals (control) and non-
ischemic animals (sham) was made by paired Student’s t-test. Data on LDH release were 
analyzed by repeated measurements ANOVA.The statistical outliers (3 data points) were 
identified with an outlier calculator at http://www.graphpad.com/quickcalcs/Grubbs1.cfm and 
excluded from analysis. A p value less than 0.05 was considered significant. Percent 
increases or decreases were also calculated for the treatment groups relative to the difference 
between control ischemic-reperfused and sham groups.  
 
 
5.4. Results 
 
5.4.1. Cell death measurements 
 
To determine the extent of cell death induced by ischemia-reperfusion, 3 different 
approaches were used: lactate dehydrogenase in heart effluents, and caspase-3 activity as 
well as DNA fragmentation in heart tissues. The degree of necrosis in the heart tissues was 
determined by measuring the amount of lactate dehydrogenase (LDH) released into the 
perfusate. As LDH is a cytosolic enzyme, its release into the perfusates indicates disruption 
of cell membrane which is a characteristic of the necrotic type of cell death. In clinical 
settings, elevation of plasma levels of LDH is used as a diagnostic test for myocardial 
infarction. 
LDH release was elevated during the initial minutes of reperfusion, remained 
relatively low (although still higher than the pre-ischemic minutes) between minutes 5 and 
35 of reperfusion, and began to rise afterwards (Figure 5.1). Since LDH did not increase 
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during the stabilization period, it is unlikely that the few minutes interval between the 
excision of hearts and cannulation on the apparatus has largely damaged the heart cells. In 
the sprouts group, it seems that LDH release remained relatively low for a more prolonged 
period of time, although it started to increase around minute 60 of the reperfusion. The 
increase in LDH release occurred faster in the berries and tea groups in comparison with the 
control. Although the tea group initially seemed to be similar to the control group, by the 
end of the experiment it showed a sharp increase in the released LDH. LDH release in the 
sprouts group, however, remained lower compared to the control. By the end of the 
reperfusion time the difference between treatment groups and control became more 
pronounced. However, none of the berries, tea, or sprouts groups significantly differed from 
the control at any time point. As hearts from the sham group were harvested right after the 
stabilization period, there is no information from them in this experiment.  
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Figure 5.1. Lactate dehydrogenase (LDH) released into the heart effluents.  
 
Aliquots of the coronary effluents were collected during 15 min stabilization period and 2 h 
reperfusion. The amount of LDH was determined and expressed as units of LDH present in the 
effluents per ml of the perfusate per gram of the wet tissue. Each point represents means ± SEM. 
The experimental groups consisted of: control n=7; berries n=6; tea n=6; and sprouts n=10. 
Because the error bars were tall, for simplicity only those from control and sprouts groups are 
presented. There was no significant difference between control and any of the other groups at 
any time point. 
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Apoptosis in the heart tissues was determined using examination of caspase-3 activity, 
one of the important effector caspases involved in apoptosis. Ischemia-reperfusion increased 
the activity of caspase-3 by 270% (Figure 5.2). All of the treatment groups showed a 
decrease in caspase activity, ranging from 43 to 86 percent, but only the decreases in the tea 
(85%) and sprouts (86%) groups were significant.  
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Figure 5.2. Caspase-3 activity in heart tissues.  
 
The activity of caspase-3 in the hearts was determined by quantification of produced p-
nitroanilide, the cleaved caspase-3 substrate. The bars represent means ± SEM. The number of 
animals per experimental group was as follows: sham n=5; control n=8; berries n=6; tea n=6; 
sprouts n=10. † is for p<0.05 vs. sham. * shows p<0.05 vs. control.  
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DNA fragmentation in the heart tissues was quantified as another indicator of cell 
death. DNA fragmentation showed a 1.9-fold increase in the control compared to the sham 
group (Figure 5.3). Although all treatment groups had a lower (66-78%) DNA fragmentation 
versus the control, only the sprouts group was found to be significant. Both berries and tea 
groups exhibited DNA fragmentation as low as sprouts; however their difference was not 
significant, perhaps because of lower statistical power due to merely 4 animals per group in 
this measurement. 
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Figure 5.3. DNA fragmentation in heart tissues.  
 
DNA was extracted from the hearts and exposed to agarose gel electrophoresis. Then, the gels 
were imaged and scanned for densitometric analysis of the separated DNA.  
A. Gel electrophoresis of the DNA. Lanes are as follows: lane 1, HindIII-digested lambda 
phage DNA; lane 2, DNA extracted from sham group; lanes 3 and 4, DNA from sprouts group; 
lane 5, DNA from tea group; lane 6, DNA from berries group; lanes 7 and 8, DNA from control 
group.  
B. Densitometric analysis of gel images. The amount of DNA has been expressed as the ratio of 
fragmented to non-fragmented DNA. The values represent means ± SEM. Some of samples from 
each groups were lost due to technical difficulties occurred during performing the assay. The 
number of animals in each bar was as follows: sham n=4; control n=6; berries n=4; tea n=4; 
sprouts n=6. † shows p<0.05 vs. sham. * indicates p<0.05 vs. control.  
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5.4.2. Assessment of oxidative stress 
 
To assess ischemia-reperfusion-induced oxidative stress in cardiac cells, two 
indicators of oxidative stress were measured: TBARS and aconitase activity. TBARS is a 
general test for oxidative damage. It detects malondialdehyde and other reactive aldehydes 
present in the samples through its reaction with thiobarbituric acid and development of a 
colorimetric product that can be identified by spectrophotometer. Ischemia-reperfusion 
caused a 60% increase in reactive aldehydes as revealed from comparison of the control 
with the sham group (Figure 5.4). Treatment groups showed up to 100% inhibition, with 
berries (73%) and sprouts (complete inhibition) being statistically significant.  
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Figure 5.4. Lipid peroxidation in heart tissues.  
 
Reactive aldehydes in the heart tissues were measured using the TBARS assay, with 
malondialdehyde (MDA) as the calibration standard. Columns are means ± SEM. The number of 
animals in each group was as follows: sham n=5; control n=8; berries n=6; tea n=6; sprouts 
n=10. † shows p<0.05 vs. sham.* is for p<0.05 vs. control.  
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Aconitase is one of the enzymes in the Krebs cycle of mitochondria responsible for 
conversion of citrate to isocitrate with the intermediate formation of cis-aconitate. Aconitase 
has an iron-sulfur centre in its active site which is sensitive to oxidation and loss of iron 
(Han et al., 2005). As ROS have been shown to inactivate aconitase, aconitase activity can 
be considered as a marker of oxidative stress. Aconitase activity was lost by 12.5 % in the 
control compared to the sham group (Figure 5.5). Treatments preserved the enzyme activity 
by 66 to 82 percent, but only the sprouts group (82%) was significant.  
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Figure 5.5. Aconitase activity in heart tissues. 
 
Aconitase activity was determined based on the ability of the tissue samples to produce cis-
aconitate from citrate present in the reaction mixture. The bars show means ± SEM. The number 
of animals in each group was as follows: sham n=5; control n=8; berries n=6; tea n=6; sprouts 
n=10. † shows p<0.05 vs. sham. * indicates p<0.05 vs. control.  
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5.4.3. Tissue glutathione levels 
 
Glutathione (GSH) is one of the most important non-enzymatic endogenous 
antioxidants in the cytosol, and has been introduced as one of the important antioxidants 
acting against reperfusion-induced oxidative stress (Haramaki et al., 1998). The level of 
GSH in the heart tissues decreased significantly by 37% after ischemia-reperfusion (Figure 
5.6). None of the treatments gave statistically significant improvement. Glutathione disulfide 
(GSSG) in the hearts was not significantly affected by ischemia-reperfusion or by any of the 
treatments (Figure 5.6).   
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Figure 5.6. Reduced (GSH) and oxidized (GSSG) glutathione in heart tissues.  
 
The bars show means ± SEM. The number of animals in each group was as follows: sham n=5; 
control n=8; berries n=6; tea n=6; sprouts n=10.  
GSH. The tissue level of GSH was determined with DTNB as described in Materials and 
Methods. * indicates p<0.05 vs. sham.   
GSSG. The tissue level of GSSG was determined by oxidation of NADPH in the presence of 
glutathione reductase as described in Materials and Methods. No significant difference was 
detected between GSSG of different groups. 
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Similarly, there was no significant difference between groups in the GSH to GSSG 
ratio, although ischemia-reperfusion caused a non-significant 38% decrease in the control 
compared to the sham group (Figure 5.7). The total amount of glutathione in the heart 
tissues was significantly decreased by 27% in the control group, but none of the dietary 
treatments was protective (Figure 5.7).   
The levels of glutathione in the liver of animals who had been fed with either regular 
(control) diet or any of berries, tea, or broccoli sprouts diets were also examined and the 
sprouts group had a significant 12% increase in the total glutathione (Figure 5.8).  
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Figure 5.7. Ratio of glutathione (GSH) to glutathione disulfide (GSSG) and total amount of 
glutathione in heart tissues.  
 
Data represent means ± SEM. The number of animals in each group was as follows: sham n=5; 
control n=8; berries n=6; tea n=6; sprouts n=10. * shows p<0.05 vs. sham. 
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Figure 5.8. Total glutathione in liver tissues.  
 
Bars are means ± SEM. The number of animals in each group was as follows: control n=8; 
berries n=6; tea n=6; sprouts n=10. * is for p<0.05 vs. control. 
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5.4.4. Evaluation of phase 2 enzymes 
 
In order to see whether some of the protection of the dietary pre-treatments had been 
rendered through induction of phase 2 enzymes, the activities of glutamate cysteine ligase 
and quinone reductase as well as the protein level of heme oxygenase-1 were determined. 
The enzyme glutamate cysteine ligase is the rate-limiting enzyme in the synthesis of 
glutathione, and so its induction might enhance cellular glutathione content and 
consequently the antioxidant potential of cells. Ischemia-reperfusion caused a 28% decline 
in the activity of glutamate cysteine ligase in hearts (Figure 5.9). Sprouts and berries did not 
prevent the loss of the activity, but tea caused a 78% significant amelioration. In liver, while 
all of the treatments seemed to elevate the activity of glutamate cysteine ligase, only the 
sprouts showed a statistically significant 40% increase (Figure 5.9).  
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Figure 5.9. Glutamate cysteine ligase activity in heart and liver tissues.  
 
The activity of glutamate cysteine ligase was determined by fluorometric detection of the 
product, γ-glutamylcysteine using the procedure described in Materials and Methods. Bars are 
means ± SEM. The number of animals in each group was as follows: sham n=5; control n=8; 
berries n=6; tea n=6; sprouts n=10. † shows p<0.05 vs. sham.* shows p<0.05 vs. control. ‡ is for 
p<0.05 vs. control.   
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Ischemia-reperfusion caused a non-significant decrease in the activity of quinone 
reductase in hearts (Figure 5.10). Hearts in the tea group had a statistically significant 147% 
protection against this decrease. In liver, sprouts increased the activity of quinone reductase 
by 44% in comparison with the control (Figure 5.10). Measuring heme oxygenase-1 protein 
in heart, there were no statistically significant differences between any of the groups (Figure 
5.11).  
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Figure 5.10. Quinone reductase activity in heart and liver tissues.  
 
The activity of quinone reductase was determined by measuring the rate of DCIP reduction in 
the presence of NADPH. Bars are means ± SEM. Heart, The number of animals in each group 
was as follows: sham n=5; control n=7; berries n=6; tea n=6; sprouts n=10. * shows p<0.05 
compared to control. Liver, The number of animals in each group was as follows: control n=7; 
berries n=5; tea n=6; sprouts n=10. † shows p<0.05 vs.control. 
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Figure 5.11. Heme oxygenase-1 protein expression in heart tissues.  
 
Samples of the heart tissues were analyzed for heme oxygenase-1 by western blotting as 
described in Materials and Methods. Columns are means ± SEM. The number of animals in each 
group was as follows: sham n=5; control n=8; berries n=6; tea n=6; sprouts n=10. No significant 
difference was observed between groups.  
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5.4.5. Heart ATP levels  
 
Measuring tissue ATP revealed very low levels of ATP in the ischemic-reperfused 
groups compared to the sham animals (Figure 5.12). However, sprouts showed a significant 
preservation of tissue ATP content compared to the ischemic-reperfused control group.   
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Figure 5.12. ATP content in heart tissues.  
 
Tissue ATP levels were determined by a luminescence kit. Columns are means ± SEM. The 
number of animals in each group was as follows: sham n=5; control n=8; berries n=6; tea n=5; 
sprouts n=10. † shows p<0.05 vs. sham. * indicates p<0.05 vs. control.  
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5.4.6. Coronary flow rate 
 
Coronary flow rate from all of ischemic-reperfused groups had a decreasing trend 
during the time of the experiment (Figure 5.13). Sprouts and to a lesser extent tea showed 
improvements; however, at no time point were the increases statistically different from the 
control. 
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Figure 5.13. Coronary flow rate during the stabilization and reperfusion time.  
 
Coronary flow rate was determined by measuring the amount of heart effluents per minute 
divided by the wet weight of heart. Each point represents means ± SEM. The number of animals 
in each group was as follows: sham n=5; control n=7; berries n=6; tea n=6; sprouts n=10. For 
better view only standard error bars of the control and sprouts groups have been shown. There 
was not significant difference between groups.  
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5.4.7. Total polyphenol content 
 
 
To compare the polyphenol content of the diets, and to see whether the effects  
exhibited by different dietary interventions could be related to the phenolic content of the 
feeds, the polyphenol content of saskatoon berries, green tea extract, and broccoli sprouts 
was determined. Green tea extract had almost 50 times more polyphenols than saskatoon 
berries and broccoli sprouts that is reasonable, as unlike saskatoon berries and broccoli 
sprouts, green tea extract contained concentrated polyphenols (Table 5.2). The polyphenol 
content of broccoli sprouts was the lowest among the three plant materials.  
 
 
 
 
Table 5.2. Total polyphenol content in saskatoon berries, green tea extract, and broccoli 
sprouts, and the calculated amount of polyphenol added to the diets.1 
 
           Gallic acid equivalents  % of diet      Polyphenol content of diets 
        (nmol/mg plant dry weight)                    (µmol/kg) 
 
Saskatoon berries         3.95±0.08                   5.0%                    1.97±0.04  
Green tea extract         165.2±1.68**             0.25%                    4.13±0.04** 
Broccoli sprouts         2.90±0.14*                 2.0%                      0.58±0.03*  
 
1 Data are the mean ± SEM.  
* indicates p<0.05 vs. broccoli sprouts. 
** indicates p<0.05 vs. saskatoon berries and broccoli sprouts.  
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5.5. Discussion 
 
We hypothesized that flavonoids would reduce myocardial cell death caused by 
ischemia and reperfusion through multiple mechanisms including attenuation of oxidative 
stress by their direct antioxidant activities and indirectly by induction of antioxidant and 
phase 2 enzymes. The results of the study herein showed that 10 days consumption of 
saskatoon berries, tea, or broccoli sprouts in the diet before ischemia and reperfusion gave 
significant protection as evidenced by lower cell death and mitigated the extent of oxidative 
stress. Sprouts and tea decreased cell death by up to 86%, as assessed by caspase-3 activity 
and/or DNA fragmentation. Sprouts and berries ameliorated oxidative stress alterations in 
lipids, as evaluated by TBARS (116 and 73 percent decrease, respectively), and sprouts gave 
82% protection to the protein aconitase. Tea was the only intervention that prevented the 
decrease in activities of the two phase 2 enzymes, glutamate cysteine ligase and quinone 
reductase, in ischemic-reperfused hearts. In liver, the only dietary treatment that caused a 
significant change in phase 2 enzyme levels was sprouts which showed a 40% increase in 
glutamate cysteine ligase activity and a 44% increase in quinone reductase activity.   
Cell death in ischemic-reperfused hearts occurs by both apoptosis and necrosis (Zhao 
& Vinten-Johansen, 2002). Both forms of cell death were tested in our study; lactate 
dehydrogenase as a marker of necrosis and caspase-3 activity and DNA fragmentation as 
representatives of apoptosis. None of the treatments had significant effect on necrosis, as 
measured by lactate dehydrogenase release into the heart effluents. Two of the treatments, 
berries and tea, seemed to worsen lactate dehydrogenase release, while sprouts appeared to 
be protective. None of these effects was statistically significant. Nevertheless, this poses the 
possibility that berries and tea may promote necrosis, and opens up an area for further 
investigation of possible effects of the compounds, either flavonoids or non-flavonoids, in 
berries and tea in stimulation of the necrotic form of cell death. Our results with lactate 
dehydrogenase release in heart effluents is in disagreement with reports from other 
investigators indicating that 10 days or 1 hour pre-treatment with catechin (Modun et al., 
2003) or 3 weeks (Al Makdessi et al., 2006) or 10 min (Fantinelli et al., 2005) pre-treatment 
with proanthocyanidins (polymers of catechins) significantly decreased lactate 
dehydrogenase release from hearts. The reason for this inconsistency is not clear to us, but 
there are some possible explanations. For example, the dose of catechin used by Modun and 
colleagues was 2.5 times the dosage of green tea catechins applied in our study. 
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Furthermore, the green tea extract used by us contained additional types of catechins such as 
epigallocatechin gallate which are more prone to cytotoxicity than catechin itself (Ohshima 
et al., 1998).  
Against apoptosis, as measured by caspase-3 activity, green tea extract and broccoli 
sprouts protected very well. Berries did not inhibit activation of caspase-3 significantly, 
although their effects did approach significance (p=0.07). Also, berries and tea groups did 
not show a significant lower DNA fragmentation, but this might have been due to low 
number of samples in this experiment as they appeared to prevent DNA fragmentation as 
effectively as sprouts. Several groups of investigators have reported the effect of catechins 
in limiting apoptosis (Townsend et al., 2004; Hirai et al., 2007) and infarct size (apoptosis 
and necrosis) (Suzuki et al., 2007; Potenza et al., 2007; Townsend et al., 2004; Aneja et al., 
2004). Anthocyanins from black soybean seed coat (Kim et al., 2006) and maize kernels 
(Toufektsian et al., 2008) also showed the potential to reduce infarct size. Recently, 
broccoli, but not broccoli sprouts, has demonstrated to attenuate myocardial cell apoptosis 
after ischemia-reperfusion (Mukherjee et al., 2008). 
All dietary treatments markedly prevented at least one of the biochemical changes 
caused by ischemia-reperfusion-induced oxidative stress. Malondialdehyde as an indicator 
of lipid peroxidation was diminished especially in berries and sprouts groups. The activity of 
oxidative stress-sensitive aconitase was also preserved by sprouts. Similar to our results, 
Amorini et al. (2003) found that reperfusion of isolated hearts with cyanidin-3-
glucopyranoside in the perfusate decreased production of malondialdehyde. Other 
investigators have reported the ability of catechin (Modun et al., 2003) and 
proanthocyanidins (Fantinelli et al., 2005; Sato et al., 1999) to prevent lipid peroxidation in 
heart ischemia-reperfusion. Likewise, 3 weeks of feeding rats with oligomeric 
proanthocyanidins from grape seeds decreased hydroxyl radicals (Pataki et al., 2002) and 
malondialdehyde (Sato et al., 1999) released into post-ischemic heart effluents. 
Despite the fact that the treatments substantially mitigated oxidative stress-induced 
changes in lipids and proteins, they did not preserve cellular reduced glutathione, nor 
improve the GSH to GSSG ratio, a biomarker which closely reflects cellular redox state (Wu 
et al., 2004a). The reason for the lack of the effect of treatments on glutathione is not clear, 
but the task of glutathione in detoxification reactions may be implicated. Dietary treatments 
in our study contained flavonoids. Oxidized flavonoids have electrophilic properties, and 
can be detoxified through conjugation with glutathione. Therefore, flavonoids might have 
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sequestered some of the cellular glutathione after being oxidized in oxidative conditions of 
ischemia-reperfusion. Formation of flavonoid-glutathione adducts has been shown in the 
presence of hydrogen peroxide and peroxidase (Galati et al., 2001; Moridani et al., 2001; 
Awad et al., 2000).  
The sprouts group had elevated total glutathione in liver which was also in agreement 
with increased liver activity of the enzyme synthesizing glutathione, glutamate cysteine 
ligase, in this group. This means that it is plausible that treatment with broccoli sprouts 
enhance glutathione synthesis in liver, the main location of glutathione synthesis in the 
body, and glutathione could then be exported from the liver to other organs in need, e.g. the 
heart when being challenged with ischemia-reperfusion-induced oxidative stress. 
Unfortunately, the ex vivo condition of our study did not allow us to examine this. 
Whereas the sprouts group had higher glutamate cysteine ligase activity in liver, the 
tea group showed a higher activity of this enzyme in heart. However, the elevation of 
glutamate cysteine ligase activity in hearts from the tea group could not be confirmed by the 
enhancement of glutathione markers in hearts, although they had relatively (non-significant) 
higher mean values for GSH, GSH/GSSG, and total glutathione compared to the other 
treatments. The higher activity of glutamate cysteine ligase in hearts of the tea group could 
be due to induction of the corresponding gene or inhibition of the loss of the enzyme activity 
following ischemia-reperfusion.   
The activity of quinone reductase followed the same pattern as glutamate cysteine 
ligase, as sprouts and tea groups exhibited higher activities in liver and heart, respectively. 
Interestingly, in liver, activities of both phase 2 enzymes were comparably higher in the 
treatment groups than in the control group, although it was only the sprouts group which 
showed a statistically significant elevation, perhaps due to the higher number of animals in 
this group. Although saskatoon berries failed to elevate activities of the two examined phase 
2 enzymes in our study, an increased induction of the glutamate cysteine ligase gene by a 
mixture of berries in the brain and muscle, but not the liver, of mice has been reported 
before (Carlsen et al., 2003). The mechanism of induction of phase 2 enzyme activities is yet 
unclear, but it has been suggested that inducers of the phase 2 genes likely react with a 
sensor molecule (possibly the Nrf2-Keap 1 complex) in the cell, modifying sulfhydryl 
groups through oxidation or alkylation (Dinkova-Kostova et al., 2001). Keap-1, the 
molecule that sequesters Nrf-2 in the cytosol, contains 9 highly reactive sulfhydryl residues 
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which are postulated to be critical for recognition by and reaction with phase 2 enzyme 
inducers.    
The expression of heme oxygenase-1 in heart tissues did not show a significant change 
between groups, which may be at least partly due to high within-group variability in this 
assay. There is no information to date on the ability of catechins or anthocyanins to induce 
or prevent loss of heme oxygenase-1. However, there are some reports of resveratrol 
induction of heme-oxygenase-1 in ischemic-reperfused hearts (Kaga et al., 2005; Das et al., 
2006). Broccoli has also shown to inhibit ischemia-reperfusion-induced reduction of heme 
oxygenase-1 (Mukherjee et al., 2008). 
The ischemic-reperfused control group for many biomarkers such as glutathione 
parameters and phase 2 enzymes displayed lower values than the sham animals. Although 
these lower quantities could have been due to the actual impact of ischemia-reperfusion on 
the cells, it is also possible that the diminutions were because some cells in the ischemic-
reperfused control group had compromised cell membrane and therefore cytoplasmic 
components of such cells have leaked to the extracellular environment (i.e. heart effluents) 
and been removed (Ferrari et al., 1990). Although the biomarkers were always expressed per 
protein content or weight of tissue, this possibility still exists as the damaged cells may have 
not been depleted of structural proteins as they have of enzymatic proteins and non-
enzymatic intracellular components (e.g. glutathione). However, this possibility is not 
corroborated by the results from oxidative stress markers, such as caspase-3 activity, DNA 
fragmentation, and TBARS, which increased in the ischemic-reperfused control group 
instead of decreasing due to the loss from the cells. Nevertheless, it is possible that these 
markers have partially been lost in the heart effluents but their elevation in the heart 
following ischemia-reperfusion has covered this loss. 
 None of the treatments significantly prevented the gradual declination in the flow rate 
during the experiment. Sham hearts were not kept on the apparatus until the end of the 
experiment, so no information is available on their perfusion rate. However, as the decrease 
in the flow rate of the sham and other animals began in the pre-ischemia minutes, i.e. after 
cannulation of hearts on the apparatus, it is likely that if there was a sham group which was 
perfused for the whole time of the experiment, the coronary flow rate would yet have such a 
decline. Such a decline in the flow rate of the sham hearts was observed in the pilot work of 
this study where hearts from sham animals were perfused for longer periods of time, e.g. 1 
or 2 h. The gradual depression in the flow rate could be due to partial obstruction of the 
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coronary vasculature as a result of artificial perfusion and lack of normal heart contractility 
and physiological vessel tonicity. Improved coronary flow in ischemic-reperfused hearts 
upon feeding animals with epigallocatechin gallate (Potenza et al., 2007) and 
proanthocyanidins (Pataki et al., 2002) has previously been reported. 
Except for the sprouts, the other treatments failed to improve cellular ATP level. The 
improved ATP content by broccoli sprouts is in concordance with the attenuated (non-
significant) amount of necrosis in the sprouts group which was evidenced by the lower level 
of lactate dehydrogenase released into the heart effluents. Similarly, ineffectiveness of 
berries and tea to prevent depletion of heart tissue ATP content was consistent with the 
higher (non-significant) occurrence of necrosis in these groups compared to the sprouts 
group. In contrast to our results with berries and green tea extract, preservation of ATP in 
ischemic-reperfused hearts has previously been reported for cyanidin-3-glucopyranoside 
(Amorini et al., 2003), epigallocatechin gallate, and gallocatechin gallate (Hirai et al., 2007).  
The drastic difference in ATP content between sham and ischemic-reperfused groups 
was not only because the sham animals did not have an ischemic period, but it was also 
because the sham hearts were not kept on the apparatus as long as the ischemic-reperfused 
hearts. It is likely that if hearts from the sham group had been perfused for the whole time of 
the experiment, their cellular ATP content would gradually decline due to a gradual 
depression in the flow rate as a result of coronary vasculature dysfunction that impairs the 
access of cardiac cells to nutrients and oxygen.  
Our study was the first to report protection by broccoli sprouts on hearts under 
conditions of ischemia-reperfusion, although the cardioprotective ability of broccoli in 
ischemic-reperfused hearts has recently been shown to be correlated with induction of phase 
2 enzymes and activation of survival pathways (Mukherjee et al., 2008). Beneficial effects 
of broccoli sprouts on other types of oxidative stress than ischemia-reperfusion have 
previously been reported. For instance, dietary broccoli sprouts decreased aging-related 
degenerative changes in hypertensive rats (Noyan-Ashraf et al., 2005) and mitigated 
hypertension-induced oxidative-related changes in cardiovascular and kidney tissues (Wu et 
al., 2004b). Also, topical application of broccoli sprouts extract to mice induced phase 2 
enzymes in skin and alleviated ultraviolet radiation-induced inflammation (Talalay et al., 
2007).  
As the polyphenol content of broccoli sprouts was lower than saskatoon berries and 
green tea extract, it is unlikely that the advantages observed herein from broccoli sprouts 
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were only due to the polyphenols. However, at least some of the benefits observed in the tea 
group, including enhancement of phase 2 enzyme activities in hearts, could be because of 
high polyphenolic content in this concentrated extract.   
Generally speaking, the beneficial effects of broccoli sprouts are attributed to 
glucosinolates, the precursors of isothiocyanates, some of which such as sulforaphane are 
potent phase 2 enzyme inducers (Fahey et al., 1997). Broccoli seeds possess high 
glucosinolate content (Pereira et al., 2002). As the seeds germinate, the amount of 
glucosinolate decreases with further reduction with the age of the sprouts. The amount of 
glucoraphanin, the glucosinolate form of sulforaphane, is higher sometimes by 10-100 times 
in young sprouts than in the mature plant (Fahey et al., 1997). Broccoli also possesses high 
levels of antioxidants, including vitamin C and flavonoids such as quercetin (Moreno et al., 
2007; Miean & Mohamed, 2001). The quantity of antioxidants is higher in sprouts than in 
the mature plant (Moriyama & Oba, 2004). 
No significant toxicity has been reported in phase 1 studies with broccoli sprout 
extracts containing either glucosinolates or isothiocyanates (Shapiro et al., 2006). One week 
consumption of 100 g/day fresh broccoli sprouts decreased oxidative stress markers in 
plasma and urine of healthy subjects (Murashima et al., 2004). These findings and the 
current study suggest that consuming broccoli sprouts in daily diet may be a safe strategy to 
prevent unforeseen cardiac events in at risk individuals. The doses in humans of broccoli 
sprouts (80-100 g fresh/day) and berries (150 g fresh/day) corresponding to those used in 
our study are achievable by a regular diet, and given that the both dosages were relatively 
low the possibility of adverse side effects seem unlikely.  
 
5.6. Conclusions 
 
1. Broccoli sprouts gave the best protection, protecting against apoptosis and oxidative 
stress, and helping preserve ATP levels.  
2. The protection by broccoli sprouts was likely not due to polyphenols, since they had 
the lowest levels among the treatments.  
3. Green tea extract, which had the highest polyphenol content, could confer some 
protection against apoptosis and loss of phase 2 enzymes in ischemic-reperfused tissues.  
 192
4. Saskatoon berries could give some protection against oxidative stress (TBARS 
formation) and indications of protection against apoptosis, but otherwise were less 
protective than the sprouts or green tea extract under these conditions and doses tested.  
5. Whether any of the treatments acted by inducing phase 2 enzymes was 
inconclusive, but green tea extract could help preserve phase 2 enzymes in heart while 
broccoli sprouts could increase their levels in liver.  
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CHAPTER 6 
 
CONCLUDING REMARKS 
 
 
6.1. General discussion  
 
As flavonoids possess a variety of biologic properties, it is plausible that they operate 
through multiple mechanisms. Acting as antioxidants, flavonoids can directly scavenge 
reactive oxygen species, but meanwhile due to the redox changes that they cause in the 
cellular environment they may also alter signaling pathways to induce endogenous cellular 
antioxidants. The data presented herein showed that flavonoids differ not only in the 
strength but also in the mechanism of the antioxidant activity. For instance, in in vitro 
experiments catechins were more effective than anthocyanins in prevention of damage 
caused by both ischemia-reperfusion and t-buOOH. However, in ischemia-reperfusion 
different catechins decreased cell death to similar degrees, while in t-buOOH-treated cells 
epigallocatechin gallate was nearly twice as protective as catechin, and proanthocyanidins 
were ineffective. Similarly, whereas quercetin exhibited very mild protection in ischemic-
reperfused cells, it caused the most powerful protection among the polyphenols tested in t-
buOOH-treated cells. Ascorbate showed similarly different actions in ischemia-reperfusion 
and t-buOOH circumstances; whereas it showed strong protection in the former, it was 
ineffective or damaging in the latter. 
The reason for the different behaviour of flavonoids and ascorbic acid in the two 
oxidative stress models tested could be the severity of oxidative stress and more likely the 
type of stress. t-buOOH has probably caused more intensive oxidative stress than ischemia-
reperfusion, validated by almost zero cell survival in many of the t-buOOH experiments 
compared to one-third to one-half cell viability in most of the ischemia-reperfusion 
conditions. On the other hand, in ischemia-reperfusion experiments, some of the cell death 
occurred due to lack of glucose and serum. Although these two shortages, as we discussed 
earlier, increase the intensity of oxidative stress, the signaling pathways that they engage to 
elevate reactive oxygen species are likely different from those initiated by hypoxia and from 
those evoked by t-buOOH. It is tempting to suggest that flavonoids have different abilities to 
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interact with various signaling pathways stimulated during any of these and other 
pathological stimuli. If this is true, then the best protective flavonoids against ischemia-
reperfusion injury might not be those which protect against other types of oxidative stress. 
Moreover, given that flavonoids act in a cell- and tissue-specific manner, and considering 
that the goal of this and other research in the medicinal area is to improve human health, any 
strategies claiming a benefit must be examined in humans or at least human cells and/or 
tissues. 
Unfortunately, due to inconsistency in the rate of cell death in H9c2 ischemia-
reperfusion experiments we could not continue the project to investigate whether some of 
the protection exhibited by catechins and ascorbic acid resulted from induction of phase 2 
enzymes. However, for catechin long- and short-term pre-treatments were tested and showed 
that the protective effect of catechin was increased in the long-term incubation time, posing 
the possibility that cellular antioxidant enzymes may have been induced and reinforced the 
cells’ ability to contend with ischemia-reperfusion. 
Consistent with the in vitro results, pre-treatment with catechins (i.e. green tea extract) 
decreased the rate of cell death in ischemic-reperfused isolated rat hearts, although catechins 
did not significantly prevent oxidative stress-induced changes in cellular biomolecules. A 
part of the catechin effects could be due to induction of phase 2 enzymes, which is in 
agreement with our hypothesis. Unlike green tea extract, the protective effect exhibited by 
berries (i.e. lower TBARS) was not mediated by induction of phase 2 and antioxidant 
enzymes. It is not clear what might have underlain the benefits of berries in rat hearts. 
Anthocyanins failed to inhibit cell death in exposure of H9c2 cells to ischemia-reperfusion 
or t-buOOH. However, this does not contradict that they have exerted protection in hearts. It 
is also possible that the benefits have been produced by other plant components present in 
the berries such as catechins (Sellappan et al., 2002) or ellagic acid (Carlsen et al., 2003). As 
berries showed lower impact on ischemic-reperfused hearts than tea and broccoli sprouts, 
one may suppose that the active components may not have been absorbed at the 
gastrointestinal tract. This possibility is excluded by reports demonstrating the 
bioavailability of anthocyanins in both aglycon and glycoside forms with rates of absorption 
corresponding to the dosage consumed (McGhie et al., 2003).  
What caused the benefits of broccoli sprouts was left unanswered by our study. Little 
data are available on the chemical composition of broccoli sprouts, except for a high content 
of glucosinolates. It is not clear whether the protective effect exhibited by broccoli sprouts 
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was due to their glucosinolate content, specific polyphenols (Maeda et al., 2008), or other 
phytochemicals.  
According to the results of the in vitro experiments, toxicity of flavonoids is more 
likely to occur in severe circumstances of oxidative stress (in our case, in t-buOOH 
conditions compared to the ischemia-reperfusion), where the reduction-oxidation reactions 
take place more quickly. For instance, whereas the toxicity of catechins did not appear in the 
ischemia-reperfusion experiments, even low concentration (25 µM) of epigallocatechin 
gallate and proanthocyanidins during 3 days pre-treatment showed toxicity in the presence 
of t-buOOH (Figure 4.5). Similarly, ascorbate showed protection in the ischemia-reperfusion 
experiments, while it revealed toxicity in t-buOOH conditions. It is worthwhile to note that 
reductants such as ascorbate are known to decompose lipid hydroperoxides, resulting in the 
formation of more reactive species (Lee et al., 2001; Baysal et al., 1989). H9c2 cells as a cell 
line were quite resistant to the stress caused by the ischemia-reperfusion in our study, 
requiring 5 h or more of ischemia to produce significant cell death. It is possible that the 
ischemia-reperfusion has not produced a severe oxidative stress in H9c2 cells. However, in 
in vivo situations, the cells typically seem more vulnerable and therefore oxidative stress 
produces more harm in the cells. That is why even short (e.g. 20 min) episodes of ischemia, 
such as that used in our study with rats, are deadly to cardiac cells. This implies that the 
possible toxicity of high doses or purified flavonoids should be taken into consideration 
while dealing with cells in vivo.  
 
6.2. Limitations and future studies 
 
6.2.1. Cell culture 
 
H9c2 cells were not a good type of cell to examine ischemia-reperfusion, as they 
showed resistance to the stress. If a comparison between different polyphenols is needed to 
be made in vitro, primary cells or a cell type more identical to the human heart is preferable. 
 
6.2.2. Ex vivo model 
 
The ex vivo model of heart ischemia-reperfusion has some drawbacks. It is not quite 
comparable to the in vivo conditions of ischemia-reperfusion. In response to a stress, it is not 
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only the harmed organ which challenges the disturbance, but the whole body responds to the 
damage. Antioxidants such as glutathione may be released from other organs especially liver 
to help the heart to survive oxidative stress. This is the fundamental principle for the remote 
ischemia preconditioning, a procedure in which brief ischemia in a remote area could 
precondition an organ against a sustained ischemia (Kanoria et al., 2007). Further, excising 
the heart and mounting it on the Langendorff apparatus damages the heart. Hearts on the 
Langendorff apparatus do not beat for the entire time of the experiment and heart muscles 
contract less strongly. Moreover, we did not perfuse the hearts with blood, which contains 
platelets and leukocytes, two major contributors to the no-reflow phenomenon. Neutrophils 
are also an important source of reactive oxygen species. Whether our treatments show the 
same results in normal hearts in vivo needs to be examined.  
 
6.2.3. Uncertain essence of broccoli sprouts 
 
Feeding broccoli sprouts to rats were the most protective intervention in our ex vivo 
study. However, it is unclear what component in the broccoli sprouts was responsible for the 
benefits. Since the content of glucoraphanin (Fahey et al., 1997) and sulforaphane 
(Nakagawa et al., 2006) is at least 10 times higher in the young rather than mature broccoli 
sprouts, the observed benefits may have resulted from these compounds. To test this, an 
equal amount of sulforaphane could be administered to rats to clarify this obscurity. It is 
noteworthy that the same pattern for the gradual decrease of glucoraphanin during 
development of the plant is not probably the case for the polyphenols, as midmaturity 
spinach has shown higher phenolic compounds than immature and mature spinach 
(Pandjaitan et al., 2005). 
 
6.2.4. High amount of catechins in green tea extract 
 
The green tea extract showed some benefits. However, effective concentrations are not 
achievable by daily drinking tea. To achieve equal amounts of catechins, one should drink 
almost 8.5 cups of green tea or 36 cups of black tea (Khokhar & Magnusdottir, 2002). 
However, lower concentrations of green tea extract may still be helpful. Future studies may 
be directed towards examining catechins in dietary achievable concentrations or testing teas 
rather than the purified extracts. 
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6.2.5. Induction of phase 2 enzymes 
 
Two of the dietary interventions, broccoli sprouts and green tea extract, increased or 
prevented loss of the activities of glutamate cysteine ligase and quinone reductase. Several 
directions can be taken to develop this finding. First, more phase 2 and antioxidant enzymes 
can be tested. Second, green tea extract preserved the activities of the two enzymes in hearts. 
It should be determined whether this preservation is mediated by protecting enzyme activity 
or increasing enzyme expression, and whether lower concentrations of the catechins can also 
exhibit the same effects. Third, broccoli sprouts increased activities of the enzymes in liver. 
It needs to be determined if this increase can be helpful for ischemic-reperfused hearts in 
vivo. Fourth, the result of the heme oxygenase-1 experiment is questionable as the standard 
errors were quite high. Due to technical difficulty, we could not re-examine the experiment, 
but more attempts are needed to confirm or reject the present results.  
 
6.2.6. Toxicity 
 
The toxicity of broccoli sprouts, green tea extract, and saskatoon berries was not 
examined in the current study. The harmlessness of these should be verified before making 
any recommendation to the public.  
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